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Talley, Todd T. Ph.D., August 2001 Chemistry
Isomalathion and Related Compounds as Active Site Probes o f Acetylcholinesterase 
Director: Charles M. Thompson
To examine the interactions o f asymmetric organophosphorus compounds within the 
steric confines o f the acetylcholinesterase (AChE) active site, the synthesis o f  the 
stereoisomers o f  isomalathion [S-( 1,2-dicarboethoxyethyl) O.S-dimethyl 
phosphorodithiolate] was conducted. The methodology used was also adapted for the first 
synthesis o f  the stereoisomers o f  the novel isoparathion thiosuccinate phosphorothiolate 
(ITP) compound [S-( 1,2-dicarboethoxyethyl) (3-methyl (3-(4-nitro-phenyl) 
phosphorothiolate]. The kinetic parameters ku K q, and kp for the inhibition o f  electric eel 
AChE (EEAChE) and soluble recombinant mouse AChE (rMAChE) by the isomalathion 
and ITP stereoisomers were determined. EEAChE demonstrated a 4-fold difference in 
anti-AChE potency between the strongest, SpRc, and weakest, SpSo isomalathion isomers 
and an 8 -fold difference in anti-AChE potency between the strongest ITP stereoisomer, 
RPRc, and the weakest, SpSc. rMAChE demonstrated a 40-fold difference in anti-AChE 
potency between the weakest isomalathion isomer, SpSc, and the most potent, RpRc, and a 
24-fold difference in anti-AChE potency between the strongest ITP stereoisomer, RpRc, 
and the weakest, SpSc, thus demonstrating both stereochemical and species differences in 
the inhibitory profiles o f the two compounds. The rate constants for reactivation, £3 , both 
spontaneous and in the presence o f  the oximes 2-PAM and TMB-4, were determined for 
both enzyme sources inhibited by the stereoisomers of both compounds. Both sources of 
AChE inhibited by isomalathion stereoisomers that were R at phosphorus demonstrated 
both spontaneous and oxime mediated reactivation while inhibition by the isomers that 
were 5  at phosphorus resulted in phosphorylated adducts resistant to reactivation even in 
the presence o f  an oxime suggesting distinct postinhibitory pathways dependent upon the 
stereochemical orientation at phosphorus. This is in contrast with the results obtained 
following inhibition with the ITP stereoisomers where the postinhibitory mechanisms 
appeared to be dependent upon the stereochemical orientation of the asymmetric carbon 
present in the diethylmalonate portion o f the molecule. These observations suggest that 
despite the similarities o f the two compounds their steric and electrostatic differences cause 
them to interact with the AChE active center by distinct mechanisms.
u
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C h a p t e r  I
INTRODUCTION
In the early 19th century, the chemistry o f organophosphorus (OP) compounds was 
launched by Lassaigne’s investigation o f the reaction o f alcohol with phosphoric acid.
Since then, more than 50,000 OP compounds have been synthesized, many o f which have 
demonstrated therapeutic and insecticide utility. Tetraethyl pyrophosphate (TEPP) 1 
(Figure 1.1), a highly potent OP compound, was first synthesized by Clermont in 1854 and 
likely influenced Lange and Krueger's 1932 paper on the synthesis o f  dimethyl- and 
diethyl-phosphorofluoridates and later spawned the modem investigation o f toxic OP 
compounds (Eto 1974).
Many OP compounds possess the potential for insidious use as chemical warfare 
agents (Taylor 1994). Prior to and during World War II, the efforts o f the Schrader's 
(Germany) and Saunders’ (England) research groups were directed toward the development 
o f chemical warfare agents. The synthesis o f the compounds O-isopropyl 
methylphosphonofluoridate (sarin) 2, 1 ,2 ,2 -trimethylpropyl-methylphosphonofluoridate 
(soman) 3, and O-ethyl-M A-dimethyl-cyanophosphate (tabun) 4 were kept secret by the 
German government while the researchers from Allied countries focused their research on 
compounds related to diisopropylphosphorofluoridate (DFP) 5 (Gallo 1991).
1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 1.1. Neurotoxic Organophosphorus Compounds.
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Many o f these compounds have been stockpiled for military use as neurotoxic 
agents or nerve gas (Caglioti 1983). Despite an international ban on the use and production 
o f these compounds, there is evidence that sarin 2 was used by Iraq during its conflict with 
Iran and during the G ulf War (Black 1993). This has led to the suggestion that exposure to 
sarin may be a contributing factor to the so-called Gulf W ar Syndrome (Ember 1996).
Sarin 2 was also used by terrorists in an attack on a Tokyo subway in 1995 which resulted 
in twelve deaths and more than 5,000 injuries (Noort 1998; Satoh 2000)
A far more benign use o f OP compounds has been their development as 
insecticides. Schrader and coworkers demonstrated that several OP compounds exhibited 
contact insecticidal activity. Their work led to the development and subsequent marketing 
o f the first practical insecticide, Bladen, in 1944 (Eto 1974). Since then, thousands o f new 
OP pesticides have been developed. As OP insecticides are generally short-lived in the 
environment, they have replaced the environmentally persistent chlorinated hydrocarbon
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
pesticides such as DDT. The use o f DDT was banned during the 1970’s in the U.S. due to 
the compound’s retention in body tissue and biomagnification (Matolczy 1988).
Pesticide use has significantly increased crop yields by diminishing the populations 
o f  threatening organisms, thus impacting numerous economic considerations. In addition, 
some insecticides have been instrumental in the reduction o f insect-bome diseases such as 
malaria and encephalitis (Caglioti 1983). The United States Environmental Protection 
Agency (EPA) estimates that approximately 60 million pounds of organophosphate 
pesticides are applied to agricultural crops annually and that nonagricultural uses account 
for another 17 million pounds per year in the U.S (EPA 2000). The structures o f some 
common OP insecticides are shown in Figure 1.2.
ii
R°TP- XRO A
Figure 1.2. Common O P Insecticides
CO2C2H5
6 : malathion R = C H 3, X = CO2C2HC
S
S 7: parathion methyl R = CH 3, X =
8 : parathion R = CH3CH2 X =
9: chlorpyrifos R = CH 3CH2 X =
Toxicity and insecticidal activity of OP compounds is mainly attributed to their 
ability to inhibit the enzyme acetylcholinesterase (AChE, choline hydrolase, EC 3.1.1.7) 
(Fukuto 1990). Inhibition o f AChE is caused by the formation of a covalent bond between 
the OP compound and a reactive serine residue present within the active site o f  the enzyme
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
that results in a phosphorylated enzyme intermediate (Aldridge 1952; Wilson I960; Cohen 
1963). The phosphonyl moiety may then react with water or other suitable nucleophiles, 
such as an oxime-reactivating agent, to regenerate an active enzyme. Alternatively, it may 
undergo post-inhibitory reactions resulting in an enzyme that is intractable to reactivation, a 
process referred to as aging (Millard 1999b). In addition to the acute toxicity caused by the 
inhibition of AChE, there is a mounting body o f evidence that suggests chronic low-level 
exposure to OP compounds may play a role in a number o f pathologies (Ragnarsdottir 
2000).
An understanding o f  the pathologies caused by OP poisoning (both acute and 
chronic) necessitates knowledge o f  the chemical mechanism o f  inhibition. It was 
previously thought that all OP's caused toxicity by an similar mechanism (covalent 
modification of AChE active site). However, kinetic and crystallographic studies 
combined with site-specific mutagenesis have demonstrated that the structure, chemical 
reactivity, and stereochemical orientation o f OP compounds can dramatically influence 
their rate and ability to inhibit AChE, and the ability o f AChE to reactivate following 
inhibition (Debord 1986; Fukuto 1990; Harel 1993; Ashani 1995; Hosea 1995, 1996; 
Bourne 1999a; Jianmongkol 1999; Dembele 2000; Doom 2000; Kraut 2000; Lesser 2000; 
Radic 2000). In addition, many commercially available insecticides have been shown to 
contain contaminants that are potentially more toxic than the parent compounds from 
which they are derived (M etcalf 1953; Chukwudebe 1989; Thompson 1989; Monje Argiles 
1990). Commercial OP pesticides, such as malathion 6  (Figure 1.2), are racemic mixtures 
and have been shown to contain OP contaminants that also have centers o f asymmetry'
4
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(Berkman 1993b). In order to fully understand the effectiveness and dangers o f  these 
compounds it is necessary to delineate the stereo-dependent nature of these interactions.
In order to discus these phenomena in a cohesive fashion, the first portion o f this 
thesis is divided into three main sections. In Section 2.1, the enzyme AChE will be 
introduced in greater detail. This will be followed by a discussion of some salient features 
o f OP chemistry in Section 2.2. Finally, this portion of the thesis will conclude with a 
discussion of how OP compounds interact with AChE in Section 2.3.
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C h a p t e r  2
BACKGROUND
2.1.1-AcetvichoIinesterase (AChE) and the Cholinergic System 
Long before the concept o f enzymes had evolved. AChE was an important 
pharmacological target. An alkaloid obtained from the Calabar, or ordeal bean, from the 
perennial plant Physostigma venenosum Balfour found in tropical West Africa contains the 
compound physostigmine. The Calabar bean, also called Esere nut, chop nut, or bean of 
Etu Esere. was once used by native tribes o f West Africa as an "ordeal poison" in trials for 
witchcraft. It was brought to England in 1840 and investigations of its pharmacological 
properties were conducted. Jobst and Hesse isolated the pure alkaloid in 1864.
Observations during the early exploration o f the cholinergic nervous system led to the 
suggestion that physostigmine inhibited the enzyme (AChE) that catalyzed the hydrolysis 
o f  choline esters and eventually established the role o f acetylcholine (ACh) as a labile 
neurotransmitter. The first therapeutic use o f the drug was in 1877 by Laqueur, in the 
treatment o f glaucoma, one o f its clinical uses today (Holmstedt 1972).
In cholinergic presynaptic neurons, ACh is synthesized by the acetylation of 
choline by acetyl coenzyme A (AcCoA). The reaction is catalyzed by choline 
acetyltransferase in the cytoplasm (Parsons 1993) and is followed by the majority o f ACh 
being sequestered within synaptic vesicles. During signal □ubocurarine, a self-propagating 
action potential transverses the neuron and triggers the synchronous release o f  the contents
6
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o f more than 100 vesicles into the synaptic cleft. Single synaptic vesicles are estimated to 
contain from 1000 to over 50,000 ACh molecules each, and it has been calculated that a 
single motor-nerve terminal contains 300,000 or more vesicles (Katz 1965).
After being released into the synaptic cleft, ACh activates cholinergic receptors 
positioned on extracellular membranes o f  the presynaptic and postsynaptic neurons and on 
proximal glia (Aschner 2000). There are two major types o f  cholinergic receptors that have 
been classified as either nicotinic or muscarinic depending on their differential response to 
the plant alkaloids from Nicotiana tabacum  (nicotine) and Amanita muscaria (muscarine), 
respectively. Evidence that tubocurarine inhibited nicotinic and atropine inhibited 
muscarinic effects o f  ACh provided further support for the proposal o f  two distinct types o f 
cholinergic receptors. Nicotinic receptors are ligand-gated ion channels. Their activation 
causes a rapid (millisecond) increase in cellular permeability to Na~ and Ca2\  
depolarization, and excitation. Muscarinic receptors belong to the G protein-coupled class 
o f receptors and act by facilitating the binding o f GTP to specific G proteins. GTP binding 
activates the G protein, which then regulates the activity o f specific effectors. These second 
messengers include enzymes such as adenylyl cyclase and phospholipases A-,, C, and D; 
channels that are specific for C a-_, K~, or Na~; and certain transport proteins. Muscarinic 
receptors contrast with nicotinic receptors in that responses to muscarinic agonists are 
slower and may be either excitatory or inhibitory. Also, these responses are not necessarily 
linked to changes in ion permeability.
7
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Figure 2.1. The Cholinergic System.
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2.1.2-AChE Hydrolysis o f  Acetylcholine
The primary biological role of AChE is the rapid termination o f the neuronal 
impulse that occurs when ACh is released into the synaptic cleft. Following the production 
o f an end-plate potential at the motor end plates o f skeletal muscle or the polarization o f the 
postsynaptic neurons, AChE removes ACh from the synaptic cleft by catalyzing its 
hydrolysis to acetate and choline (Ch) (Figure 2.2). In order to avoid hyperpolarization, 
which results in desensitization and/or cell death, ACh must be removed from the synaptic 
cleft almost immediately. Removal is accomplished by strategic localization o f AChE in 
presynaptic and postsynaptic membranes and in the basal lamina in the neuromuscular 
junction. AChE has one o f the highest rate constants known (A'cat = 1.6 x 104 s"1) and 
A'cat/ATi - 2 x 108 (Rosenberry 1975; Quinn 1987), implying a rate close to the limit o f  
diffusion controlled reactions.
A number o f studies have demonstrated that the probable mechanism for AChE 
catalyzed hydrolysis o f  ACh is as represented in Scheme 2.1. A peripheral anionic site 
near the surface of the enzyme facilitates initial association and alignment o f ACh 
(Szegletes 1999). ACh is propelled toward the active site o f the enzyme by electrostatic 
interactions between the negative charge o f an anionic site, or choline binding subsite 
(Trp86), and the positive charge on the ACh nitrogen (E + S) resulting in an enzyme-
Figure 2.2. Acetylcholine Hydrolysis.
AChE
acetylcholine acetic acid choline
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substrate complex (ES). There is also evidence that AChE posses a permanent dipole 
moment that assists with this orientation and docking o f positively charged substrates 
(Porschke 1996). Acetylation o f the serine hydroxyl (-OH. Ser203) within the esteratic site 
is catalyzed by the basic imidazole moiety B (His447) and the acidic moiety AH (tyrosine 
hydroxyl), which leads to the acetylated enzyme EA. Free enzyme E is then regenerated by 
a deacetylation step that occurs within milliseconds.
AChE hydrolysis o f  ACh demonstrates the hallmark elements o f  an acid-base 
catalyzed reaction, including both the acetylation and deacetylation reactions. While the 
reaction steps outlined in Scheme 2.1 provide a simplistic representation o f  the AChE 
active site and demonstrate a reasonable mechanism for the hydrolysis o f  ACh, it must be 
emphasized that the enzyme is a highly complex and dynamic protein. Consequently, in 
addition to the regions described above, there are a number o f peripheral sites and 
hydrophobic/hydrophilic regions that may be involved in allosteric modulation o f the 
enzyme’s activity and in protein-protein interactions (Shafferman 1992).
10
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Scheme 2.1. The Mechanism of Acetylcholine Hydrolysis by Acetylcholinesterase.
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2.1 .3-Inhibition o f  AChE 
Many substances, including a number OP compounds, have demonstrated varying 
degrees of anti-AChE potential. When inhibited, the enzyme is unable to hydrolyze ACh 
resulting in the rapid accumulation o f  the neurotransmitter in neuromuscular junctions and 
nerve synapses. The build-up o f  ACh leads to hyperpolarization o f the postsynaptic 
neuron, which may eventually result in cell death. The in vivo manifestations range from 
mild confusion to convulsions, coma, and death (Sultatos 1994). The chemically altered 
enzymes may also possess the ability to elicit an autoimmune response with potentially 
deleterious consequences (Rosenberg 1999). The inhibition o f  AChE by OP compounds 
defines a central concept o f this thesis and will be discussed in greater detail in the 
following sections.
2 .1 .4-Structural Features o f AChE 
The three-dimensional structure o f acetylcholinesterase demonstrates three 
functional regions o f the enzyme (Sussman 1991; Bourne 1995; Bourne 1999b). The 
catalytic triad is nearly centrosymmetric to each subunit and resides at the base of a narrow 
gorge. The gorge is approximately 20 A in depth and is lined with 14 highly conserved 
aromatic residues (Koellner 2000), which may contribute up to 60% o f its surface (Axelsen 
1994). The residues of the catalytic triad, Ser203, His447, and Glu334, are at the base of 
the gorge. The catalytic mechanism resembles that o f other hydrolases, where the serine 
hydroxyl group is rendered highly nucleophilic through a charge-relay system involving the 
glutamate carboxyl group, the imidazole on the histidine, and the hydroxyl of the serine. 
Adjacent to this region is an oxyanion hole formed by the main chain N-H functions of
12
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G ly l2 l, G lyl22, and Ala204. Residues Glyl22, Trp233, Phe295, Phe297 and Phe338 
form the acyl pocket responsible for AChE’s acetyl ester specificity (Harel 1995; 1996).
The peripheral anionic site, located near the gorge opening and defined by Trp286, Tyr72, 
and Tyrl24, has been demonstrated to be involved in catching and guiding substrate 
molecules into the active site, and likely gives rise to allosteric modulation o f the enzymes 
activity (Zhou 1998; Botti 1999; Golicnik 2001). A point o f  constriction, formed mainly 
by the side chains o f  Tyrl21 and Phe330. separates the upper and lower parts o f the gorge 
(Koellner 2000). As the cross-section of ACh is much larger than the narrowest part o f  the 
gorge, large-amplitude fluctuations o f at least part o f  the gorge wall are necessary to allow 
substrate to enter. Such fluctuations are actually seen in molecular dynamics simulations o f 
tacrinz-torpedo californica AChE (TcAChE) complex (Wlodek 1997; 2000).
13
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Figure 2.3. Crystal Structure of AChE.
Zoran Radic http://phrtaylO.ucsd.eda/zoran/ 
AChE has been isolated from a wide variety o f  animals (Fukuto 1990; Sultatos
1994) including insects, fish, reptiles, birds, and mammals and belongs to a large family o f 
proteins that demonstrate a common folding motif, termed the a/(3 hydrolase fold (Ollis 
1992). This gene family o f serine hydrolases contains such exquisite diversity that 
members such as thyroglobulin (Swiilens 1986a; 1986b) and the tactins, glutactin, 
electrotactin, and neurotactin (de la Escalera 1990; Olson 1990; Botti 1998), are typified by 
their non-hydrolase functions while maintaining the common structural matrix (Taylor
14
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1994). Members o f this family from mammalian sources include butyrylcholinesterase 
(Lockridge 1987), cholesterol esterase (Kyger 1989), lysophospholipase (Han 1987), and 
the microsomal carboxyl esterases (Korza 1988; Long 1988).
Analysis o f  the three-dimensional structure and residues necessary for catalytic 
activity divide the serine hydrolases into subgroups. Members of the subgroup that 
includes AChE, contain a catalytic triad similar to the one described prior for AChE. This 
arrangement is essentially the mirror image o f that found in serine proteases, such as 
trypsin and chymotrypsin (Sussman 1991). As with serine proteases, esterases o f the a/p- 
hydrolase fold, including AChE, are susceptible to inhibition by OP compounds. The 
His440 is conserved by all members o f the family and serves as a reference position 
(Taylor 1994). Several members of the family, including all o f  the cholinesterases, contain 
three conserved disulfide loops.
Amino acid sequencing and molecular cloning have demonstrated that a single gene 
encodes acetylcholinesterase. Alternate processing o f the mRNA leads to the formation of 
multiple products (Schumacher 1986; Gibney 1988). AChE exists in two general classes of 
molecular forms, heteromeric associations o f catalytic subunits with structural subunits and 
simple homomeric oligomers o f catalytic subunits {i.e., monomers, dimers, and tetramers). 
One heterologous form is a tetramer o f catalytic subunits disulfide-linked to a lipid-linked 
subunit and is found on the outer surface o f the membrane. The other consists o f  tetramers 
o f catalytic subunits, disulfide linked to each of three strands o f a collagen-like structural 
subunit. The homomeric forms are found as soluble species in the cell, presumably for 
export, or associated with the outer membrane o f the cell through either an intrinsic
15
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hydrophobic amino acid sequence or an attached glycophospholipid (Massoulie 1993: 
Taylor 1994; Bourne 1999b).
2-1.5-Non-catalvtic Properties of AChE 
Certain brain regions contain large amounts o f AChE, but lack acetylcholine and 
the biosynthetic capacity to generate it. This disparity in localization combined with the 
significant amount of AChE that is secreted into the extracellular space implies that AChE 
may have signaling functions that are independent o f  its function in ACh catalysis (Small 
1996; Bourne 1999b). AChE has been shown to play an important role during both pre- 
and postnatal development in animal studies (Dembele 2000; Eriksson 2000; Lesser 2000: 
Xie 2000; Fordham 2001). It has been demonstrated that the level o f  ACh regulates 
expression of both nicotinic and muscarinic receptors (Schwartz 1983; Aronstam 1987; 
Buccafiisco 1987; Buccafiisco 1991) thus AChE plays a modulatory role in learning, 
memory, and behavior (Greenfield 1984; Terry 1993; Prendergast 1997, 1998; Cummings 
2000). Further, AChE and ACh have been described as being involved in the modulation 
of cell movement and proliferation during development (Lauder 1999). AChE is 
transiently expressed during discrete periods o f neural development o f the thalamocortical 
pathways. Transient AChE activity is correlated with the specific growth o f  thalamic 
axons into the cortex and synaptogenesis with cortical neurons (Robertson 1993).
Recently, it has been shown that there are significant sequence similarities between AChE 
and cell adhesion proteins that function during morphogenic events. AChE has been 
shown to play a specific morphogenic role during neurite outgrowth (Dupree 1994; 1995;
16
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Bigbee 1999; 2000; Sharma 2001) and this neuritogenic ability o f  AChE has been shown to 
be independent o f its traditional catalytic role (Layer 1995a; 1995b; Stemfeld 1998).
These non-catalytic properties o f  AChE may play a role in some neuropathologies. 
Alzheimer’s disease (AD) is a complex and multifaceted neurodegenerative disease 
affecting aged populations. The pathogenesis and the etiology are not well defined, 
although a “cholinergic deficit hypothesis” has been suggested (Perry 1986). One o f the 
most specific and consistent features is an early and severe degeneration of the forebrain 
cholinergic system, as demonstrated by the correlation observed between the cholinergic 
pathology and dementia (Geula 1994). There is a colocaiization o f AChE with amyloid (3- 
peptide in the brain o f AD patients that indicates a presence, if  not an active role, in 
amyloid plaque formation (Bertoni-Freddari 1990; Ulrich 1990a; 1990b; Carson 1991; 
Moran 1993; Geula 1994). It has also been demonstrated that AChE accelerates the 
assembly o f amyloid (3-peptides into Alzheimer’s fibrils (Alvarez 1997; Reyes 1997; 
Alvarez 1998; Inestrosa 1998).
Structure and sequence comparisons between recombinant mouse AChE 
(rMAChE) and amyloid (3-peptide reveal a conserved helix-loop-helix motif (Sticht 1995; 
Bourne 1999b). This region o f monomeric rMAChE interacts with the peripheral anionic 
site o f  other rMAChE monomers to assist in the aggregation o f  the enzyme’s tetrameric 
form (Bourne 1999b). This information, combined with the colocalization o f AChE with 
amyloid (3-peptide deposits has led to the hypothesis that the helix-loop-helix domain o f the 
amyloid (3-peptide may interact in a similar fashion with the peripheral anionic site o f 
AChE, that could then serve as a  nucleation site to promote aggregation (Bourne 1999b).
17
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Furthermore, in the amyloid [3-peptides and prion proteins, an a-helix to P-sheet 
conversion has been proposed to accompany aggregation (Soto 1995). Sequence analysis 
has demonstrated that Glnl5-Gly37 region o f  the amyloid protein is very similar to the 
M etl20-Glyl42 portion o f  the prion protein (Sticht 1995). This region has been suggested 
to undergo a-helix to P-sheet transition during pathogenic states (Beyreuther 1994;
Kocisko 1994; Nguyen 1995). That these regions share structural and sequence similarities 
with the helix-loop-helix domain of AChE is quite intriguing.
The enhancement o f cholinergic transmission in AD is a major goal for potential 
therapeutic agents such as Tacrine (COGNEX). AChE has long been an attractive target 
for the rational design o f  mechanism-based inhibitors because of the pivotal role it plays in 
the central nervous system (Trabace 2000a; 2000b). Current AD therapies focus upon 
central inhibition o f  AChE, which enhances the function o f central cholinergic neurons by 
permitting ACh to remain in the synaptic cleft longer. The resulting increase in 
extracellular ACh concentrations may reverse central cholinergic hypofunction and 
improve cognitive functions in AD (Kelly 1999). Most drugs currently used 
therapeutically have been shown to improve AD symptomatically, but it is controversial 
whether there is an effect on the disease progression (Giacobini 1998b; 2000a). The 
clinical usefulness o f  AChE inhibitors in the treatment o f AD has been limited by either an 
extremely short or an excessively long half-life, hepatic toxicity, and severe peripheral 
cholinergic side effects (Kelly 1999; Giacobini 2000).
18
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2.2-1-Organophosphorus Compounds 
In order to discuss OP insecticides in detail, a brief review o f nomenclature, 
structure, and chemical reactivity is necessary. Systematic analysis o f  the relationships 
between the structure o f OP compounds and their ability to inhibit AChE have 
demonstrated chemical reactivity to be the single most important property in dictating anti- 
AChE potency, i.e., the phosphorus ester must be reactive enough to phosphorylate the 
hydroxyl moiety of the active center serine (Fukuto 1990). The rate and extent o f the 
AChE inhibition depends upon the nature o f the OP structure, which influences 
phosphorylation through the electronic environment around the phosphorus. OP 
insecticides are esters o f  pentavalent phosphorus acids and typically belong to the 
phosphorothionate (P=S) class o f compounds. General structures of several OP insecticide 
compound types are shown in Figure 2.4. It is a requirement for anti-AChE activity that 
one o f the ligands attached to the phosphorus atom be a good leaving group. This aspect o f 
OP reactivity and its relationship to biologically activity is o f pivotal importance and wall 
be discussed in greater detail in the following sections.
19
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Figure 2.4. General Structure of OP Compounds
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Rates o f alkaline hydrolysis for a series o f compounds that included diethyl p- 
nitrophenyl phosphate (paraoxon, 10) and some o f its substituted phenyl analogs were 
found to parallel their bimolecular rate constants for inhibition (kt) o f  erythrocyte AChE via 
pseudo first order kinetics (Aldridge 1952). A subsequent study using a larger series o f 
diethyl phenylphosphates demonstrated that the rate o f inhibition o f fly-head AChE by 
paraoxon analogs was dependent upon the effect o f  phenyl substituents (Fukuto 1956).
The authors demonstrated a linear relationship for the anti-AChE potency o f  the 
compounds vs their Hammett’s sigma constants, hydrolysis rates, and P-O-phenyl infrared 
stretching frequencies. The data indicated that activity was directly related to the electron- 
withdrawing properties o f  the respective substituents. Compounds with strongly electron- 
withdrawing substituents demonstrated enhanced reactivity toward AChE, and compounds 
with weakly electron-withdrawing or electron-donating substituents were poor inhibitors or 
were devoid of activity. For example, the concentration of paraoxon 10 needed to affect 
50% inhibition o f AChE was 10,000-fold less than dimethyl-p-methylphenylphosphate.
20
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These trends are due to the ability o f  strongly electron-withdrawing substituents to attract 
electrons away from the phosphorus atom. The resulting electron-deficient center is more 
susceptible to nucleophilic attack by the serine hydroxyl moiety o f the enzyme.
Figure 2.5. Parathion, Paraoxon, and Isoparathion
EtO1'
EtO
O•L
CT
8 : parathion 10 : paraoxon 11: isoparathion
The chemical reactivity o f an OP compound also depends on the ;t-atom linkage 
and the cr-ligand connectivity. When comparing phosphorothiolate esters (P-S-R) with 
their phosphate analogues, it is apparent that phosphorothiolates are more chemically 
reactive. Paraoxon 10, with a P-O-R linkage, undergoes hydrolysis nearly 500 times 
slower than its phosphorothiolate analog, isoparathion 11, which contains a P-S-R linkage 
(Heath 1961). The greater polarizability imparted by the sulfur atom and the decreased pTr- 
drr contribution to the P-S bond due to less efficient orbital overlap is at least partially 
responsible for the difference in reactivity (Eto 1974). In the 7r-bond case, oxygen is more 
electronegative than sulfur and, consequently, P = 0  bonds are more polarized than P=S 
bonds. Greater polarization imparts greater electrophilicity to the phosphorus atom thus 
increasing its susceptibility to hydrolysis and nucleophilic attack (Van Wazer 1958; Fest 
1973; Matolczy 1988). An example o f  this feature is demonstrated by comparing the
21
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hydrolytic Un. values for parathion 8 (203,000 h) and paraoxon 10 (22,200 h), a difference 
o f approximately 10-fold (O'Brien 1967).
2.2.2-Thiono-Thiolo Rearrangement 
Dialkyl phosphorothionate compounds are prone to undergo thiono-thiolo 
rearrangements. Isomerization can be induced by thermal, chemical, and to a lesser extent, 
photochemical means (Chukwudebe 1989).
Figure 2.6. Thiono-Thiolo Rearrangement
s  oIi II
r i ° ^ / S dR2 RiS"/P^OR2
R-iO RiO
phosphorothionate phosphorothiolate
The rearrangement can be promoted by reaction o f a phosphorothionate with an alkyl 
iodide to form the S-alkyl isomer by first alkylating the thionate followed by dealkylation. 
Bimolecular or self- isomerization occurs at elevated temperatures (80-180 °C) when one 
phosphorothionate is dealkylated to form an ambient ion pair that realkylates at the more 
nucleophilic sulfur atom (Fest 1973; Eto 1974). Isomerization may also occur at room 
temperature over long periods of time when phosphorothionates are stored in polar atrophic 
solvents and is fastest when the alkyl group transferred is a methyl (Eto 1974; Matolczy 
1988). These reactions are summarized in Figure 2.7.
22
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Figure 2.7. Alkyl Iodide Catalyzed- and Self-Isomerization of the Thiono-Thiolo
Rearrangement.
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This type o f transformation can have very deleterious results when it occurs during 
the manufacture and storage o f phosphorothionate insecticides. The resulting 
phosphorothionate compounds are considerably more toxic than the original 
phosphorothionate compounds due, in part, to the increased chemical reactivity o f the P=0 
moiety relative to that o f  P=S. In formulations of the commercially available pesticide 
malathion 6, as much as 10% o f the resultant isomalathion contamination has been found. 
It has been shown that approximately 90% o f malathion 6 is isomerized to isomalathion 12 
at 150 °C (Figure 2.8). In the same study, parathion 8 and parathion methyl 7 were 
isomerized to the S-ethyl or S-methyl thiolate in 80% and 90% yield, respectively, under 
the same conditions (M etcalf 1953).
Figure 2.8. Isomerization of Malathion to Isomalathion.
S C 0 2Et O C 0 2Et
CH30 ^ P'-s ^ O C°2 Et --------------------^  CH3S^/P'-s - ^ 0 C°2 Et
c h 3o  1SU °  c h 3o
6 : malathion 12: isomalathion
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2.2.3-OP Structure-Reactivitv Relationships 
Other factors affecting the anti-AChE potential o f  OP esters are the steric properties 
o f  the individual compounds. The importance of steric influences becomes apparent when 
comparing a series o f  ethyl p-nitrophenyl alkylphosphonates where the alkyl group 
substituent was correlated with their alkaline hydrolysis rates and anti-AChE potency 
(Fukuto 1958). In general, the rates o f hydrolysis decreased with increasing chain length 
and/or chain branching. While this trend was typically mirrored by a decrease in the 
compounds reactivity' toward AChE, a close examination o f the data revealed that as chain 
length increased from three to six carbons the inhibitory ability o f the compounds 
decreased dramatically. Hansch and Deutsch (1966) later verified these observations by 
demonstrating the anti-AChE activities o f the compounds correlated with the Taft’s steric 
substitution constant Es. It has also been shown that the rate of inhibition decreases with 
increasing bulkiness o f  the ligands that remain attached following inhibition of AChE, i.e., 
compounds that contain methoxy groups react with AChE fastest, followed by compounds 
containing ethoxy, n-propoxy, and isopropoxy ligands (Gallo 1991).
2.2-4-Stereochemical Aspects o f OP Compounds 
Many OP compounds are pentavalent at phosphorus and are asymmetric if  the 
ligands attached to the s/?3-tetracoordinated phosphorus atom are non-equivalent. The 
ligands attached to the phosphorus may also possess centers of asymmetry, thus dictating 
the possibility o f three basic types o f stereogenic OP compounds: those that contain 
phosphorus stereogenicity, those with carbon stereogenicity, and those with both carbon 
and phosphorus stereogenicity. Examples o f these three types o f asymmetric OP
24
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compounds are given in Figure 2.9. This steric subtlety has been demonstrated to have 
direct consequences on the interactions o f AChE with a number of OP compounds and will 
be discussed in greater detail in subsequent sections.
Figure 2.9. Three Basic Types o f  OP Stereogenicity.
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2.2.5-Metabolic Activation o f  OP Insecticides
Many common insecticides contain a P=S m oiety despite the fact that 
phosphorothionate esters typically exhibit very poor anti-AChE activity. The comparative 
lack o f inhibitory potency demonstrated by P=S esters is explained primarily in terms of 
their reduced chemical reactivity due to the decreased polarization of a P=S bond compared 
to a P= 0 bond. Compounds that contain P=S esters still maintain insecticidal efficacy 
despite their apparent lack of anti-AChE activity, and this implies some form o f metabolic 
activation for the compounds.
It has been demonstrated that the toxicity o f phosphorothionate insecticides is due 
primarily to metabolic oxidation of the P=S moiety to its corresponding P = 0  form. This 
metabolic activation o f phosphorothionate insecticides is mediated, in part at least, by the 
mixed function oxidases (MFO), including several members o f the cytochrome P-450 
family of enzymes (Hajjar 1982; Hodgson 1982; Levi 1985, 1988). These proteins 
represent a ubiquitous system of enzymes that are responsible for the oxidation o f foreign
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compounds in animals. A classical example of this oxidation o f a phosphorothionate to its 
corresponding oxon is found in the conversion o f parathion 8 , which is essentially devoid 
o f anti-AChE activity, to paraoxon 10, an OP compound that demonstrates comparatively 
high inhibitory potency (Fukuto 1990).
2.2.6-Metabolic Degradation o f  OP Insecticides 
OP insecticides are tertiary esters and as such they are susceptible to hydrolytic 
degradation. Enzymatic or chemical hydrolysis o f any ester bond attached to the 
phosphorus generally leads to a non-toxic product (Eto 1974). Enzymatic hydrolysis is 
mediated by a number o f different esterases that are typically referred to as hydrolases or 
phosphotriester hydrolases (Fukuto 1990). Metabolic degradation may also take place at a 
site on the molecule that is distant from the phosphorus center. An example o f this is the 
carboxylesterase-catalyzed hydrolysis o f  malathion 6 to its nontoxic carboxylic acid 
derivatives, malathion a -  and p-monoacid (14 and 15) and malathion diacid 16. 
Alternatively, the S-C bond of malathion may be cleaved to form O, O- 
dimethyldithiophosphate (DMDTP) 17 which can then undergo further oxidation to form 
O, O-dimethylthiophosphate (DMTP) 18. DMTP is also the primary hydrolytic metabolite 
o f  malaoxon 13 the toxic product o f  metabolic oxidation o f  malathion. In turn, DMTP can 
be oxidized to form O, O-dimethylphosphate (DMP) 17. These reactions are summarized 
in Figure 2.10.
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Figure 2.10. Metabolic Activation and Degradation o f Malathion.
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2.2.7-Malathion and Isomalathion 
Malathion 6, when pure, is relatively nontoxic to mammals (see Table 2.1).
Because the rate o f  metabolic degradation o f  malathion to the nontoxic compounds (Figure 
2.10) is faster than the rate o f metabolic oxidation o f  the P=S in malathion 6 to the P = 0  of 
malaoxon 13. Insects, however, possess comparatively lower concentrations o f the
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enzymes responsible for detoxication. Consequently, insects are much more susceptible to 
the toxic effects o f  malathion 6.
Table 2.1. Relative Toxicity o f Biologically Active Compounds.
Compound LD5o mg/kg (oral, rats)
Glucose 35,000
Ethanol 10,000
Aspirin 3.750
NaCl 3,500
Malathion 3.000
Valium 710
Diazinon 400
Caffeine 300
Nicotine 230
DDT 120
Malaoxon 90
Cocaine 17
Strychnine 5
Paraoxon 2
Malathion 6 has been employed to manage the medfly problem in California 
(Barinaga 1991) and in Florida (1996-1997). Malathion 6 also has been established in 
veterinary medicine (Osweiler 1984), and in public health practices as an anti-infective 
agent (Wester, 1989) to control insect vector-borne diseases such as malaria (anopheles 
mosquito), dengue (aedes aegvpti), yellow fever {aed.es) (Caglioti 1983), and West Nile 
virus in New York. However, as one of the class o f phosphorothionate insecticides it is 
prone to thermal and photochemical induced isomerization (Section 2.2.2) to form toxic 
impurities including trimethyl phosphorothioates and isomalathion 12 which have been 
shown to potentiate or enhance the toxicity o f  malathion formulations (Aldridge 1979;
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Mallipudi 1980; Toia 1980; Lin 1984). Therefore, the safety o f malathion usage is linked 
to its purity and storage.
Isomalathion 12 is the 5-methyl isomeride o f malathion 6 found in commercial 
formulations o f the insecticide and is formed as a result o f  a thiono-thiolo rearrangement. 
Like most S-alkyl isomerides o f pnosphorothionate insecticides, isomalathion shows 
dramatically enhanced anti-AChE potency relative to malathion due to the enhanced 
chemical reactivity o f  the P=0 bond, and the decreased pri-dTi contribution o f the S-alkyl 
ligands (Fest 1973; Thompson 1989). Consequently, racemic isomalathion is a 3000-fold 
more potent anti-AChE agent than malathion (Thompson 1989).
Isomalathion 12 has been shovm to be not only an inhibitor o f  AChE but also an 
inhibitor of the mammalian detoxifying enzyme, carboxylesterase (Talcott 1979; Toia 
1980; Lin 1984; Ryan 1985). When carboxylesterase is inactivated, the normal side chain 
ester hydrolysis detoxification pathway is removed (2.2.6), and metabolic activation from 
malathion 6 to malaoxon 13 dominates the metabolism causing the latent toxicity (anti- 
AChE potency) to be observed in mammals (Cohen 1984; De Matteis 1989).
O f all the impurities found in malathion formulations, isomalathion 12 is the 
strongest potentiator o f  toxicity. A 0.5% isomalathion contamination of malathion 
formulations reduced the LD50 from 12,500 to 4400 mg/kg (Umetsu 1977; Toia 1980). The 
isomalathion content in malathion formulations, therefore, has been a matter o f 
considerable concern, especially since the 1976 epidemic malathion poisoning in Pakistan. 
2800 Pakistani pesticide applicators were acutely poisoned while 5 died during a malaria 
control program (Baker 1978; Iyer 1984). The poisonings were attributed to the unusually 
high isomalathion content of the formulation employed (Aldridge 1979; Iyer 1984).
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A structurally significant feature o f malathion 6 is the presence o f  a center o f 
asymmetry at the succinate carbon. While the chiral integrity at the carbon is maintained in 
the formation o f the S-methyl isomer, a new chiral center is generated at the phosphorous 
providing four total stereoisomers o f  isomalathion (Figure 2.11). It has been shown in 
several cases that differing sources o f  AChE may be stereoselectively inhibited by chiral 
OP isomers (Ooms 1965: Wustner 1973: Eya 1985; Armstrong 1987). A most striking 
case was reported by Jarv in which there was a 4200-fold difference in the inhibition rate of 
AChE between the enantiomers o f isopropyl- methylphosphonofluoridate (Jarv 1984). In 
the case o f isomalathion the relationship between AChE inhibition and asymmetry at both 
carbon and phosphorous was investigated (Berkman 1993a; 1993b: 1994).
Figure 2.11. Stereoisomers of Isomalathion.
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2.2.8-Pesticide Utility 
There are estimates that pests destroy nearly half o f  all agricultural produce during 
production and storage (Perutz 1991). Prior to harvest, grain losses in developing countries 
o f the Near East are reported to be approximately 23% with the largest losses in the
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production o f cereal crops, especially rice (Hayes 1991). It is believed that nearly one third 
of all potential crop, livestock, and timber yields are lost to insects or other pests (Caglioti 
1983).
Approximately 3 billion pounds o f pesticides are produced in the U.S. annually, 
one-third o f which are insecticides. U.S. consumers purchased roughly 25% o f all 
insecticides resulting in annual sales o f  nearly $900 million (Welling 1988). National and 
international agricultural organizations estimate that as much as 45 percent o f the world's 
crops continue to be lost to insects and other pests. In the United States alone, about $20 
billion worth of crops (one-tenth o f  production) are lost each year. It has been estimated 
that without the use o f pesticides, the price for fruits and vegetables would increase 50 to 
100% in first world countries (Schuhmann 1976). Some have suggested that the increase in 
cost would result in drastic changes o f  both diet and personal disposable income that may 
result in thousands o f premature fatalities (Gray 2000). In addition, some insecticides have 
been instrumental in the reduction o f  insect-bome diseases such as malaria and encephalitis 
(Caglioti 1983). Such factors have contributed to the continued use of pesticides despite 
their potential dangers as neurotoxic agents.
2.2.9-Risks Associated with OP Insecticides 
The World Health Organization estimates that approximately 3 million acute 
pesticide poisonings occur annually leading to approximately 250,000 fatalities, o f  which 
99% occur in developing countries. In Sri Lanka nearly 13,000 people are admitted 
annually to hospitals for pesticide poisonings that result in approximately 1000 fatalities. 
Provincial hospitals in Thailand reported that OP poisoning alone was the eighth most
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common illness requiring hospitalization in 1995 (Satoh 2000). This is in stark contrast 
with the United States. O f the more than 2 million human poisonings reported in 1996 only 
4% were associated with pesticide exposure and only 20 cases, 4 of which were suicide, 
resulted in death (Lockridge 2000).
The risk o f pesticide overexposure is greatest for those who are directly involved in 
their application including mixing concentrates and loading aircraft for aerial pesticide 
application (Bames 1976). EPA guidelines for protecting U.S. agricultural workers from 
pesticide exposure include the use o f protective clothing. In 1974 protective clothing was 
documented as ‘'at least a hat or other suitable head covering, a long sleeve shirt and long 
legged trousers or a coverall type garment, shoes and socks”. Revision o f  these 
recommendations by the EPA and USDA include a liquid-proof raincoat or apron, trousers 
outside o f  boots, unlined neoprene gloves, wide brimmed waterproof hats, unlined 
neoprene boots, and goggles or face shields (Stone 1988). Unfortunately, recent studies 
have demonstrated protective clothing may actually serve as a toxin delivery device by 
sequestering the toxic compounds in close proximity to the skin (Wester 2000) and that 
dermal exposure is a major route o f intoxication (Krieger 2000). Other steps have also 
been taken to prevent the occurrence o f  acute poisoning such as medical monitoring of 
agricultural workers (Ames 1989). However, the efficacy o f these measures has recently 
been questioned (Bames 1999; Ohayo-Mitoko 2000).
While these protective measures may have reduced the number o f  acute pesticide 
intoxications among U.S. agricultural workers, considerable risk remains for those in 
developing countries. An estimated 40,000 farm workers o f third world countries die each 
year from pesticide poisoning. Many o f  these poisonings result from “lack o f knowledge,
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unsafe attitudes, and dangerous practices” (Forget 1991). Often workers are poisoned 
because either they are unable to read, understand, or implement safety instructions, or the 
instructions themselves are inadequate (Perutz 1991). Inferior technology available to 
small farmers such as ^faulty sprayers, lack o f protective equipment adapted for tropical 
conditions, and non-existent first aid provisions” combined with an overall lack o f  
information are perhaps the most important factors contributing to pesticide poisonings in 
developing countries (Forget 1991).
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2.3.1 -Inhibition of AChE by OP Compounds 
The acyl pocket o f  the active center, the choline subsite o f the active center, and the 
peripheral anionic site o f  AChE constitute three distinct binding domains for inhibitory 
ligands and form the basis for specificity differences between AChE and BChE (Taylor
1994). Reversible inhibitors, such as propidium and the peptide toxin fasciculin, bind to 
the peripheral anionic site on AChE (Bourne 1995; Radic 1999). Edrophonium and tacrine 
bind to the choline subsite in the vicinity o f  Trp8 6  and Glu202 (Harel 1993). AChE 
inhibitors that have a carbamoyl ester linkage, such as physostigmine and neostigmine, are 
hydrolyzed by AChE. but much more slowly than ACh. At physiological pH both the 
quaternary amine, neostigmine, and the tertiary amine, physostigmine, exist as cations. By 
serving as alternate substrates with a binding orientation similar to acetylcholine, attack by 
the active center serine yields the carbamoylated enzyme. In contrast to the acetyl enzyme, 
methylcarbamoyl AChE or dimethylcarbamoyl AChE is very stable with r, 2  for hydrolysis 
o f  the dimethylcarbamoyl enzyme o f 15 to 30 minutes. Sequestration o f the enzyme in its 
carbamoylated form inhibits the enzyme-catalyzed hydrolysis o f ACh for extended periods 
o f time, 3 to 4 hours in vivo (Taylor 1996).
OP esters inhibit AChE by a process analogous to that of the carbamates. 
Specifically, inhibition is caused by a chemical reaction between the phosphorous 
containing moiety o f the OP compound and the hydroxyl functionality o f the serine residue 
within the active site o f AChE, resulting in a phosphorylated enzyme. Unlike the 
intermediates formed by carbamoylation o f the enzyme’s active site, phosphorylated 
enzymes are highly stable and resistant to hydrolysis. The authors of one study 
demonstrated that it took several weeks for brain AChE activity to return to normal after
34
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
exposure to the neurotoxic OP compound diisopropyl phosphorofluoridate (DFP) (Sung 
1987).
OP's inactivate AChE by phosphorylation o f the active site serine hydroxyl where 
one ligand (X) about phosphorus is displaced (Scheme 2.2). The resulting covalently 
modified enzyme is essentially without catalytic activity. The first step in the inactivation 
o f AChE involves the reversible formation of an enzyme-inhibitor complex and is 
represented by the dissociation constant, KD (Main 1964). Kd is generally considered a 
measure o f the OP-inhibitor's affinity for the enzyme's active site (Fukuto 1990). The 
second step o f inhibition results in the irreversible phosphorylation o f  AChE by an OP 
inhibitor. Covalent modification o f the serine hydroxyl o f the enzyme is responsible for the 
ultimate loss in the enzyme's activity (i.e. the inability to hydrolyze ACh). The 
phosphorylation rate constant, kp, is considered a quantification of the reactivity o f  the OP 
inhibitor or the enzyme-inhibitor complex (Main 1964: Fukuto 1990).
Scheme 2.2. Inhibition of Acetylcholinesterase by an OP Compound.
H-O H-'
k ,[ENZ*OP-X] ENZ-OP + X’ (1)ENZ + OP-X
 1
k \
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A more useful parameter that describes the overall rate o f  inhibition is the 
bimolecular reaction (or rate) constant, k,-. This parameter is a function o f  both K d and kp 
(kj = kp/KD) and is a measure o f the potency o f  an OP inhibitor. The bimolecular inhibition 
reaction constant, k,- (as well as K&) for OP's are determined experimentally by the 
following equation:
where [/] is the concentration o f  the OP inhibitor, At is the time that the AChE is reacted 
with the inhibitor, v is the activity or velocity o f substrate breakdown by AChE, and k  = 
kp/K0. Typically !/[/] is plotted vs. A//Alnv or 1/Alnv and k-, is the slope o f  the resultant line 
(Main 1964).
Inhibitory potencies (k)  can also be determined experimentally by the use o f the 
following equation:
where the time dependent loss o f  enzyme activity is monitored in the presence o f  a single 
concentration of OP inhibitor (Aldridge 1950). This equation is more convenient to work 
with from an experimental point o f  view as it has one less variable and requires only one 
inhibitor concentration. This equation, however, ignores the reversible step o f inhibition 
and is consequently most valid when K d is several-fold greater than the inhibitor
l/[z] = (Ar/Alnv)A'i- l/K o (2)
Alnv = [/]£jAr (3 )
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concentration (Main 1964). Furthermore, Main (1964) established that k\ values obtained 
using this approach vary inversely with inhibitor concentration. This implies that the 
comparison o f  inhibitory potencies m ay be invalid if  the inhibitor concentrations used for 
the evaluation are significantly different.
The bimolecular rate constant o f  inhibition, k\, can also be expressed in terms o f an 
IC5 0  value. This parameter represents the molar concentration of inhibitor that will result in 
a 50% reduction o f  enzyme activity during a discrete period o f incubation with the 
inhibitor. Consequently, when used as a measure o f  OP reactivity toward AChE lower IC5 0  
values are indicative o f  greater inhibitory potency. The IC5 0  value o f a compound can be 
determined from the bimolecular rate constant o f  inhibition by the following relationship 
(Eto 1974).
IC5 0  = 0.695/(ALtj) (4)
2.3.2-Phvsiologic Implications o f  OP Intoxication 
OP inactivation o f AChE results in the rapid accumulation of ACh in 
neuromuscular junctions and neural synapses promoting continued and uncontrolled neural 
transmission which eventually leads to desensitization, neuronal failure, and cell death. 
Inactivation o f AChE is manifested in stimulation o f the nicotinic and muscarinic receptors 
of autonomic organs and skeletal muscles, as well as over stimulation o f cholinergic 
receptors (predominantly muscarinic) o f  the CNS. Consequently, the numerous symptoms 
elicited by exposure to OP compounds can be explained by considering the locations o f 
nicotinic and muscarinic receptors throughout the central and peripheral nervous system
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and the consequences of their activation. Many o f  these symptoms are summarized in 
Table 2.2. In addition to their potentially lethal acute cholinergic effects, 
organophosphorus compounds have been shown to: induce apoptosis o f neuroblastoma 
cells (Carlson 2000): disrupt regulation o f antioxidant enzymes (Panemangalore 2000); and 
interact with cholinergic receptors (Ward 1993; 1996; Zhang 1997: Lim 2000).
Table 2.2. Symptoms of Acetylcholinesterase Inhibition.
Nervous
System
Receptor
Type
Target Tissue Symptoms
Central Muscarinic
and
Nicotinic
Brain Confusion, Hypothermia. Lethargy, 
Tremors, Slurred Speech, Loss o f 
Reflexes, Depression, Convulsions, 
Coma, Paralysis
Peripheral Muscarinic Heart and Blood 
Vessels 
Lungs 
Bladder 
GI Tract 
Exocrine Glands
Bradycardia, Hypotension 
Bronchial Constrictions. Excess 
Secretions 
Incontinence
Nausea, Vomiting, Diarrhea 
Salivation, Miosis, Sweating, Blurred 
Vision, Lacrimation
Nicotinic Heart and Blood 
Vessels
Skeletal Muscle
Tachycardia, Hypertension 
Fasciculations, Ataxia, Weakness. 
Involuntary Twitching, Convulsions, 
Paralysis
Following inhibition, AChE may recover its enzymatic activity if  the serine- 
phosphate bond is cleared via hydrolysis to regenerate an active serine residue. The 
mechanism o f  this type o f reactivation is analogous to the second step o f the AChE- 
catalyzed hydrolysis o f ACh, i.e., the water facilitated hydrolysis o f the acetoxy moiety 
depicted in Scheme 2.3. Unfortunately, the rate o f  this spontaneous reactivation for an 
enzyme inhibited by an OP compound is often far less (>107  fold) than the turnover rate of
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the natural substrate (Eto 1974). Sequestration o f  the enzyme in its phosphorylated form 
inhibits the enzyme-catalyzed hydrolysis o f ACh for extended periods o f time in vivo.
Scheme 2.3. Spontaneous Reactivation of AChE.
/
Z.
ENZ-OP + H20 ENZ + OP-OH (5)
S p o n t a n e o u s
R e a c t i v a t i o n
2.3.3-Non-Anticholinesterase Effects Associated with OP Exposure
Chronic low-level exposure to OP compounds has also been demonstrated to have 
deleterious effects. Since the introduction o f these compounds, there have been several 
epidemics o f OP poisonings including Ginger Jake paralysis, the Moroccan oil crisis, 
Spanish toxic oil syndrome, and Cuban blindness syndrome (Stine 1996; Purdey 1998). 
Further, OP compounds are implicated in a number o f pathologies including 
organophosphorus compound-induced delayed neurotoxicity (OPIDN) (Randall 1997), 
polyneuropathy (McConnell 1994; Lotti 1999), sensory neuropathy (Stephens 1995; 
Moretto 1998), peripheral neuropathy (Ernest 1995; Amitai 1998; Bums 1998), 
Parkinson’s disease (Bhatt 1999; Muller-Vahl 1999), motor neuron disease and multiple 
sclerosis (Purdey 1998), chronic neurological sequelae (Steenland 1994; Ames 1995),
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distal axonopathies accompanied by disintegration o f  myelin (Stine 1996), asthma 
(Hodgson 1992), immune dysfunction (Thomas 1995), farmers’ flu (Stephens 1995), 
psychiatric disorder (Stephens 1995), schizophreniform and depressive psychosis (Marrs
1995), chronic dietary poisoning (Hodgson 1992), miscarriages (Ballantyne 1992), 
induced hypothermia (Gordon 1998a), systemic illness (Weinbaum 1997), sleep 
disturbance (Bell 1996), skin disease (Weinbaum 1995), eye injury (W einbaum 1995), 
Saku disease (Dementi 1994), birth defects (Sherman 1996), mental retardation (Claudio 
2000: Goldman 2000; Weiss 2000), G ulf W ar syndrome (Ember 1996; Jamal 1998), 
intermediate syndrome (Mani 1992; Sudakin 2000), myalgic encephalomyelitis (ME) or 
chronic fatigue syndromes (Corrigan 1994), multiple chemical sensitivity (MCS) 
syndrome (Ashford 1998), delayed psycho-neurodegenerative syndrome (Purdey 1998), 
childhood leukemia (Meinert 2000; Schuz 2000), and a host of developmental 
abnormalities (Barr 1999; Xie 1999, 2000; Eriksson 2000; Lockridge 2000; Fordham 
2001). OP compounds have also been cited as a potential cause o f bovine spongiform 
encephalitis (BSE or mad cow disease) and the related human condition known as 
Creutzfeldt-Jakob disease (CJD) (Brugere-Picoux 1996; Purdey 1996a, 1996b, 1998; 
Axelrad 1998; Gordon 1998b).
2.3.4-Spontaneous Reactivation o f  AChE Inhibited bv OP Compounds 
The ability o f  AChE to spontaneously recover from inhibition by an OP compound 
is dependent upon a number of factors including the enzyme source, pH, ionic strength, and 
temperature (Lieske 1980, 1990; Lanks 1981; Fisher 2000). In addition, the rate at which 
AChE recovers from OP inhibition is also dependent upon the nature and reactivity of the
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appended phosphoryl group (Lieske 1980, 1992; Clothier 1981; Langenberg 1988; Wallace 
1988; Lotti 1991; Wilson 1992; Berkman 1993b; Ashani 1995; W'ong 2000). The rate o f 
spontaneous reactivation is greatest when OP compounds that contain less bulky ligands (Y 
and Z in Scheme 2.3) are used to inhibit AChE. One example o f  this phenomena is the 
observation that dimethoxy phosphorylated AChE (Y = Z = OCH3) reactivates with rates 
that are 15 and 30-fold faster than the corresponding diethoxy and di-n-propoxy 
phosphorylated AChE, respectively (Gallo 1991). As a result, AChE possessing a di- 
isopropoxy phosphate moiety is essentially recalcitrant toward reactivation but is 
susceptible to other possible mechanisms (Eto 1974).
2.3.5-Oxime M ediated Reactivation o f AChE Inhibited bv OP Compounds
The observation that inhibited AChE could be reactivated by the nucleophilic attack 
o f water led Wilson and colleagues to explore the possibility that reactivation may be 
promoted by use o f  stronger nucleophiles such as oximes (Wilson 1955; 1958). It has since 
been shown that reactivation o f AChE is affected by several factors including the relative 
strength of the nucleophile, the orientation of the nucleophile with respect to the OP-AChE 
conjugate, and the prevention o f the process known as ‘aging’ which is discussed in greater 
detail in the following section. These considerations have led to the development of 
various oximes as potential antidotes to AChE poisoning (Froede 1971; Wilson 1992) 
including 2-pralidoxime (2-PAM) 20, l-[4'-(aminocarbonyl)-r-pyridinio]-methoxymethyl- 
2-(hydroxyiminomethyl)pyridinium (HI-6 ) 21, and ACY-trimethylenebis(pyridinium-4- 
aldoxime) (TMB-4) 22 (Wilson 1992). The structures o f these compounds are illustrated in 
Figure 2.12.
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Figure 2.12. Oxime Reactivating Agents.
OHI
HO N
NH2
O
20: 2-PAM 21: HI-6
HO
N
22: TMB-4
Nucleophilic reactivation of OP inhibited AChE is proposed to proceed via the 
mechanism outlined in Scheme 2.4 (Aldridge 1975; Luo 1999). As the process is similar to 
that of spontaneous reactivation it is not surprising that oxime-mediated displacement of 
the OP moiety is dependent upon both the source o f the enzyme and the nature o f the 
ligands attached to the phosphorus atom (Lotti 1991). As in the case o f spontaneous 
reactivation, smaller ligands are displaced with greater efficacy than compounds with 
bulkier functionalities. This is demonstrated by the observation that the reactivation rate 
constant, fa, for dimethyl phosphorylated AChE (Y = Z = OMe) is 60-fold greater than for 
the corresponding diethyl conjugate (Clothier 1981) which has been demonstrated to 
reactivate significantly faster than the diisopropyl OP-AChE conjugate (Taylor 1996). It is 
postulated that this trend is due in part to the dimensional constraints imposed by the gorge 
structure obstructing oxime access (Ashani 1995; Wong 2000).
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Scheme 2.4. Oxime-Mediated Reactivation.
R H C = N -0-^  z  
0 = P -Y
"CHR
H-O
ENZ-OP + 'ON=CHR ------ —-----► ENZ + OP-O N=CH R (6)
O x i m e - M e d i a t e d
R e a c t i v a t i o n
2.3.6-Non-Reactivation and Aging o f  AChE Inhibited bv OP Compounds 
Some OP-enzyme adducts may undergo post-inhibitory reactions that include 
secondary dealkylation o f the conjugated OP, resulting in an anionic phosphylated 
conjugate that is particularly resistant to all forms o f reactivation, a process known as aging 
(Scheme 2.5). When compared to other serine hydrolases that catalyze phosphylation 
reactions with OP inhibitors, AChE has a remarkably enhanced rate of aging (Millard 
1999b). The rate enhancement for AChE toward aging has been primarily attributed to the 
precise juxtaposition o f  the departing alkyl group with specific amino acid residues within 
the enzyme active site (Ashani 1995; W ong 2000).
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Scheme 2.5. Aging of Phosphorylated AChE.
O -R
O -
ENZ-OP + H20 *AG ENZ-OP' + ROH (7)
The negative charge introduced by the loss of an alkyl group during the aging 
process imposes a significant subsequent barrier to dephosphylation due to the inherent 
resistance o f anionic phosphoesters to nucleophilic attack (Westheimer 1987). However, 
electrostatic repulsion alone is an inadequate explanation o f  the truly irreversible character 
o f aged AChE as the presence o f  a negative charge on simple phosphorus diesters retards 
nucleophilic attack by less than 100-fold (Kirby 1970). It has also been demonstrated that 
protein denaturation o f aged AChE-DFP adducts permits significant base-catalyzed 
dephosphorylation (Segall 1993) and that reactivation of anionic OP-chymotrypsin 
conjugates by an intramolecular nucleophile is possible (Kaiser 1971). These observations 
suggest that aged OP-AChE resistance to reactivation is due, in part, to specific interactions 
between the OP and the structural constraints of the enzyme.
The report o f  the x-ray crystal structures of phosphylated TcAChE combined with 
kinetic data for a number o f AChEs modified by site specific mutagenesis has elucidated a 
number o f structural futures that appear to facilitate the aging process (M illard 1999b). 
Prominent among these is the region defined by the amide backbone hydrogens o f  residues
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Gly 121. G lyl22, and Ala204 (Sussman 1991). This portion of the enzyme active center, 
termed the oxyanion hole, is believed to stabilize the phosphonyl oxygen o f  an OP inhibitor 
through a hydrogen bond network and is thought to facilitate the reactions o f  inhibition and 
reactivation, and paradoxically, the mechanisms associated with aging (Hosea 1995; Wong 
2000).
Polarization present in the P=0 bond makes the phosphorus atom more susceptible 
to nucleophilic attack by both the serine hydroxyl during inhibition and the potentially 
reactivating nucleophiles, fTO or oxime, during spontaneous or oxime-mediated 
reactivation, respectively (Hosea 1995; Wong 2000). That all o f  the resolved crystal 
structures from both aged and “pro-aged” AChE-OP conjugates available thus far have the 
phosphonyl oxygen positioned within hydrogen bonding distance o f this region supports its 
putative role in stabilizing the bound OP adduct before, and after, aging (Millard 1999a; 
Millard 1999b; Ordentlich 1999). Aging may in fact enhance this interaction as electronic 
rearrangement could place the formal negative generated during the reaction partially, or 
entirely, in the dipolar oxyanion hole (Millard 1999b).
A final bit o f evidence for the importance of this region is provided by site-specific 
mutagenesis. Replacement o f G ly l2 1 or Gly 122 in human AChE (HuAChE) and 
equivalent residues in human BChE (HuBChE) has demonstrated markedly reduced 
reaction rate constants for OP inhibitors (Broomfield 1995; Millard 1995). In one study the 
decrease in inhibitory activity toward the Gly 121 Ala HuAChE mutant for the phosphates 
DEFP, DFP, and paraoxon and the phosphonates sarin and soman, was considerable 
(2000 to 6700-fold), irrespective o f size o f the alkoxy substituents on the phosphorus 
atom. This, however, contrasts with the data from the same study for the Gly 122 Ala
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HuAChE mutant where the relative decline in reactivity toward phosphonates (460 to 500 
fold) differed from that toward the phosphates (12 to 95-fold) (Ordentlich 1998).
The choline binding subsite, which is generally considered to be Trp 8 6  (Harel
1996), has been strongly implicated as having an active role in the aging process. It has 
been suggested that Trp8 6  contributes to aging by stabilizing the evolving carbonium ion 
that is thought to form during postinhibitory reactions o f 5p HuAChE-somanyl conjugates 
via a cation-ru interaction. This assertion is supported by the observation that the 
Trp 8 6 Ala HuAChE mutation resulted in an 1850 to 3300-fold decrease in the rate o f 
aging relative to the wild type (Shafferman 1996). However, it has subsequently been 
demonstrated that the rate enhancement is virtually nonexistent for the Rp soman 
diastereomers (Ordentlich 1999).
The acyl pocket defined by Phe295 and Phe297 is another region that has been 
demonstrated to play an active role in the process o f aging. The planar aromatic side 
chains of Phe295 and Phe297 are believed to provide an environment o f steric occlusion 
that in addition to conferring substrate specificity may hinder the access o f  H 2 O or 
oxime-reactivating agents to the appropriate face o f  the OP-AChE conjugate thus 
precluding reactivation (Hosea 1995; Ordentlich 1999; Wong 2000). It has also been 
suggested that congestion conferred by these residues may actually prevent OP 
compounds with bulky ligands from undergoing the process o f  aging by perturbing the 
optimal alignment o f the phosphonyl oxygen with the afore mentioned oxyanion hole 
(Wong 2000).
Another important structural feature suggested by the crystal structures o f aged
AChE is the favorable electrostatic interaction possible between the N e2  o f  the active site
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imidazolium and one o f the oxygen atoms of the anionic OP moiety. Hydrogen bonding 
between His447 (the donor) and an oxygen of the OP moiety (the acceptor) demonstrates a 
geometry similar to that observed in other aged serine hydrolases (Kossiakoff 1981: Harel 
1991; Wei 1995). The observations also provide support for the hypothesis that the 
catalytic histidine is immobilized in a protonated state in the aged enzyme, locking the 
phosphylated active site in a structural and electrostatic analog o f  the tetrahedral 
intermediate assumed by the natural substrate during hydrolysis (Kossiakoff 1980). The 
recent study o f Millard et al. (Millard 1999a) demonstrates that the histidine of the catalytic 
triad assumes a radically different orientation prior to the aging reaction. The observation 
implies an active role for the residue during the aging process that is separate from its 
function of stabilizing the anionic product of the reaction.
Aging is not the only phenomenon that results in AChE that is resistant to 
reactivation. Non-reactivation, as defined by Thompson et al. (Thompson 1992), may be 
caused by a number o f  factors including; steric occlusion o f  the phosphorylated active site 
that restricts the access o f reactivating nucleophiles due to the enzyme’s limited ability to 
accommodate bulky ligands within its structure (Hosea 1995; Wong 2000), possible 
modification o f  the enzymes tertiary structure resulting in loss o f  normal enzyme function 
(Grubic 1995; Morel 1999; Sentjurc 1999), and covalent modification o f a residue other 
than serine (Mullner 1980). That these post inhibitory processes result in a time-dependent 
loss o f the enzyme’s ability to reactivate but do not involve a secondary dealkylation of the 
OP-AChE adduct demonstrate that non-reactivation is clearly distinct from aging.
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2.3.7-Influence o f Stereochemistry on the Mechanisms of Inhibition. Reactivation.
and Aging
Numerous studies using OP compounds with centers o f asymmetry have 
demonstrated that the stereochemical orientation o f the phosphorus moiety and, to a lesser 
extent, the attached alkyl carbons directly effects the inhibitory potency o f  an OP 
compound (Benschop 1984a; 1984b; de Jong 1984; 1987; 1989; Berman 1989; Hosea 
1995; 1996; Ordentlich 1999; Wong 2000). In addition, oxime reactivation kinetics have 
also demonstrated structural and chiral preferences is for the attached organophosphorus 
(Wong 2000). The observations suggest orientational constrains for the OP compounds 
attack o f the active site series and oxime attack o f  the phosphoserine that results from 
inhibition o f AChE by an OP compound.
Studies of the inhibition and reactivation kinetics o f a series o f enantiomerically 
pure organophosphonates demonstrated that AChE was inhibited 200-fold faster with the 
5p than the Rp enantiomer o f  cycloheptyl methylphosphonyl thiocholine (Hosea 1995; 
W ong 2000). The study demonstrated that enlargement o f the acyl pocket size caused the 
R p  enantiomer to become more reactive while reaction with the Sp enantiomer was slightly 
reduced. In fact, the F297I mutant o f  rMAChE displayed inverted stereospecificity. The 
authors were able to use molecular docking experiments to construct a visual correlation of 
the kinetic data. If the phosphonyl oxygen was positioned in the oxyanion hole and the 
leaving group directed out o f  the gorge, the Rp, but not the Sp, enantiomer engendered steric 
hindrance between the alkoxy group and the acyl pocket. Replacing F297 with lie 
accommodated the bulky alkoxy group o f the Rp isomer in the acyl pocket, allowing similar 
orientations o f the phosphonyl oxygen and the leaving group to the Sp isomer.
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Later studies by the same group demonstrated that the S? isomers o f  these types of 
compounds were in general comparatively more potent inhibitors o f  wild type AChE than 
the corresponding Rp isomers (Hosea et al. 1996). In contrast, phosphorylated enzymes 
resulting from inhibition by the Sp isomers have been demonstrated to undergo both 
spontaneous and oxime-mediated reactivation readily while AChE phosphorylated by the 
corresponding RP isomers reactivate at greatly reduced rates (Wong 2000). The authors o f 
these studies concluded the Sp isomers were better positioned for both the phosphorylating 
and dephosphorylating reactions within the confines o f the enzymes active site.
These stereochemical trends in inhibitory potency have also been observed for a 
number of other compounds including the methyl phosponofluoridates sarin 2  and soman
3. However, in the case o f soman the reactivity o f wild type HuAChE toward the Sp soman 
diastereomers was an amazing 4.0 to 7.5 x I04-fold higher than that toward the Rp 
diastereomers (Ordentlich 1999). Further, the recently released crystal structures of aged 
7cAChE inhibited by sarin 2, soman 3, and DFP 5 suggest the orientation proposed by 
Hosea et al. (Hosea 1995: Wong 2000), with the phosphonyl oxygen positioned in the 
oxyanion hole and the leaving group directed out o f the gorge, is essentially correct 
(Millard 1999b).
2.3.8-Summarv
It is evident that the phosphorylation o f AChE by an OP inhibitor, and the 
subsequent recovery o f  the enzymes catalytic activity, are directly associated with both the 
nature and stereochemical orientation of the OP compound. When compared to planar 
substrates, the ground-state tetrahedral geometry of OP anti-AChE compounds adds a
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distinctive feature for mapping the three-dimensional organization o f the enzyme. O f late, 
OP compounds that contain stereocenters within their structure have generated 
considerable interest due to their stereodependent interactions with the dissymmetric 
enzyme active site (Lin 1998; Yu 1998; Greenblatt 1999; Taylor 1999; Hirashima 2000; 
Wong 2000). The stereoselectivity displayed by AChE in reactions with OP compounds 
affords another aspect o f structural information in the analysis o f the steric and 
hydrophobic elements o f the enzymes active center (Ordentlich 1999).
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C h a p t e r  3
O B JE C T IV E S
1. Synthesize and characterize the individual stereoisomers o f  isomalathion to 
verify the synthetic route proposed by Berkman et al. (1993b).
2. Combine key reactions o f the synthesis o f  isomalathion with the synthesis 
o f isoparathion methyl (Ryu, 1991) to generate a new stereoisomeric 
isoparathion thiosuccinate phosphorothiolates (ITP) to be used as probes o f 
cholinesterase.
3. Determine and compare the inhibitory and postinhibitory kinetic profiles for 
the individual isomalathion stereoisomers and the individual ITP 
stereoisomers vs. electric eel acetylcholinesterase (EEAChE) and 
recombinant m ouse acetylcholinesterase (rMAChE).
4. Propose stereodependent phosphorylation model(s) and/or mechanisms 
consistent with the data obtained in Objective 3.
51
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C h a p t e r  4
SY N T H E S IS
4.1-Isomalathion
Highly enantioenriched samples o f each isomer were necessary for this study. 
There were two previously reported synthetic routes from which to choose (Berkman 
1993b). The first method involved demethylation o f (/?)- or (S')-malathion 6  with (-)- 
strychnine to form the methylstrychninium desmethyl ( R ) -  or (5)- malathion salts (23RpSc 
and 235'piS’c in Scheme 4 .1). Repeated fractional crystallization o f the resulting 
diastereomeric mixtures results in separation o f the individual, "resolved" diastereomers. 
The individual phosphorothioic salts are then reacted with dimethyl sulfate (DMS), which 
leads to preferential sulfur alleviation (as opposed to oxygen alkylation), to afford each 
isomer o f isomalathion. While this procedure is not technically complicated, it first 
involves the preparation of enantioenriched malathion followed by two different sets of 
conditions for dealkylating and realkylating the salts. This is o f  some concern as there is a 
moderately acidic a  -proton on the stereogenic carbon of a diethyl malate derivative that 
may racemize. Further, under rigorous conditions, Ei-type elimination may be possible via 
abstraction of this proton to produce an alkene (diethyl maleate), which removes the 
asymmetry o f the final product - disastrous to the synthesis.
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Scheme 4.1. Synthesis of Isomalathion Stereoisomers via Strychnine Resolution of
Malathion.
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The second pathway, outlined in Scheme 4.2, begins with the demethylation o f 
(9,(9.S-trimethylphosphorodithioate 24 by (-)-strychnine, followed by repetitive fractional 
recrystallization to resolve the diastereomeric methylstrychninium salts o f  0,5-dimethyl 
phosphorodithioate 25a and 25b. The pathway circumvents the problem o f  having carbon 
stereocenter present throughout several synthetic manipulations. The resolved salts are 
then reacted with the enantiomers o f diethyl trifluoromethanesulfonyl malate (triflates; 26R 
and 265), which are derived from commercially available (-) and (-f-)-malate. As this 
method provided greater control over both the stereogenic carbon and phosphoms centers, 
it was deemed the more suitable and reliable pathway.
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Scheme 4.2. Synthesis of Isomalathion Stereoisomers via Strychnine Resolution of
0,0,S-Trimethylphosphorodithioate.
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In order to attain the isomalathion stereoisomers by the path outlined in Scheme 
4.2, multigram quantities o f 0,0,5-trimethylphosphorodithioate 24 were first required.
0 ,0,5-Trimethyl phosphorodithioate is prepared from 0,0-dim ethyl phosphorodithioic 
acid 27. which was obtained by refluxing a mixture of methanol and phosphorus 
pentasulfide (P4 S 1 0 ) in benzene for 48 h followed by filtration and evaporation of excess 
solvent and starting materials. The resultant reaction mixture affords a greenish, smelly oil 
(Scheme 4.3). This was then reacted with excess sodium bicarbonate in methanol to 
produce the sodium 0,0-dim ethyl phosphorodithioate salt (28, Scheme 4.3). Compound 
28 was then alkylated by refluxing with dimethyl sulfate (DMS) in methanol for 
approximately three hours to generate crude 0,0,5-trimethyl phosphorodithioate 24. This 
crude solution was then filtered and dried down to a pale yellow oil which was further 
purified by Kugelrohr distillation (Scheme 4.3). Purified 0,0,5-trim ethyl 
phosphorodithioate was then refluxed in a solution of (-)-strychnine and methanol for 
approximately 24 hours which results in chemoselective removal o f a methyl group from 
an oxygen ester (O-Me cleavage). Diastereomeric crystals o f  the methylstrychninium- 
0 ,0,5-dimethyl phosphorodithioate salts (25a and 25b) were both deposited on cooling o f  
the reaction mixture and upon selective fractional crystallization. The diastereomeric 
crystals were then dissolved in a minimum o f hot methanol and allowed to crystallize 
overnight. This first crop o f crystals was recrystallized twice more from methanol to 
produce the (+) salt (note: the (-) and (+) salts are so named because of their respective 
rotations; 25a). The mother liquor from the first crop was evaporated down to a solid and 
crystallized three times from 95% ethanol to generate the (-) salt 25b. Despite the reported 
"in-house" success o f this procedure, it proved to be a cumbersome procedure and a severe
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bottleneck. Multiple runs o f this reaction were required in order to produce several grams 
o f each diastereomer. Several grams were required because the majority o f  compound 
weight is made up in the strychnine-resolving agent, which is eventually discarded in favor 
of the phosphorus ester. Eventually, the desired products were isolated in low yield (10- 
20% compared with the 45% previously reported), however, these recoveries were offset 
by the excellent purity as demonstrated by the J1P NMR analysis and the specific rotations 
(see Table 4.1).
With the resolved methylstrychninium-0,0,5-dimethyl phosphorodithioate salts 
(25a and 25b) in hand, it was necessary to generate the triflates o f  (2R) and (25) diethyl 
malate 26R and 265, which would be used to introduce the thiosuccinate ligand via S- 
displacement at the triflate center (Sn2). Bis-ethyl esterification o f  (/?)- and (5)-malic acid 
29R and 295 was accomplished by bubbling HCl gas through a solution o f ( R ) -  or (5)- 
malic acid in absolute ethanol. Upon bubbling the gaseous HCl, the solution warmed and 
the HCl introduction was halted. The reaction was capped and sealed at 0 °C for 
approximately 48 h. The product, ( R ) -  or (5)-diethyl malates (30/? and 305) were then 
purified by Kugelrohr distillation. The spectral properties o f each isomer were identical to 
that reported (Cohen, 1966) with the exception o f the specific rotations which were roughly 
equal and opposite (see Table 4.1). The next step involved the conversion o f  the diethyl 
malate hydroxyl group into a good leaving group, in our case a triflate. The purified ester 
was mixed with 2-6-lutidine (a hindered base) in anhydrous methylene chloride and cooled 
to -78 °C to reduce elimination reactions. Trifluoromethanesulfonic anhydride was added 
and the reaction stirred at room temperature. Once this addition was completed, the
mixture was gradually warmed to room temperature and mixed with diethyl ether and a
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small am ount o f  Celite® to precipitate out the resulting lutidine/ triflate salts. Owing to  the 
high reactivity o f  the triflates, these compounds were used in the next step without further 
purification. Previous studies in our group (Berkman 1993a) showed that leaving groups 
other than triflate were not amenable to this reaction sequence.
Scheme 4.3. Production of Synthetic Intermediates.
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In o rder to minimize the potential for racemization, a small amount o f the (/?)- and 
(^-triflates 26R  and 265 were removed for spectral analysis and conformation o f 
conversion w hile the remainder o f  each isom er was added immediately to a stirring 
suspension o f  either the (+) or (-) methyl strychninium salts 25a and 25b in acetonitrile that 
had been chilled to 0 °C. Once the addition o f  the respective triflate was completed the 
mixtures w ere allowed to come to room temperature and stirred for approximately two
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hours. When the reaction had reached completion as demonstrated by TLC, diethyl ether 
and a small amount of Celite® was added to crash out the resulting triflate/strychninium 
salts. The mixtures were then filtered and dried down to a light tan oil containing putative, 
stereochemical pure isomalathion and approximately 10-20% of the O-alkylated side 
product. Each isomalathion isomer was then separated from its corresponding O-alkylated 
side product by silica gel chromatography (hexane/diethyl ether, 1:1) to give a colorless oil.
4.2-Malathion
The (R) and (5) triflates o f  diethyl malate 26 R and 26S  were added dropwise to 
stirring mixtures o f the sodium 0,0-dim ethyl phosphorodithioate salt 28, in THF, chilled to 
0 °C to generate (5)- and (i?)-malathion (6S and 6R) respectively (Scheme 4.4). These 
mixtures were then brought to room temperature and allowed to stir for approximately two 
hours until TLC indicated the reaction was complete. The mixtures were then partitioned 
between diethyl ether and water. After separation of the aqueous and organic layers, the 
aqueous layer was extracted two more times with diethyl ether. The ether layers were then 
combined, extracted with brine, dried over sodium sulfate, and concentrated to an oil. This 
was then purified by silica gel chromatography (hexane/diethyl ether, 1:1) to give a 
colorless oil.
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Scheme 4.4. Synthesis of Malathion and Isomalathion.
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CF3S 0 3" ^ C 02Et ■ 28 ^CH 3 0 ^ s ^ C 0 ^Et MMPP C° 2Et
THF, 0 °C CH30  CH2CI2 CH3O
26R: diethyl (R)-O- ’ 6S: (S)-malathion reflux. 24 h 13S: (S)-malaoxon
[(trifloromethyl)sulfonyl]- 
malate
Q 02Et S C 0 2Et O C 0 2Et
CF3SQ3̂ ^ C° 2Et 28 . C H30 ^ s ^ CQ2Et - MMPP, . c H30 ^ s ^ C° 2Et 
THF, 0 °C C H 3 °  CH2CI2 C H 3 °
26S: diethyl (S)-O- 6R: (R)-malathion reflux, 24 h 13#?: (R)-malaoxon
[(trifloromethyl)sulfonyl]- 
malate
4-3-MaIaoxon
(/?)- and (5)-malaoxon 13/f and 135 were also prepared for structural and inhibitory 
comparisons. To accomplish this, a portion o f both the (R )- and (S)-malathion 6R  and 65 
samples were dissolved in methylene chloride and added to a stirring suspension of 
monoperoxyphthalic acid, magnesium salt (MMPP) in methylene chloride at room 
temperature (Scheme 4.4). The mixtures were then heated at reflux for 24 h and cooled to 
room temperature, and partitioned between diethyl ether and saturated sodium bicarbonate 
solution. Once the organic layer was separated, the aqueous layer was extracted twice 
more with diethyl ether. The organic layers were then combined, dried over sodium 
sulfate, and condensed to a colorless oil. The crude (/?)-and (5)-malaoxon samples were 
then individually purified via gravity chromatography using silica (hexane/diethyl ether, 
1:2 ).
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4.4-ITP Stereoisomers 
A modification o f  the pathway outlined in Scheme 4.2 was used to generate highly 
enantioenriched samples o f  the stereoisomers o f a novel isoparathion thiosuccinate 
phosphorothiolate (ITP) compound 31. Specifically, the diastereomeric 
methylstrychninium salt o f isoparathion methyl 32a and 32b obtained from the 
demethylation of parathion methyl 7 by (-)-strychnine is followed by repetitive fractional 
recrystallization. The resolved (-) or (+) methyl strychninium salts 32a and 32b are mixed 
with THF and the resulting suspension chilled to 0 °C. The (R )- and (S)- triflates o f diethyl 
malate 26R  and 265’ dissolved in THF at 0 °C are then added dropwise to the stirring 
mixtures. Once the addition o f the respective triflate was completed the mixtures were 
allowed to come to room temperature and stirred for approximately two more hours. When 
the reaction had reached completion, as demonstrated by TLC, diethyl ether and a small 
amount o f Celite* was added to precipitate the resulting triflate/strychninium salts. The 
mixtures were then filtered and dried down to an oil containing putative, stereochemical 
pure ITP. Each ITP isomer was then purified via flash chromatography on silica gel 
(diethyl ether/petroleum ether, 2:1) to give a colorless oil. During these studies it was 
observed that the stereoisomers o f this particular compound were prone to undergo 
hydrolysis in protic solvents and during chromatography. Consequently, a small amount (< 
5 %) of jP-nitrophenol was detected in all samples. Repeated attempts to further purify the 
stereoisomers by flash chromatography resulted in significantly decreased yields.
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Scheme 4.5. Synthesis of ITP Stereoisomers via Strychnine Resolution of Parathion
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In order to attain the ITP stereoisomers by this method, multigram quantities of 
O.O-dimethyl-p-nitrophenoxy phosphorothionate (parathion methyl, 7) was required. 
Parathion methyl is prepared by mixing 0,0-dim ethyl phosphorochloridothionate 33, 
dissolved in anhydrous acetone, with anhydrous sodium carbonate. p-Nitrophenol is then 
added to the mixture and the resulting suspension is heated to reflux for approximately 4 h. 
When the reaction is complete, as demonstrated by TLC, die mixture is cooled to room 
temperature, filtered through a plug o f  Celite*. and evaporated to an oil. The oil is 
dissolved in diethyl ether, washed twice with saturated sodium carbonate and brine, dried 
over sodium sulfate, followed by evaporation of the excess solvent. The crude product is 
dien purified by flash chromatography using silica (diethyl ether/petroleum ether, 1:3) to 
give a colorless oil.
Purified parathion methyl 7 was then refluxed in a equimolar solution o f (-)- 
strychnine and methanol for approximately 24 hours which results in chemoselective 
removal o f  a methyl group from an oxygen ester (O-Me cleavage). Diastereomeric crystals 
o f the methylstrychninium-isoparathion methyl salts (32a and 32b) were deposited both on 
cooling o f the reaction mixture and upon selective fractional crystallization. These 
diastereomeric crystals were then dissolved in a minimum o f  hot methanol and allowed to 
crystallize overnight. The first crop o f crystals was recrystallized twice more from 
methanol to produce the (-) salt 32a. The mother liquor from the first crop was evaporated 
down to a solid and crystallized three times from acetonitrile to generate the (+) salt 32b.
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4.5-Spectral Characterization 
Once the isolation and purification of each compound was completed a full 
structural and stereochemical characterization was undertaken. Spectral data can 
sometimes provide excellent markers o f  chemical structure and stereochemical purity and, 
'H , 1jC, and31P (when applicable) NMR spectral analysis was conducted on each 
compound. As a number o f  the compounds were stereoisomers, the NMR spectral data 
was useful in confirming and comparing structures, but not absolute configuration 
assignment. While j lP NM R was used to assess contamination by diastereomers, 
polarimetry was conducted on each chiral sample to estimate and verify its 
enantioenrichment (see Table 4.1).
The j lP NMR data listed in Table 3 demonstrates what a powerful tool jIP NMR 
can be. As there is a considerable difference in the chemical shift as one goes from a P=S 
to a P=0, it is quite easy to follow the course of a reaction. Furthermore, as each 
phosphorus atom in a phosphorus containing molecule produces only one sharp definitive 
peak with a chemical shift that is directly related to the phosphorus atom’s immediate 
environment, phosphorus containing impurities are easily spotted.
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Table 4.1. Spectral Data.
Com pound [«In 3IP N M R 5
6R (7?)-malathion +79.7(1.25) 96.15
65" (S)-malathion -80.0(1.25) 96.15
7 parathion methyl - 66.09
13/? (/?)-malao.\on +51.5 (0.59) 28.30
13S (5)-malaoxon -49.2 (0.63) 28.30
12RR (/?P/?c)-isomalathion +42.0 (0.57) 58.30
12RS (/?P5c)-isomalathion -57.5 (0.63) 56.91
12SR (5P/?c)-isomalathion +58.9 (0.67) 56.90
1 ISIS' (5pSc)-isomalathion -44.2 (0.62) 58.27
25a (+) methylstrychninium O.S-dimethyl 
phosphorodithioate
+ 16.2(0.64) 78.87
25b (-) methylstrychninium O.S-dimethyl 
phosphorodithioate
-13.4 (0.63) 78.79
305" (S')-diethyl malate -9.82 (0.55) -
30/? (/?)-diethyl malate +9.59(1.35) -
2dS (S)-0-(Trifluoromethanesulfonyl)-diethylmalate +32.6(1.39) -
26R (/?)-0-(TrifluoromethanesulfonyI)-diethylmalate -30.1 (1.71) -
32a (-) methylstrychninium isoparathion -22.9 (0.45) 55.85
32b (+) methylstrychninium isoparathion +23.0 (0.10) 55.85
31 RR (RPRc)-lTP + 13.0(1.10) 23.76
31RS (RPSc)- ITP -16.3 (0.91) 23.68
31 SR ( S pR c )-  ITP +16.0 (0.86) 23.67
3155 (SpSch ITP -12.9(1.00) 23.75
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C h a p t e r  5
RESULTS AND DISCUSSION
5.1-Determination o f  the Kinetic Properties o f  rMAChE and EEAChE.
To ensure that optimal substrate concentrations were used during these studies, the 
rate of ATCh-I hydrolysis, v, was determined for a series o f substrate concentrations. [S], 
for both EEAChE and rMAChE. The average o f  20 experiments (n = 20) per enzyme is 
graphically represented in Figure 5.1. The values from the logarithmic portion o f the graph 
generated from each experiment were subjected to Lineweaver-Burk, Eadie-Hofstee, and 
Woolf analysis to determine the apparent Michaelis-Menten constants (Km apparent) and 
the value o f Vmax for both enzymes. These three methods o f analysis were chosen to 
facilitate direct comparison o f the kinetic parameters obtained with those found in a wide 
spectrum o f the contemporary literature. The mean and standard deviation o f the values 
obtained from each o f these methods o f analysis are listed in Tables 5.1 and 5.2 for 
EEAChE and rMAChE, respectively. The values o f  Km apparent generated are within 
reasonable agreement o f the 46 p.M value published by others using more rigorous methods 
o f  analysis (Hosea 1996).
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Figure 5.1. Concentration Dependence of Acetylthiocholine Hydrolysis for EEAChE
and rMAChE.
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Table 5.1. Apparent Michaelis-Menten Kinetic Constants for the Hydrolysis of
ATCh-I by EEAChE3.
Method K m Apparent (p.M) krnax (S'') R"
Lineweaver-Burk 215 ± 48 222 ± 48 0.999
Eadie-Hofstee 200 ± 26 213 ± 2 4 0.991
W oolf 205 ± 30 2 14±  15 0.992
an = 20
■  rMAChE
■  EEAChE
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Table 5.2. Apparent Michaelis-Menten Kinetic Constants for the Hydrolysis of
ATCh-I by rMAChE3.
Method Km Apparent (p.M) Vmax(s"') R2
Lineweaver-Burk 93 ±5 81 ±3 0.994
Eadie-Hofstee 84 ± 4 77 ±3 0.996
W oolf 79 ±7 75 ± 4 0.999
an = 20
It is important to note that, as demonstrated by the data presented in Figure 5.1. 
enzyme activity decreases slightly at very high substrate concentration. This phenomenon, 
termed substrate inhibition, is well documented for AChE (Quinn 1987: Taylor 1994) and a 
number of other enzymes including fumarase and ribonuclease exhibit this process 
(Aldridge 1975). The process has been proposed to occur directly at the active center 
(Froede 1986) or indirectly through interactions with a peripheral site which are believed to 
either induce conformational changes to the active center o f the enzyme allosterically 
(Barak 1994: 1995: Ordentlich 1995; Velan 1996; Marchot 1998; 1999; Radic 2000) or by 
formation o f a “steric blockade” of the entrance to the active site (Rosenberry 1996; 1999; 
Szegletes 1998; 1999; Mallender 1999; 2000). Studies using ligands selective for the 
peripheral anionic site combined with site-specific mutagenesis suggest that the binding 
site for substrate inhibition may consist o f structural elements that overlap with, or are the 
same as. those that make up the peripheral anionic site (Radic 1991; 1994; Shafferman 
1992; Duran 1994; Boume 1995; 1999; Velan 1996; Marchot 1999).
The phenomenon contrasts with the apparent substrate activation that has been
observed for BuChE (Radic 1993; Vellom 1993). It has been demonstrated through the use
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o f site-specific mutagenesis that replacement o f residue Phe297 o f rMAChE with an 
isoleucine residue (F297I) not only eliminates the substrate inhibition observed with 
ATCh-I for the wild type enzyme, but also confers some elements o f  substrate activation 
seen for BuChE (Vellom 1993). It has been proposed that the physiological role o f 
substrate inhibition may be an essential element in the regulation o f the residence time of 
ACh in the synaptic cleft. A sensor site, such as the peripheral anionic site on AChE. could 
trigger an inhibitory response to the initially high concentration o f ACh near the 
presynaptic membrane. This could allow ACh to diffuse into the synaptic cleft to interact 
with the receptor prior to its hydrolysis by an AChE (Shafferman 1992).
5.2-lnhibition o f  rMAChE and EEAChE by DFP.
The neurotoxic compound DFP was evaluated as an inhibitor o f EE AChE and 
rMAChE to provide a frame o f reference with better known OP compounds and to serve as 
an external standard during the development of the microplate assays outlined in Methods 3 
and 4 o f Section 7.3.3. Despite its lack of a center of asymmetry, the decision to use DFP 
was based upon the extensive body o f  literature available for the compound, the well 
documented postinhibitory properties of the compound (i.e. inhibition o f AChE with DFP 
eventually leads to an aged enzyme), and the commercial availability o f the compound.
The kinetic parameters k\ , ATD, and kp were determined experimentally using Eqn. 2 
(Section 2.3.1) and are listed in Table 5.3. The values obtained are in excellent agreement 
with those previously reported for HuAChE and 7cAChE (Millard 1999b).
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Table 5.3. Concentration Dependent Kinetic Data for the Inhibition of rMAChE and
EEAChE by DFP3.
Enzy me Source kx (xtO3 M'1 m in1) Kd OiM) Ap (min'1)
rMAChE 29 ± 5 51 ± 7 1.5
EEAChE 12 ± 3 34 ± 6 0.4
TcAChEb 20 ± I 70 ± 2 0 1.5
HuAChEb 50 ± I 13 ± 2 0.6
an = 11
b(Millard 1999b)
In addition, the kinetic parameters for both spontaneous reactivation and 
reactivation in the presence of an oxime (2-PAM and TM B-4) were determined 
experimentally using Eqn 7 (Section 7.3.3) and the results obtained are listed in Table 5.4.
Table 5.4. Reactivation Data for rMAChE and EEAChE Inhibited by DFP3.
Enzyme
Source
k3 (spon) 
min’1 (xl0‘3)
%
spontaneous
reactivation
k 3
(2-PAM)
min-'
(xlO'3)
% 2-PAM  
reactivation (TMB-4)
min'1
(xlO'3)
% TMB-4 
reactivation
rMAChE 0.3 ±0.1 <1 5.2 ± 2 3.1 9.8 ± 3 6.5
EEAChE 0.8 ± 0 .2 <1 6.9 ± I 5.7 14 ± 6 8.4
an = 8
The results confirm the observation that DFP is only a moderately potent inhibitor 
o f AChE. This is due primarily to the steric properties o f  the isopropyl ligands hindering 
the compounds approach to the active site within the spatial confines o f the enzyme (Gallo 
1991). In contrast, the data presented in Table 5.4 demonstrates the irreversible nature o f
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DFP inhibition. As discussed in Section 2.3, the effect is believed to be due, in part, to the 
dimensional constraints imposed by the gorge structure obstructing the access o f potentially 
reactivating nucleophiles (Ashani 1995; Wong 2000).
5.3-lnhibition o f EEAChE bv the Stereoisomers o f Isomalathion 
To examine the stereoselective inhibition o f EEAChE, the inhibition kinetics 
profiles o f the individual stereoisomers o f  isomalathion were determined in a concentration 
dependent manner as described in Methods 3 and 4 o f Section 7.3.3 using Eqn. 2 and the 
kinetic parameters determined are presented in Table 5.5. A 4-fold difference in anti- 
AChE potency was found between the strongest isomer, S?Rc -isomalathion, and weakest 
isomer, SpSc isomalathion. The isomalathion stereoisomers with R configuration at the 
asymmetric carbon displayed greater inhibitory potency toward EEAChE than those with 
the S' configuration at the asymmetric carbon. However, the attenuation o f the inhibition 
reaction by the stereogenic carbon was further modulated by the chirality o f the 
phosphorus-containing portion o f the molecule. The difference in inhibitory strength when 
changing the configuration at carbon from R to S’ was 4.7-fold when the configuration at 
phosphorus was S. In contrast, the difference was only 1.5-fold when comparing the two 
isomers that had the R configuration at phosphorus. In a similar fashion, the carbon 
stereocenter attenuated the effect on inhibitory potency exerted by the stereochemical 
orientation o f  the phosphorus. A comparison between the isomers that had S  or R 
configuration at the phosphoms demonstrate a 1.8-fold difference in inhibitory potency 
when the stereochemical orientation o f  the carbon is R, but only a 1.2-fold difference in 
inhibitory potency is observed for the stereoisomers with the S configuration at carbon.
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These observations demonstrated that the carbon and phosphorus asymmetric centers of 
isomalathion act independently during the inhibition of EEAChE and are consistent with 
the observations obtained during previous studies (Berkman 1994). That the 
stereochemical orientation o f  the carbon has less o f an effect on the inhibitory potency of 
an OP compound with two stereocenters relative to the influence o f the configuration at 
phosphorus is also consistent with the observations of others (Ordentlich 1999).
Table 5.5. Concentration Dependent Kinetic Data for the Inhibition o f EEAChF. by
Isomalathion Stereoisomers3.
Isomer k{ (xlO3 M 1 m in 1) tfD(pM) kp (m in 1)
R pRc 25 ±  10 7.8 ± 3 0.20
RpSc 17 ±  4 8.2 ± 2 0.14
SpRc 44 ± 12 32 ± 8 1.4
SpSc 12 ±  3 250 ± 56 3.0
an = 20
The kinetic parameters KD and kp were also determined for the interactions of the 
individual isomalathion stereoisomers with EEAChE (Table 5.5). As reported for the 
stereoisomers o f malaoxon (Berkman 1994), the k\ values typically paralleled the 
dissociation constants, Ko, such that the isomer with the greater affinity for the active site 
was the stronger inhibitors. An example o f this is displayed by the 7.8-fold stronger
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affinity for (or weaker disassociation from) the active site determined for the S, R isomer 
versus it’s 5, 5  counterpart and was a 3.7-fold more potent inhibitor. However, as implied 
by Eqn. 2 a compound’s affinity for the active site is not the only determinant o f  inhibition. 
A comparison o f the Ko values obtained for the R , R isomer and the 5. 5  isomer would lead 
one to expect a 32-fold difference in inhibitory potency. This is in contrast to the 2.1-fold 
difference in inhibitory potency observed for the two isomers. These observations can, in 
part, be rationalized by the unusual magnitude o f  kp (3.0) for the S', S' isomer. The reactivity 
o f  the compound tow'ard the enzyme, kp. partially compensates for the poor affinity toward 
the active site.
The values determined for the kinetic parameter kp during the inhibition of 
EEAChE by R , R and R, S  isomalathion stereoisomers are nearly identical, consistent with 
the results reported for the inhibition o f RBAChE by malaoxon (Berkman 1994). This is in 
contrast with the more than 2.1-fold difference observed in the kp values determined for the 
S, S  and S, R isomers. That the stereochemistry o f the carbon significantly influenced the 
phosphorylation only when the S, S  and S’, R isomers o f  isomalathion were used as the 
inhibitors suggest that the thiosuccinyl ligand remains attached following inhibition by 
these isomers as depicted in Path B of Scheme 5.1. Conversely, the lack of significant 
variance in the observed kp values for the R , R and R, S  can be rationalized if  the 
thiosuccinyl ligand is the primary leaving group thus negating its ability to exert 
stereochemical influence over the reaction as depicted in Path A o f  Scheme 5.1.
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Scheme S.l. Proposed Mechanisms for the Inhibition of AChE by Isomalathion.
O C 0 2Et
CH3S",P̂ S'^ v _ /C°2Et
CH30
MRpRc or 12/?PSC (Rp)-isomalathion
Path A
AChE
O C 0 2Et
CH30",p^ s ^ \ / c 0 2Et
CH3S
12SP/?C or 12SPSC (Sp)-lsomalathion
Path B
AChE /  1
OCH
The time-dependent method for determining the bimolecular rate constant o f  
inhibition ( k \ ) against EEAChE was also performed for the isomalathion stereoisomers. 
The values are presented in Table 5.6. The values generated by this method show the same 
inhibition trend and stereoisomer preference but the concentration dependent data (Table 
5.5), does differ significantly in key elements (Figure 5.2). First, it is noteworthy that the 
rank order o f inhibitory potency (SpRc > RpRc >  SpSc >  RpSc)  is conserved between the two 
methods.
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Table 5.6. Time Dependent Kinetic Data for the Inhibition of EEAChE by the
Isomalathion Stereoisomers3.
Isom er Iq (xlO3 M 1 m in 1)
R PRC 21 ± 3
RpSc 0.63 ± 1
SPRC 144 ± 6
SpSc 3 ±  1
an = 10
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Figure 5.2. Comparison of the Bimolecular Rate Constants of Inhibition 
(A', xlO3 M'1 min"1) Obtained by the Concentration Dependent Method and Time 
Dependent Method for the Inhibition o f EEAChE by the Stereoisomers of
Isomalathion.
Concentration Time Dependent SpSc
Dependent
During the course of the time-dependent experiments it was observed that EEAChE 
inhibited by the stereoisomers containing the S  configuration at phosphorus consistently 
provided linear data similar to that shown in Figure 5.3 (Panel A). In contrast, the data 
obtained by this method of analysis for EEAChE inhibited by the isomers that were R 
configuration at phosphorus was consistently non-linear despite repeated variance o f the
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inhibitor concentration and numerous attempts to attenuate the conditions o f  the study 
(Figure 5.3, Panel B). These differences in inhibitory behavior provide further evidence 
that the isomers o f  isomalathion interact with EEAChE by two distinctly different 
mechanisms dependent upon the stereochemical orientation o f the phosphorus. Further, 
these results were so intriguing that a detailed kinetic analysis o f the phenomenon was 
conducted which is detailed in a subsequent section.
Figure 5.3. C om parison o f  the D ata  O btained  from the Inhibition o f  E E A C h E  by  
Isom alathions (P anel A) and the R P Isom alith ion  (Panel B) D u rin g  the T im e
D ependent M ethod o f  A nalysis.
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5.4-Inhibition o f  rMAChE bv the Stereoisomers o f  Isomalathion 
To explore the possibility o f species-dependent variations in stereoselectivity (Lee 
1978; Wallace 1991), inhibition o f rMAChE by the isomalathion stereoisomers was 
investigated. Further, a recombinant source of mammalian ACh£ was sought as recent 
studies have demonstrated the presence of other esterases in the tissue homogenates 
traditionally used during anti-AChE assays that can directly influence the kinetic 
parameters obtained from them (Mortensen 1998; Moretto 2000). Also, observations by 
members o f  our group have identified a number o f  impurities present in the commercial 
preparations o f EEAChE that may affect the outcome o f studies preformed with this source 
(George 2000). In addition to the well-documented purity' o f  rMAChE, its extensive 
characterization and the prevalence of this enzyme source in the contemporary literature 
facilitates direct comparison o f  results obtained from it.
The kinetic parameters k,, Ad, and kp for the inhibition o f rMAChE by the 
isomalathion stereoisomers were determined experimentally using Eqn. 2 and the results 
obtained are presented in Table 5.7. The 40-fold difference in anti-AChE potency between 
the weakest isomer (SpSc isomalathion) and the most potent isomer (RpRc isomalathion) 
was considerably greater than that observed for EEAChE. That rMAChE demonstrated a 
greater ability to discriminate between the stereoisomers was not unexpected as species- 
dependent, stereoselective inhibition against varying sources o f AChE has been observed 
for the fonofos oxon enantiomers (Lee 1978). The results from the inhibition o f  AChE 
obtained from several different sources by the stereoisomers o f isomalathion are 
represented in Figure 5.4 for comparison.
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Table 5.7. Concentration Dependent Kinetic Data for the Inhibition of rMAChE by
the Isomalathion Stereoisomers3.
Isom er j6j (xlO3 M 1 m in 1) Rp (m in 1)
R pR c 190 ±  34 0.89 ±  0.3 0.17
RpSc 42 ± 6 9.3 ± 2 0.39
SpRc 32 ± 4 150 ± 3 0 4.8
SpSc 4.8 ± 2 770 ±  80 3.7
an = 20
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Figure 5.4. Comparison of the Bimolecular Rate Constants of Inhibition 
(A'i x 103 M'1 min'1) for AChE from Different Sources Inhibited by the Stereoisomers
o f Isomalathion3.
600
500
400
300
200
100
MBAChE HBAChE RBAChE rMAChE EEAChE
“Mouse brain AChE (MBAChE); hen brain AChE (HBAChE) (Jianmongkol 1999); 
rat brain AChE (RBAChE) (Berkman 1993a)
Both RpRc- and /?PSc-isomalathion were more potent inhibitors o f rMAChE than 
the corresponding isomers with S  configuration at phosphorus. This trend in inhibitory 
potency has been observed for a number of OP compounds that are structurally equivalent 
including S  isoparathion methyl (Ryu 1991), the chemical warfare agents sarin and soman 
(Millard 1999b; Ordentlich 1999; Spruit 2000), and a series o f  chiral organophosphonates
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(Hosea 1995; Hosea 1996; Wong 2000). It has been demonstrated that the acyl pocket 
region o f the enzymes active site is primarily responsible for dictating the enantiomeric 
preference displayed by AChE. Specifically, site-specific mutagenesis and crystallographic 
studies combined with molecular docking experiments have implicated Phe295 and Phe297 
o f mammalian AChE as dominant residues (Hosea 1995; Hosea 1996; Millard 1999b; 
Ordentlich 1999; Wong 2000). It has been proposed that the influence o f these residues is 
due to their ability to sterically hinder the approach of one stereoisomer relative to another 
thereby reducing the compounds ability to achieve the orientation necessary for optimal 
phosphonyl transfer (Hosea 1995; Hosea 1996). It has also been demonstrated that in 
addition to governing the stereoselectivity o f AChE with respect to the phosphorus chirality 
that, at least for soman, this region plays a role in determining the enzym e’s ability to 
discriminate between stereoisomers that only differ in the orientation o f  their stereogenic 
carbon (Ordentlich 1999).
As observed for EEAChE, the inhibition o f rMAChE was dependent upon the 
stereochemical orientation of both the phosphorus atom and the asymmetric carbon present 
in the isomalathion stereoisomers. A 6-fold difference in inhibitory potency is observed for 
the isomers that were R at carbon when the orientation o f the phosphorus was switched 
from R t o S  while an 8.8-fold difference observed when the configuration at carbon was S. 
In contrast, changing the orientation o f the asymmetric carbon from R  to 5  resulted in a 4.5- 
fold difference in inhibitory' potency when the orientation at the phosphorus was R while a 
difference o f  6.7-fold was observed between the isomers that were S’ at phosphorus.
The kp values obtained for the inhibition of rMAChE by the RpRc  and RpSc 
isomalathion isomers were very similar in magnitude, consistent with the results obtained
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with EEAChE. In contrast, the kp values obtained from the inhibition o f rMAChE by the 
SpSc and SpRc were considerably different than those obtained from there respective 
enantiomers. These observations provide further evidence that there are two distinct 
mechanisms for the inhibition o f  AChE by the stereoisomers of isomalathion dependent, 
primarily, upon the stereochemical orientation o f  the phosphorus atom.
Previously, it had been suggested that inhibition of AChE by the four isomalathion 
isomers proceeded via a common mechanism (i.e. displacement of the thiosuccinyl ligand 
with inversion o f the phosphorus configuration (Berman 1989a)). If this hypothesis is 
correct, then the putative (5)- or (/?)-0,S-dimethylphosphorothiolated AChE adduct should 
be the result o f  the inhibition reaction. These AChE conjugates should then be identical to 
the phosphorylated enzymes that would result from inhibition by (5)- or (/?)-isoparathion 
methyl as depicted in Scheme 5.2.
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Scheme 5.2. Convergent Mechanisms for the Inhibition of AChE by Isomalathion
and Isoparathion Methyl.
O C 0 2Et
CH3S'';P'-s - ^ ^ C 0 2Et
CH30
12Rp/?c 12 /?pSq
(Rp)-lsomalathion
O C 0 2Et
CH3 0 ";P' - q ' ^ ^ ' C° 2Et
CH3S
12Sp/?Q or 125pS^
(Sp)-lsomalathion
(R)-0,S-dimethyl 
phosphorothiolated AChE
(S)-O.S-dimethyl 
phosphorothiolated AChE
i i  I | j  i i
c h 3o  CH3S
33S (S)-lsoparathion 33R (R)-lsoparathion
Methyl Methyl
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5.5-Reactivation o f  EEAChE and rMAChE inhibited bv the Stereoisomers o f
Isomalathion
If, as suggested by Scheme 5.2, the inhibition o f AChE by isoparathion methyl 
and isomalathion proceeds by a convergent mechanism then the reactivation profiles 
(reversible removal o f  phosphorus group) o f AChE inhibited by these two compounds 
should be comparable. In order to clarify the mechanistic ambiguity o f  these processes 
and attempt to identify the stereochemical influences upon reactivation, the rate constants 
for both spontaneous reactivation and reactivation in the presence o f the oximes 2-PAM 
and TMB-4 were determined experimentally for both EEAChE and rMAChE using Eqn. 
7. The results obtained from these studies are listed in Tables 5.8 and 5.9 and are 
presented graphically in Figures 5.5 and 5.6.
Table 5.8. Reactivation Data for EEAChE Inhibited by the Stereoisomers of
Isomalathion3.
Isomer
kj (spon) 
min-1 (xlO-3)
%
spontaneous
reactivation
kj (2-PAM) 
min-1 (xlO°)
% 2-PAM  
reactivation
ki (TM B-4) 
min-1 (xlCH)
% T M B -4  
reactivation
RpRc 5.3 ± 1 32 74 ± 19 85 79 ± 4 89
RpSc 2.2 ± 1 28 61 ± 2 0 72 76 ± 15 87
SpRc 0.3 ±  I <1 1.4 ± I 8 3 ± I 11
SpSc 0 ±  1 <1 1.2 ± 1 1.5 2.5 ±  I 4
an = 16
84
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 5.5. Reactivation Rate Constants (k3 xlO'3 min*1) for EEAChE Inhibited by the
Stereoisomers of Isomalathion.
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Table 5.9. Reactivation Data for rMAChE Inhibited by the Stereoisomers of
Isomalathion3.
Isomer
A'3  (spon) 
min-1 (xl(H)
% spontaneous 
reactivation
As (2-PAM) 
min*1 (xHH)
% 2-PAM  
reactivation
kj (TM B-4) 
min-1 (xlO-J)
% T M B-4  
reactivation
R PR C 1 4  ±  4 3 2 3 8  ± 6 8 2 8 0  ±  1 0 9 8
RpSc 4 .2  ± 2 18 3 1  ± 5 7 3 7 6 ±  11 9 7
SpRc 1 .8  ±  1 9 9 . 2  ± 3 13 1 0  ± 3 1 5
SpSc 0  ±  1 < 1 0 . 9  ±  1 1 .7 1 .2  ±  1 2 .3
an = 8
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Figure 5.6. Reactivation Rate Constants (k3 xlO'3 m in 1) for the Reactivation o f  
rMAChE Inhibited by the Stereoisomers o f Isomalathion.
70
60
40
30
20
RpRc RpSc SpRc SpSc
Following 20 h o f inhibition with each o f the isomalathion isomers, the EEAChE 
and rMAChE samples were diluted 100-fold with 0.1 M phosphate buffer to halt further 
inhibition. The spontaneous reactivation rate constants, k3, were calculated from the slope 
of the initial portion (0-10 min) o f  the graph generated by plotting ln(l00/%'mhibition) vs. 
time. Rate constants for oxime-mediated reactivation, k3 (2-PAM) and k3 (TMB-4), were 
determined in a similar fashion with the exception that the solution used to halt inhibition 
was 0.1 mM of the oxime used.
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By 60 min. both spontaneous and oxime mediated reactivation reached a plateau 
that was assigned the total percent reactivation relative to uninhibited enzyme. Enzyme 
activity was monitored for up to 24 h and in all cases only negligible increases in enzyme 
activity (>2 %) relative to the control was observed.
The ky values for EEAChE inhibited by RpRq or RpSc isomalathion obtained in the 
presence of 2-PAM, k 3  (2-PAM ), were 14- and 30-fold greater than those obtained for 
spontaneous reactivation. It is interesting that TMB-4 proved to be slightly more 
effective reactivating agent than 2-PAM for EEAChE inhibited by these isomers 
generating k 3  (TMB-4) values that were 15- and 36-fold greater than the £ 3  for 
spontaneous reactivation. A similar reactivation rate trend was observed for rMAChE 
inhibited by the isomalathion isomers. The k3  (2-PAM) values obtained were 3- and 7.4- 
fold greater than the k 3  for spontaneous reactivation while the ky (TMB-4) values 
obtained were 5.7- and 18-fold greater. That both spontaneous and oxime-mediated 
reactivation rates for these two diastereomers are so similar in magnitude suggests that 
the resultant phosphorylated enzymes were chemically and stereochemically equivalent.
This is in stark contrast with the results obtained from EEAChE and rMAChE 
inhibited by SpRq or SPSc isomalathion. These samples proved to be refractory to both 
spontaneous and oxime m ediated reactivation and showed only negligible amounts o f 
total returned activity following treatment with the oximes. The small amount of 
reactivation that was detected is most likely due to the 1-3 % contamination by the 
respective enantiomers that led to reactivateable enzyme.
A comparison o f  this data with the spontaneous and oxime-mediated reactivation 
rates reported for the inhibition o f  several sources o f AChE by the stereoisomers of
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isoparathion methyl suggest some intriguing mechanistic implications. EEAChE and 
rMAChE inhibited with the li?-isomalathion stereoisomers had £ 3  values that were not 
significantly different from each other and are similar to the £ 3  values for enzyme inhibited 
with the configurationally equivalent (S)-isoparathion methyl (Berkman 1993b; 
Jianmongkol 1999), which suggests that both /?p-isomaIathions and (S)-isoparathion methyl 
generate the Rp 0,S-dimethyl phosphate adduct upon reaction with AChE as depicted in 
Scheme 5.2.
In contrast, AChE inactivated by SpRc or SpSc isomalathion had significantly 
different Ar3  values from enzyme inhibited with the configurationally equivalent 
(^?)-isoparathior. methyl (Berkman 1993b; Jianmongkol 1999). As observed with other 
sources o f AChE, EEAChE and rMAChE inhibited with either of the Sp-isomalathion 
stereoisomers were found to be intractable to reactivation, even though the enzyme 
inhibited with the corresponding (/?)-isomer o f isoparathion methyl could be reactivated 
with a measurable rate. These surprising results indicate the Sp-isomalathions do not yield 
the expected 0,S-dimethyl phosphorylated AChE adducts with loss o f diethyl thiosuccinyl 
as the primary leaving group. Rather, they suggests that the Sp-isomalathions inhibit AChE 
by a different mechanism from that o f  the # P-isomalathions with loss o f thiomethyl as the 
primary leaving group to yield an inhibited enzyme containing a diethyl thiosuccinyl ligand 
capable o f undergoing further reactions that render the enzyme refractory to reactivation 
(Berkman 1993a; Berkman 1993b; Jianmongkol 1999).
Methoxy was discounted as the primary leaving group in the inhibition o f AChE by 
SpSc isomalathion for the following reasons. First, thiomethyl is predicted to be a better 
leaving group than the methoxy ligand. It is known that methanethiol (pKa =  10.0) is a
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stronger acid than methanol (pATa = 15.5), and its conjugate base is therefore better able to 
delocalize the resultant negative charge (Vollhardt 1999). Second. Thompson et al. 
demonstrated that inhibition of AChE with methamidophos proceeds primarily with loss o f 
thiomethyl instead o f  the methoxy group as depicted in Scheme 5.3 (Thompson 1982).
Scheme 5.3. Mechanism for the Inhibition of AChE by Methamidophos.
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- s c h 3
CH3O- 7  "SCH3
h 2n
34 methamidophos
AChE
Several of the postinhibitory processes that are possible following inhibition of 
AChE by either o f the two Sp-isomalathion stereoisomers are represented in Scheme 5.4. 
In path A, displacement of the thiosuccinyl ligand via a general base catalyzed 
mechanism is shown while path B depicts an intramolecular phosphorylation by a second 
enzyme residue and path C represents the [3-elimination o f diethyl fumarate or diethyl 
maleate. Another alternative to these mechanisms is occlusion of the approach of 
incoming nucleophiles (fTO or oxime) owing to steric crowding by the thiosuccinyl 
ligand. If the succinyl thiolester-phosphorus bond were cleaved by the action o f water or 
oxime, the remaining phosphoryl conjugate would become charged and therefore would 
be unable to undergo reactivation by nucleophiles.
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Scheme 5.4. Possible Non-Reactivatable Pathways for S P Isomalathion.
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With the aid o f our collaborators, Dr. Rudy J. Richardson and co-workers at the 
University o f Michigan in Ann Arbor, a study was carried out to determine the identity o f 
the adduct that renders AChE refractory towards reactivation when inhibited with SpSc 
isomalathion. Using matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF-MS), the hypothesis was tested that inactivation o f AChE by 
SpSc isomalathion proceeds with loss o f thiomethyl as the primary leaving group, and loss 
o f thiosuccinate as the secondary leaving group (Doom  2000). The results o f the study 
demonstrated that the identity o f  the adduct that renders EEAChE refractory or resistant 
towards reactivation after inhibition with SpSc isomalathion was in fact the O-methyl 
phosphate adduct as predicted by path A of Scheme 5.4. A peak with mass corresponding
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to the active site peptide containing the catalytic Ser with a covalently bound O-methyl 
phosphate adduct was found in the mass spectra o f treated but not control samples. 
Identities o f  the modified active site peptide and adduct were confirmed using reflectron 
MALDt-TOF-MS, and peaks corresponding to loss of adduct as phosphorous/phosphoric 
acid methyl ester were observed (Figure 5.7). The results demonstrate that inhibition of 
EEAChE by SPSc  isomalathion proceeds with loss o f thiomethyl instead of 
diethylthiosuccinyl as the primary leaving group followed by rapid expulsion of diethyl 
thiosuccinyl as the secondary leaving group to yield an aged enzyme.
Figure 5.7. Representative MALDI-TOF-MS Spectra o f Digested EEAChE 
Separated by HPLC Prior to Inhibition (panel A) and Following Inhibition (panel B)
with SpSc Isomalathion.
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Table 5.10 displays the average masses o f the measured and theoretical protonated 
molecular ion (MH~) corresponding to peptides o f interest. Figure 5.7 shows representative 
MALDI-TOF-MS spectra of digested EEAChE separated with HPLC. Panel A o f Figure
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5.7 shows a peak with mass corresponding to that o f  the unmodified active site peptide 
(2659.3 Da) containing the catalytic Ser found in the control sample. Panel B o f Figure 5.7 
shows the peak with a mass corresponding to that o f the active site peptide (2753.9 Da) 
containing the catalytic Ser with an O-methyl phosphate adduct found in the sample treated 
with SpSc isomalathion. Acid-catalyzed hydrolysis o f the OP adduct in the HPLC mobile 
phase may be responsible for presence o f  unmodified active site peptide.
Table 5.10. Masses of Theoretical and Observed MET1" for Unmodified and Modified
Active Site Peptides of EEAChE3.
preparation peptideb theoretical A m 
(theoretical)0
observed A m 
(observed)0
unseparated unmodified 2657.0 2659.3
modified 2751.0 94.0 2753.9 94.6
HPLC
separated
unmodified
modified
2657.0
2751.0 94.0
2658.0 
(± 0.9 )d 
2751.9 
(± l.0)d
93.9 
(± 1-3)
“Conditions used tor the preparation and analysis o f the active site peptide containing the 
catalytic Ser were as described in Doom 2000.
bActive site peptide containing the catalytic Ser in the control (unmodified) and SpSc 
isomalathion-treated (modified) samples.
“Difference in mass between modified and unmodified active site peptide which takes into 
account the Ser proton lost in the phosphorylation reaction.
dMean ± SE (n = 4 or 5 experiments for unmodified and modified samples, respectively).
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The data generated by this study provides the first direct chemical identification o f 
the OP adduct formed following inhibition o f  EEAChE with SpSc isomalathion. The 
identity of the adduct resulting from inhibition o f  EEAChE with SpSc isomalathion as 
determined by MALDI-TOF-MS is strikingly different from that predicted by the 
conventional mechanism o f  inhibition and aging (Scheme 5.2). That the HPLC and 
MALDI-TOF-MS analysis o f peptides of electric eel enzyme did not reveal any peaks with 
mass representing the active site peptide with an O.S-dimethyl phosphate or O-methyl 
thiophosphate adduct is further evidence that that inhibition of EEAChE by SpSc 
isomalathion proceeds with loss o f  thiomethyl instead of diethylthiosuccinyl as the primary 
leaving group followed by rapid expulsion of diethyl thiosuccinyl as the secondary leaving 
group to yield an aged enzyme as depicted in Path A o f Scheme 5.4.
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5.6-Inhibition o f EEAChE by the ITP Stereoisomers 
To further examine the stereoselective inhibition o f EEAChE, and define the 
correlation between stereochemistry and the leaving group differences, the inhibitory 
profiles of the individual ITP stereoisomers were determined in a concentration-dependent 
manner as described in Methods 3 and 4 o f Section 7.3.3 using Eqn. 2. The kinetic data 
that was collected is presented in Table 5.11.
A 7.9-fold difference in anti-AChE potency was found between the strongest 
isomer, /?P̂ C-ITP, and weakest isomer, SpSc-ITP. The ITP stereoisomers with Rc 
configuration displayed greater inhibitory potency toward EEAChE than those that had the 
Sc configuration, similar to the results obtained from the inhibition off EEAChE by the 
stereoisomers o f isomalathion. However, the attenuation o f the inhibition reaction by the 
stereogenic carbon was further modulated by the chirality o f the phosphorus-containing 
portion o f the molecule. The difference in inhibitory strength when changing the 
configuration at carbon from Rc to Sc was 4-fold when the configuration at phosphorus was
S. In contrast, the difference was 4.8-fold when comparing the two isomers that had the R 
configuration at phosphorus. In a similar fashion, the carbon stereocenter attenuated the 
effect on inhibitory potency exerted by the stereochemical orientation o f the phosphorus. A 
comparison of the isomers that had S or R configuration at the phosphorus demonstrate a
1.8-fold difference in inhibitory potency when the stereochemical orientation o f the carbon 
is R , but only a 1.2-fold difference in inhibitory potency is observed for the stereoisomers 
with the S configuration at carbon. These observations suggested that the carbon and 
phosphorus asymmetric centers o f ITP isomers act independently during the inhibition o f 
EEAChE and are consistent with the observations obtained during the analysis o f  EEAChE
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inhibited by the isomalathion stereoisomers. That the stereochemical orientation of the 
carbon has less o f an effect on the inhibitory potency by an OP compound with two 
stereocenters relative to the influence o f  the configuration at phosphorus is also consistent 
with the observations obtained during the analysis o f EEAChE inhibited by the 
isomalathion stereoisomers.
Table 5.11. Concentration Dependent Kinetic Data for the Inhibition of EEAChE by
the ITP Stereoisomers3.
Isomer k i  (xlO3 M'1 min'1) KD(piM) A'p (m in 1)
RpRc 110 ± 12 15 ±  9 1.6
RpSc 23 ± 6 3 ± 1 0.07
S p R c 56 ± 13 12 ± 4 0.66
SpSc 14 ± 5 26 ± 4 0.36
an = 20
The kinetic parameters K d and ky were also determined for the interactions of the 
individual ITP stereoisomers with EEAChE. As observed for the stereoisomers of 
isomalathion, the k\ values typically paralleled the disassociation constants, K d, such that 
the isomer with the greater affinity for the active site was the stronger inhibitors. An 
example o f this is displayed by the 2.2-fold stronger affinity for (or weaker disassociation 
from) the active site determined for the SyRc-isomer versus its SpSc counterpart and was a
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4-fold more potent inhibitor. However, as implied by Eqn. 2 a compound’s affinity for the 
active site is not the only determinant o f inhibition. A comparison o f the Kd values 
obtained for the ^?pi?c-isomer and the 5pSc-isomer would lead one to expect less than a 2- 
fold difference in inhibitory potency. Yet the two isomers demonstrate a 7.8-fold 
difference in inhibitory potency. These observations can, in part, be rationalized by the 
relative magnitude of kp ( 1.6) for the RpRc- isomer. The reactivity o f the compound toward 
the enzyme. kp. partially compensates for its comparatively low affinity toward the active 
site.
The values determined for the kinetic parameter kP during the inhibition o f 
EEAChE by RpRc- and R PSc~ stereoisomers are considerably different ( 1.6 vs. 0.07, 
respectively). These observations are in contrast with those obtained from the inhibition o f 
EEAChE by the stereoisomers o f isomalathion, which demonstrated nearly identical kp 
values for the corresponding isomers. This suggests that unlike the isomalathion 
stereoisomers, inhibition o f EEAChE by RpR c-  and /?p5’c-ITP is dependent upon the 
stereochemical orientation o f the asymmetric carbon present in the thiosuccinyl portion of 
the molecule. This is further demonstrated by the fact that the isomers with R  configuration 
at carbon are, for EEAChE, the strongest pair o f  inhibitors and have the highest kp values.
The time-dependent method for determining the bimolecular rate constant o f 
inhibition was also performed to compare with the concentration dependent method and the 
values obtained are presented in Table 5.12. The values generated by both methods are in 
good general agreement (time-dependent values proportionally lower) and are contrasted 
graphically in Figure 5.8. In particular, it is noteworthy that the rank order o f  inhibitory 
potency (RpRc > SPRc > RpSc > -SpSc) is conserved between the two methods.
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Table 5.12. Time Dependent Bimolecular Rate Constants of Inhibition
(A', xlO3 M'1 min'1) for the Inhibition of EEAChE by the ITP Stereoisomers3.
Isomer k ,  (xlO3 M'1 min ')
R p R c 66 ± 4
R p S c 9 ± 1
S p R c 17 ± 5
S p S c 5 ± 1
an = 10
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Figure 5.8. Comparison of the Bimolecular Rate Constants of Inhibition 
(A'; xlO3 M'1 min'1) Obtained by the Concentration Dependent Method and Time 
Dependent Method for the Inhibition of EEAChE by the ITP Stereoisomers
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5.7-Inhibition o f rMAChE bv the ITP Stereoisomers 
For comparison with EEAChE inhibited by the ITP stereoisomers and with the data 
obtained from the inhibition o f rMAChE by the stereoisomers o f isomalathion the 
stereodependent inhibition of rMAChE by the ITP isomers was determined in a 
concentration dependent manner using Methods 3 and 4 o f Section 7.3.3 and Eqn. 2. In 
addition, the stereodependent inhibition profiles o f rat cerebellum AChE (RCAChE) and
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rat spine AChE (RSAChE) inhibited by the ITP isomers were determined (numeric data not 
shown) for further comparison. The results obtained from rMAChE are listed in Table 5.13 
and are contrasted with the values obtained from the inhibition o f RC AChE, RSAChE, and 
EEAChE graphically in Figure 5.9.
Table 5.13. Concentration Dependent Kinetic Data for the Inhibition of rMAChE by
the ITP Stereoisomers3.
Isomer ki (xlO3 M 1 m in 1) kp (m in 1)
RpRc 220 ±  17 36 ± 5 8.0
RpSc 110 ±  12 15 ±  4 1.6
SpRc 82 ± 8 25 ± 5 2.0
SpSc 9 ± 4 73 ±  13 0.68
an = 20
The k\ values from the inhibition o f  rMAChE by the ITP stereoisomers were 
roughly 2-fold greater than those observed during the inhibition o f EEAChE. The one 
exception to this trend is the k\ value obtained for the inhibition o f rMAChE by the SpSc 
isomer, which was only two thirds the value obtained from the inhibition of EEAChE by 
the same isomer. A 23.7-fold difference in anti-AChE potency was found between the 
strongest isomer, i?p7?c-ITP, and weakest isomer, SpSc-ITP. This difference is three times 
greater that observed during the inhibition EEAChE by the same isomers. That rMAChE is
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better able to discriminate between the stereoisomers than EEAChE is consistent with the 
data obtained during the study o f  the interactions o f isomalathion stereoisomers with the 
same enzyme sources. The ITP stereoisomers with Rp configuration displayed greater 
inhibitory potency toward rMAChE than those that had the 5p configuration, similar to the 
results obtained from the inhibition o f rMAChE by the stereoisomers o f  isomalathion. 
Attenuation o f the inhibition reaction by the stereogenic phosphorus was also modulated by 
the chirality o f the asymmetric carbon present in the molecule. The difference in inhibitory 
strength when changing the configuration at carbon from Rp to Sp was 11.8-fold when the 
configuration at carbon was S. In contrast, the difference was 2.2-fold when comparing the 
two isomers that had the R configuration at carbon. In a similar fashion, the phosphorus 
stereocenter attenuated the effect on inhibitory potency exerted by the stereochemical 
orientation of the carbon. A comparison of the isomers that had S  or R configuration at 
carbon demonstrate only a 2-fold difference in inhibitory potency when the stereochemical 
orientation o f the phosphorus is /?, but an 8.8-fold difference in inhibitory potency is 
observed for the stereoisomers with the S' configuration at phosphorus. These observations 
demonstrated that the carbon and phosphoms asymmetric centers o f  ITP isomers act 
independently during the inhibition o f rMAChE and are consistent with the observations 
obtained during the analysis o f  EEAChE and rMAChE inhibited by the isomalathion 
stereoisomers. That the stereochemical orientation of the carbon has less o f an effect on the 
inhibitory potency o f  an OP compound with two stereocenters relative to the influence of 
the configuration at phosphorus is also consistent with the observations obtained during the 
analysis of EEAChE and rMAChE inhibited by the isomalathion stereoisomers.
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The kinetic parameters KD and kP were also determined for the interactions o f the 
individual ITP stereoisomers with rMAChE. In contrast with the observations obtained for 
the stereoisomers o f isomalathion, the k\ values did not typically parallel the disassociation 
constants. Ko- An example o f this is shown by the following data. The RpSc isomer had a 
2.4-fold stronger affinity for (or weaker disassociation from) the active site than determined 
for the RpRc  but surprisingly, the RpRc  isomer was a 2-fold more potent inhibitor. These 
observations can, in part, be rationalized by the extremely high value o f kp (8.0) observed 
for the RpRc- isomer. The reactivity o f  the compound toward the enzyme, £p, partially 
compensates for its comparatively low affinity for toward the active site.
The values determined for the kinetic parameter kp during the inhibition of 
rMAChE by R PRc  and RpSc stereoisomers are different by 5-fold. These observations are 
in contrast with those obtained from the inhibition o f rMAChE by the stereoisomers of 
isomalathion, which demonstrated nearly identical kp values for the corresponding isomers. 
This suggests that, unlike the isomalathion stereoisomers, inhibition o f rMAChE by RpRc- 
and i?P5c-ITP is dependent upon the stereochemical orientation o f the asymmetric carbon 
present in the thiosuccinyl portion o f  the molecule consistent with observations obtained 
for EEAChE inhibited by the ITP stereoisomers.
102
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 5.9. Bimolecular Rate Constants (A', xlO3 M"1 min'1) for the Inhibition of AChE
from Different Sources by the ITP Stereoisomers.
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The data from the inhibition of EEAChE and rMAChE imply that the ITP 
stereoisomers are interacting with these sources o f  AChE in a manner that is distinct from 
the mechanisms observed for the isomalathion stereoisomers despite their inherent 
structural similarities. This is surprising considering the observed values for the kinetic 
parameter k\ for both sets o f  stereoisomers are very similar in both rank order and 
magnitude as demonstrated in Figure 5.10.
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Figure 5.10. Comparison of the Bimolecular Rate Constants (A,- xlO3 M'1 min'1)
Determined for the Inhibition of EEAChE and rMAChE by the ITP Stereoisomers
and the Stereoisomers o f Isomalathion.
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An examination o f the general ITP structure reveals that, like the isomalathion 
stereoisomers, there are two potential leaving groups present in the molecule. Therefore, 
inhibition o f AChE by the ITP stereoisomers has the potential to generate two different 
phosphorylated adducts as depicted in Paths A and B o f  Scheme 5.5. The kinetic data 
presented in Sections 5.3-5.5 combined with the MALDI-TOF-MS analysis o f  EEAChE 
presented in Section 5.5 provide compelling evidence for the hypothesis that the inhibition 
o f AChE by the stereoisomers o f isomalathion occurs via different mechanisms dependent
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upon the stereochemical orientation of the phosphorus moiety (see Scheme 5 .1). That the 
two groups o f  stereoisomers demonstrated subtle differences in the observed kinetic 
parameters K& and kp warranted further investigation.
Scheme S.5. Possible AChE Adducts Resulting from Inhibition by the ITP
Stereoisomers.
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5.8-Reactivation of EEAChE and rMAChE inhibited by the ITP Stereoisomers
If, as suggested by the inhibition kinetic data in the two previous sections, the 
inhibition o f AChE by the ITP and isomalathion stereoisomers proceeds by divergent 
mechanisms, then the reactivation profiles o f  AChE inhibited by paths A and B (Scheme 
5.5) should be quite different. In an attempt to clarify the mechanistic ambiguity o f these 
processes and to identify the stereochemical influences upon reactivation the rate 
constants for both spontaneous reactivation and reactivation in the presence o f  the oximes 
2-PAM and TMB-4 were determined experimentally for both EEAChE and rMAChE 
using Eqn. 7. The results obtained from these studies are listed in Tables 5.14 and 5.15 
and are presented graphically in Figures 5 .1 1 and 5.12.
Following 20 h o f  inhibition with each o f the ITP isomers, the EEAChE and 
rMAChE samples were diluted 100-fold to halt further inhibition. The spontaneous 
reactivation rate constants, £3 , were calculated from the slope o f  the initial portion (0 - 1 0  
min) o f the graph generated by plotting ln(100/%inhibition) vs. time as described 
previously. Rate constants for oxime-mediated reactivation, k 3  (2-PAM) and £ 3  (TMB-4), 
were determined in a similar fashion with the exception that the solution used to halt 
inhibition was 0 .1 mM o f the oxime used.
By 60 min, both spontaneous and oxime mediated reactivation reached a plateau 
that was assigned the total percent reactivation relative to uninhibited enzyme. Enzyme 
activity was monitored for up to 24 h and in all cases only negligible (> 2 %) increases in 
enzyme activity, relative to the control, were observed.
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Table 5.14. Reactivation Data for EEAChE Inhibited by the ITP Stereoisomers3.
Isomer
Ji3 (spon) 
min-1 (xlO-3)
% spontaneous 
reactivation
A-s (2-PAM) 
min-' (xlO-3)
% 2-PAM  
reactivation
ki (TM B-4) 
min-1 (x lO 3)
% T M B-4 
reactivation
RpRc 13 ± 2 27 148 ± 2 0 93 179 ±27 97
RpSc 19 ± 5 35 49 ± 13 67 48 ± 15 69
S pR c 0.6 ± I 4 202 ±  30 95 189 ± 33 91
SpSc 2.3 ± 1 15 55 ± 14 72 73 ± 13 79
an =  16
Figure 5.11. Rate Constants (£ 3  xlO'3 min'1) for the Reactivation of EEAChE
Inhibited by the ITP Stereoisomers.
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Table 5.15. Reactivation Data for rMAChE Inhibited by the ITP Stereoisomers.
Isomer
ki (spon) 
mirr* (xlO-3)
%  spontaneous 
reactivation
A-3 (2-PAM) 
min-1 (xlO-5)
% 2-PAM  
reactivation
it3 (TMB-4) 
min-1 (xlO-3)
% T M B -4  
reactivation
RpRc 3 ± 1 9 137 ± 15 91 163 ± 17 95
RpSc 5 ± 2 15 43 ± 6 52 40 ± 13 61
S pRc 0.8 ± I 190 ± 8 98 189 ±11 97
SpSc 8.2 ± 3 27 41 ± 7 61 7 0 + 1 0 80
an = 8
Figure 5.12. Rate Constants (A3 xlO'3 min"1) for the Reactivation of rMAChE
Inhibited by the ITP Stereoisomers.
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The fa values for EEAChE inhibited by the RpRc or SpRc ITP stereoisomers 
obtained in the presence o f 2-PAM, k 3  (2-PAM), were 11.4- and 336-fold greater than 
those obtained for spontaneous reactivation. In the presence o f the oxime TMB-4, these 
isomers generated k3 (TMB-4) values that were 13.8- and 3 15-fold greater than the £3  for 
spontaneous reactivation. A similar trend was observed for rMAChE inhibited by the 
same isomers. The £ 3  (2-PAM) values obtained were 46- and 237- fold greater than the 
£ 3  for spontaneous reactivation while the fa (TMB-4) values obtained were 54- and 236- 
fold greater. That both the spontaneous and oxime-mediated reactivation rates for these 
two diastereomers are so similar in magnitude for both enzyme sources suggests that the 
resultant phosphorylated enzymes undergo similar mechanisms o f reactivation.
This is in stark contrast with the results obtained from EEAChE and rMAChE 
inhibited by RpSc or SpSc ITP stereoisomers. For both enzyme sources these isomers 
demonstrated very limited spontaneous and oxime mediated reactivation and 
demonstrated only a partial return o f  activity following treatment with the oximes.
While these results are fairly consistent with the values o f kp and Ko obtained from 
the inhibition of EEAChE and rMAChE by the ITP stereoisomers, they contrast 
surprisingly with the kinetic behavior observed for the isomalathion stereoisomers with the 
same enzyme sources. It was assumed that replacing the thiomethyl moiety present in the 
isomalathion stereoisomer with a functionality that was a better leaving group would result 
in a set o f  compounds that would demonstrate similar, i f  not enhanced, kinetic behavior. 
That the kinetic parameters observed for the ITP stereoisomers are so divergent from those 
o f  the isomalathion stereoisomers suggests that this assumption was based upon an
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oversimplification o f  the processes that influence the tendency o f a compound to 
demonstrate anti-AChE potency and to undergo the postinhibitory reaction of aging.
It is possible that the steric and electrostatic differences between the two ligands 
cause the molecules to assume different orientations thus altering their interactions with the 
enzyme. That the k\ values obtained for the ITP stereoisomers are comparable in both 
magnitude and stereochemical preference to the isomalathions and other structurally 
equivalent asymmetric OP compounds implies the ITP stereoisomers initial approach to. 
and interactions with, the active site o f the enzyme follow a mechanism that is common to 
these types o f compounds. However, comparison o f the kinetic parameters kp, and £ 3  
(both spontaneous and oxime-mediated) obtained form the inhibition o f EEAChE and 
rMAChE by the ITP stereoisomers and the isomalathions reveal distinct differences. These 
differences may be the result o f  slight perturbations in the architecture o f the enzyme’s 
active site.
In the case o f the isomalathion stereoisomers it was shown that the primary leaving 
group was either the thiomethyl ligand or the thiosuccinyl ligand depending primarily upon 
the stereochemical orientation o f the phosphorus moiety. The enhanced displacement 
reactivity o f  the p-nitrophenoxy ligand present in the ITP stereoisomers relative to that o f 
the thiosuccinyl ligand may result in greater competition between these two potential 
leaving groups. This may result in two distinct sets o f  phosphorylated enzymes following 
inhibition by a single ITP isomer, the populations o f which are dependent upon the 
stereochemical orientation o f the phosphorus moiety (see Scheme 5.5).
This hypothesis might explain the observed £ 3  values obtained from the inhibition 
o f EEAChE and rMAChE by the ITP stereoisomers. Very little spontaneous reactivation
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was observed for both enzyme sources regardless o f which isom er was used for the 
inhibition reaction. In contrast, at least some oxime-mediated reactivation was observed in 
all cases, the magnitude o f which was directly related to the stereochemical orientation o f 
the asymmetric carbon. If the ITP stereoisomers assume an orientation with the 
phosphonyl oxygen positioned within the putative oxyanion hole and the phosphorylated 
serine apical to the position that was occupied by the ejected leaving group, as suggested by 
the crystal structures o f  AChEs inhibited by other OP compounds (Millard 1999a: Millard 
1999b; Ordentlich 1999). then the stereochemical orientation about the phosphorus moiety 
of the OP-AChE adduct is essentially “locked” into place following the inhibition reaction 
(Hosea 1995; Wong 2000). As the ITP stereoisomers contain two potential leaving groups, 
one o f which possesses a center o f asymmetry, this alignment imposed by the structural 
constraints o f  the enzymes active site implies that six unique AChE conjugates are possible 
following the inhibition o f AChE. If these putative adducts were to undergo the 
postinhibitory reactions o f reactivation or aging, it is feasible that they would do so in a 
stereodependent manner as the three dimensional orientation o f  the ligands present could 
directly impact the accessibility o f the reactivating nucleophiles (tTO  or oxime) to the 
phosphorylated active site. Conversely, the steric bulk of the remaining ligands combined 
with their inherent stereochemical orientation may perturb the optimal alignment o f the 
phosphonyl oxygen within the putative oxyanion hole due to the dimensional constraints 
imposed by the gorge structure, thus reducing the susceptibility o f  the phosphorylated 
enzyme to nucleophilic attack (Ashani 1995; Wong 2000). A schematic representation of 
these possibilities is shown in Scheme 5.6. Note that for the purpose of illustration the 
view presented in Scheme 5.6 is looking down the P=0 bond.
I l l
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Scheme 5.6. Possible Inhibitory and Postinhibitorv Mechanisms for the Inhibition of
AChE by the ITP Stereoisomers.
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5.9-Observation of Abnormal Kinetics 
As mentioned previously, during the time-dependent determination o f the rate 
constant o f inhibition for the stereoisomers of isomalathion versus EEAChE. it was 
observed that the Rp isomers afforded consistently abnormal data as depicted in Panel B o f 
Figure 5.3. These observations were so intriguing that a detailed kinetic analysis o f this 
phenomenon was conducted on the RpSc isomer o f isomalathion. The averages of three 
individual assays at six different inhibitor concentrations are represented graphically in 
Figure 5.13 and a comparison o f  the results obtained is presented in Table 5.16.
Table 5.16. Comparison o f the Kinetic Parameters Obtained at Different 
Concentrations of RpSc Isomalathion.
Experiment M
Relative [ij 
M o/[*]a
Aobs
Relative A0bS
(A’obs)o/ (A’obs).V
A, Relative Aj , 
(A O o W a  y In tC rC ept
A 4.07 X  10° I -4.60 x 10° 1 628 I 1.89
B 1.42 X 10^ 3.49 -6.51 x 10'3 1.42 106 0.168 1.86
C 2.76 X  I0a 6.78 -8.84 x 10'3 1.92 74 0.117 1.86
D 4.60 X 10"4 11.30 -1.20 x I O'2 2.60 60 0.095 1.86
E 1.42 X  I O'3 34.87 -2.12 x I O'2 4.60 34 0.054 1.77
F 2.76 X 10’3 67.78 -2.97 x 10'2 6.46 24 0.039 1.58
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Figure 5.13. Comparison of the A'„bs at Different Concentrations of RpSc Isomalathion
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It is interesting to note that although the rate o f inhibition is first order, the lines do 
not converge at 100% activity as would be expected. Another interesting characteristic of 
the data is that the first order rates are not linearly related to the concentration o f  the 
inhibitor. Similar kinetics have been noted for the compounds coroxon and haloxon 
(Aldridge 1969, 1975). More recently it has been demonstrated that paraoxon and methyl 
paraoxon also exhibit this behavior at extremes of concentration (Kardos 2000). The 
intercepts on the vertical access indicate a considerable degree o f  inhibition, which must be 
produced very quickly. The same inhibition was obtained when the inhibitor and substrate
114
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are added either together or the substrate was added first. Such findings suggest a rapid 
equilibrium process, which is usually characteristic of reversible inhibition.
Another theoretical explanation for this phenomenon is that the inhibitor and 
substrate react together to produce a reversible inhibitor. However, this is unlikely for the 
following reasons: (1 )-if the inhibitor is added to the enzyme just after or together with the 
substrate the same inhibition is obtained, (2)-if the substrate and the inhibitor are 
preincubated before the enzyme is added, the inhibition is independent o f the time o f  the 
incubation, and (3)-the reversible inhibition decreases with increasing concentrations of 
substrate. These factors suggest that the explanation o f the unexpected kinetic behavior 
must be made on the basis o f the compound being the active inhibitor. It has also been 
suggested that these results may be caused by rapid reactivation o f the inhibited enzyme. 
However, this possibility was discounted by the observation o f similar kinetics for the SpSc 
isomalathion isomer, a compound that has been demonstrated to age rapidly (Doom 2000).
Another possible explanation for the abnormal kinetic behavior observed during the 
inhibition o f  AChE by a number o f compounds involves a second binding site on the 
protein that is distinct from the active site. Reversible binding to this other site is thought 
to impede subsequent phosphorylation o f the active site by either causing steric occlusion 
o f the gorge entrance or through allosteric modification o f the enzymes function thereby 
decreasing the reactivity o f  the active site. The existence o f a peripheral binding site was 
first suggested by Changeux (Changeux 1966) and was later implicated as causing the 
abnormal kinetic behavior observed by Aldridge and Reiner for the compounds coroxon 
and haloxon (Aldridge 1969, 1975). Numerous studies using site-specific mutagenesis 
have since established the existence of a peripheral binding site that binds ligands such as
115
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propidium and fasciculin (Shafferman 1992; Barak 1994; Radic 1994; Velan 1996). 
However, the exact mechanism by which these compounds inhibit the hydrolysis o f ACh 
remains ambiguous (and the source o f  much debate) as they have demonstrated elements 
indicative of both steric occlusion and allosteric modulation (Taylor 1975. 1994; Berman 
1980; Radic 1984, 1991. 1995, 1999, 2000; Barak 1995; Bourne 1995; Rosenberry 1996. 
1999; Velan 1996; Szegletes 1998. 1999; Mallender 1999, 2000).
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5 .10-Conclusions
1. The synthetic route proposed by Berkman et al. (1993b) was demonstrated to be 
a reliable method for the generation o f  the individual stereoisomers o f  
isomalathion.
2. Combination o f  key reactions from the syntheses o f isomalathion and 
isoparathion methyl was demonstrated to be an effective method to generate the 
individual stereoisomers o f a new stereo isomeric isoparathion thiosuccinate 
phosphorothiolate (ITP) compound.
3. Comparison o f the inhibitory kinetic profiles for the isomalathion stereoisomers 
vs. EEAChE and rMAChE demonstrated both stereoselectivity in inhibitory- 
potency o f  the stereoisomers and species-dependent variations in 
stereoselectivity.
4. The postinhibitory kinetic profiles for the isomalathion stereoisomers vs. 
EEAChE and rMAChE demonstrated that, as suggested by examination o f the 
kinetic parameters KD and /rp, the stereochemical orientation o f the phosphorus
. atom directly affects both the mechanisms of inhibition and the postinhibitory 
mechanisms associated with aging or nonreactivation.
5. MALDI-TOF-MS analysis o f  EEAChE inhibited by the isomalathion 
stereoisomers confirmed the presence o f two distinct mechanisms o f inhibition 
dependent upon the stereochemical orientation of the phosphorus atom (i.e. loss 
of the thiosuccinyl or thiomethyl ligand).
6 . The inhibitory kinetic profiles for the ITP stereoisomers vs. EEAChE and 
rMAChE were similar in both magnitude and rank order o f  inhibitory potency
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to those observed for the isomalathion stereoisomers and other structurally 
equivalent asymmetric OP compounds. This implies the ITP stereoisomers 
initial approach to, and interactions with, the active site o f  the enzyme follow a 
mechanism that is common to these types o f  compounds.
7. The spontaneous and oxime-mediated reactivation rates for EEAChE and 
rMAChE inhibited by the RPRc or SPRC ITP stereoisomers were similar in 
magnitude for both enzyme sources. This suggests that the resultant 
phosphorylated enzymes undergo similar mechanisms o f reactivation.
8 . The spontaneous and oxime-mediated reactivation rates obtained from 
EEAChE and rMAChE inhibited by RPSc or SpSq ITP stereoisomers were 
similar in magnitude for both enzyme sources, but were considerably lower 
than those observed for their corresponding enantiomers (R pRq or SPRc ITP). 
This suggests the OP-AChE adducts that result from inhibition by this pair of 
diastereomers are different from those generated by the inhibition o f AChE by 
the RpRq or S pRq ITP stereoisomers.
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C h a p t e r  6
FUTURE WORK
Stereoselective inhibition o f  other g/B-hvdrolases 
As AChE is a member o f  the a/p-hydrolase superfamily, it would be of 
biochemical and toxicological interest to determine whether related enzymes are 
stereoselectively inhibited by the ITP and isomalathion stereoisomers. In particular, it 
would be interesting to determine whether the difference in mechanism of AChE 
inactivation between the Rp and the Sp isomers is conserved for other oc/(3-hydrolases. Such 
a study would further our understanding o f the mechanistic commonalities and differences 
that exist among the members o f this enzyme superfamily and would provide information 
about other potential targets o f  OP poisoning.
Stereoselective Inhibition o f Carboxvlesterases 
The mammalian toxicity o f commercial malathion preparations is believed to be 
attenuated by the isomalathion content through inhibition o f  carboxvlesterases. The 
stereodependent inhibitory' profile o f the isomalathion stereoisomers vs. these enzymes 
should be examined and contrasted with their corresponding anti-AChE potencies. This 
type o f analysis may provide a better understanding of the toxicological profiles o f the 
individual stereoisomers and aid in the identification of the contribution of each
119
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stereoisomer to the overall toxicity o f a racemic mixture. The ITP and isomalathion 
stereoisomers may also provide a means to pharmacologically characterize the 
polymorphic variants that have been demonstrated for a number o f  esterases.
Stereoselective inhibition o f  other A C hE’s 
Site-specific mutagenesis of AChE has generated a number o f mutants in resent 
years. The ITP and isomalathion stereoisomers may be valuable tools for the examination 
o f reactivity in relation to the geometric confines o f the active center o f  AChE. A 
combined understanding o f the structure o f AChE and its mutants with the enantiomeric 
selectivity they display for OP compounds constitutes a powerful approach for delineating 
the orientation o f the reactants involved in OP inhibition and reactivation o f AChE. Also, 
an examination o f the inhibition and reactivation profiles o f AChE from other sources 
inhibited by the ITP or isomalathion stereoisomers may reveal novel species-dependent 
variations in the mechanisms of inhibition and reactivation.
MALDI-TOF-MS Characterization o f the Adducts Formed bv the Inhibition o f AChE
bv the ITP Stereoisomers
The inhibitory and postinhibitory kinetic profiles o f EEAChE and rMAChE
inhibited by the ITP stereoisomers suggest that, as observed for the isomalathions, the
mechanisms of inhibition and nonreactivation are determined by the stereochemical
orientation o f the particular isomer. However, the postinhibitory data obtained from
inhibition o f  EEAChE and rMAChE by the ITP stereoisomers were considerably different
from that obtained with the isomalathion stereoisomers. MALDI-TOF-MS characterization
o f AChE inhibited by the ITP stereoisomers would allow direct chemical determination of
120
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the adducts formed, and would elucidate the ambiguity concerning the identity o f the 
primary leaving group. It would also further our understanding o f  the mechanism o f ITP 
inhibition o f AChE.
M olecular Docking Studies 
The availability o f  the X-ray crystal structures for a number o f AChE’s and other 
esterases allows molecular modeling o f the ITP and isomalathion stereoisomers within the 
active sight o f  the enzymes. Molecular docking studies would lend further insight into the 
proposed stereochemically determined shift in primary leaving group that is suggested by 
the inhibitory and postinhibitory kinetic data that has been determined for the two sets of 
stereoisomers. Analysis o f the results obtained from such studies combined with those 
from MALDI-TOF-MS characterization o f  the adducts formed by the inhibition of AChE 
by the ITP and isomalathion stereoisomers would increase our understanding o f the 
structural features of the AChE active site and gorge that influence the mechanisms of 
inhibition and nonreactivation.
Immunological Characterization o f  AChE Inhibited bv the ITP and Isomalathion
Stereoisom ers
The processes o f inhibition and aging o f  AChE following treatment with the ITP or 
isomalathion stereoisomers may result in a modification o f the enzymes three-dimensional 
structure. Perturbations o f  the enzyme’s native structure may cause the enzyme to be “mis- 
recognized” by an organism’s immune system. In addition to possibly eliciting deleterious 
immunological effects in vivo, the resultant formation o f antibodies against the modified
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enzyme may provide a means o f detecting and/or purifying AChE that has been exposed to 
an OP compound.
Further Evaluation o f  the Abnormal Kinetic Behavior Observed D uring the Inhibition
ofEEA ChE
The abnormal kinetics observed during the inhibition of EEAChE should be more 
rigorously investigated. As discussed in Section 5.9. the results obtained with high 
concentrations o f the inhibitor were significantly different than the results obtained for the 
same inhibitor at lower concentrations (see Table 5.16 and Figure 5.13). This trend was 
observed for all OP inhibitors screened during this study, including DFP and SpSc 
isomalathion, which implies that the phenomenon is due to some inherent property of 
AChE. The data further suggests that RpSc isomalathion is interacting with a site on the 
enzyme that is distinct from the active site. However, it is not possible to ascertain from 
this data whether this secondary interaction occurs at the peripheral anionic site or some 
other region o f the enzyme. In order to delineate this ambiguity, it will be necessary to 
repeat the kinetic analysis o f  these inhibitors in the presence and absence o f  AChE 
peripheral site inhibitors such as fasciculin, gallamine, D-tubocurarine, and propidium.
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C h a p t e r  7
EXPERIMENTAL
7.1 -General
Commercially available reagents were purchased from Aldrich Chemical Co., 
Milwaukee, WI. All solvents and reagents were purified when necessary by standard 
literature methods. Melting points were determined on a Fisher-Johns melting point 
apparatus. Analytical thin-layer chromatography (TLC) was conducted on E. Merck 
aluminum-backed, 0.2 mm silica gel 60 F2 5 4 , TLC plates. Flash chromatography was 
performed with Kieselgel 60, 230-400 mesh (Merck). Elemental analyses were performed 
by Midwest Microlab Ltd., Indianapolis, IN.
Proton ( ‘H), carbon ( IjC), and phosphorus (3 IP) NMR spectra were recorded on a 
Varian VXR 400-NMR instrument in deuterated chloroform (CDCI3) unless specified 
otherwise. Pertinent proton frequencies are tabulated in the following order: chemical shift 
(* in ppm), multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet), coupling 
constant (J in  hertz), and the number of hydrogens. Proton and carbon frequencies o f 
spectra obtained are relative to chloroform ('H , 7.24 ppm; l3 C, 77.0 ppm) as an internal 
standard unless specified otherwise. Phosphorus chemical shifts are relative to phosphoric 
acid (H3PO4) in CDCI3 as an external standard.
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Caution: The OP chemicals synthesized and used in this study are hazardous 
anticholinesterases and should be handled by trained personnel in a well-ventilated hood. 
The OP chemicals described are hydrolyzed by 3 M  NaO H to render them inactive as 
AChE inhibitors.
7.2-Svn thesis
? ° 2 H E tO H  r  f ° * E t
H cA - - 0 0 ^  HCI(g) H O ' ^ - ' C ° 2E t
29R 30R
(/?)-Diethyl malate (30/?). This synthesis has been described previously (Cohen 
1966) and is presented here with slight modification. HC1 gas was bubbled through a 
solution o f (/?)-malic acid (20 g, 150 mmol) in 200 mL o f  absolute ethanol for 20 min. The 
solution was then capped, sealed, and stored at 0 °C for 48 h. Purification via Kugelrohr
distillation (80 °C at 0.6 mm Hg) gave a colorless oil (26.95 g, 94 % yield), [a]^ = + 9.59°
(c -  0.55, CHCI3 ). ‘H NMR 6  1.27 (t, J  = 7.2 Hz, 3 H), 1.31 (t, J =  7.2 Hz, 3 H), 2.75-2.90 
(m, 2 H), 4.18 (q, J=  7.1 Hz, 2 H), 4.28 (q, J =  7.2 Hz, 2 H), 4.49 (t, J  = 5.3 Hz. 1 H). ,3C 
NMR 5 14.0,38.7,60.9,61.9,67.2, 170.4, 173.
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Q 0 2H EtOH Q 02Et
H O ^ C° 2H HCI(s) H O ^ C° 2Et
2 9 S  30S
(5)-Diethyl malate (305). Prepared as described for 30R  starting with (5) malic 
acid 295 (20 g, 150 mmol). Purification via Kugelrohr distillation (80 °C at 0.6 mm Hg)
gave a colorless oil (27.40 g, 96 % yield), [a]2̂ = - 9.98° (c = 1.35, CHCI3). The NMR 
spectral data o f this material was identical to that o f (/?)-diethyl malate (30R).
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C 0 2Et (CF^SO?)?Q > C 0 2Et
H O ^ ^ " 00261 2-6-lutidine CF3S 0 3̂ v̂ ' C02Et 
30R CH2CI2, -78 °C 2 6 R
(R)-0-(TdfluoromethanesulfonyI)-diethyI malate (26/?). This synthesis has 
been described previously (Berkman 1993) and is presented here with slight modification. 
Trifluoromethanesulfonic anhydride (2.00 mL, 11.9 mmol) was dissolved in 10 mL CH 2 CI2  
under an Ar(g) blanket and chilled to -78 °C. In a separate flask, (/?)-diethyl malate (30/?) 
(2.00 g, 10.6 mmol) and 2,6-lutidine (1.24 mL, 10.6 mmol) were dissolved in 10 mL 
CH2 CI2  at room temperature, and added dropwise to the anhydride solution over 15 
minutes. After the addition was complete, the reaction mixture was brought to 0 °C for 1 
hour and then allowed to warm slowly to room temperature until TLC indicated the 
consumption o f (/?)-diethyl malate. The reaction mixture was concentrated to an oil 
followed by the addition o f ether to precipitate the lutidinium salt. The salt was filtered in 
vacuo and washed three times with 50 mL ether. The filtrate was concentrated to an oil
(3.47 g, 100% crude yield), [a]* = -30.1° (c=  1.71, CHCI3 ). ‘H NMR: 6  1.29 (t, / =  7.2 
Hz, 3 H), 1.34 (t, J  = 7.2 Hz, 3 H), 3.06 (d, J=  5.7 Hz, 2 H), 4.22 (dq, J = 2.1, 7.2 Hz, 2 H), 
4.33 (dq, J=  2.1, 7.2 Hz, 2 H), 5.49 (t, J — 6.0 Hz, I H). 1 3 C N M R 6  13.8, 19.9,36.8,61.8, 
63.2, 78.8, 112.5, 116.2, 120.5, 124.7, 166.0, 167.5.
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C 02Et (CF3S 0 2)20 Q 02Et
HQ^ ^ C 0 2Et 2-6 -lutidine CF3S0 3' ' ' '^ - ' 'C° 2Et 
30S CH2CI2. -78 °C 26S
(5)-0-(Trifluoromethanesulfonyl)-diethyI malate (26S). Prepared as described 
for 26/? starting with (5)-diethyl malate (3051. 2.00 g, 10.6 mmol) [cc]^ = + 32.6° (c = 1.39,
CHClj). Workup provided an oil (3.47 g, 100% crude yield). The NMR spectral data of 
this material was identical to that o f  (/?)-0-(Trifluoromethanesulfonyl)-diethyl malate 
(26/?).
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sli
CH30",P̂ s -Na+
CH30
28
Sodium 0,0-dim ethyI phosphorodithioate (28). This synthesis has been 
described previously (Berkman, 1993) and is presented here with slight modification. 
Methanol (22 ml) was added dropwise to a stirring suspension o f phosphorus pentasulfide 
(30 g. 67 mmol) in benzene (120 mL), at room temperature. The mixture was then heated 
to reflux for 48 h, cooled to room temperature, filtered, and the remaining solvent removed 
in vacuo to afford a greenish oil. The crude product was then used immediately for the 
conversion to sodium O.O-dimethyl phosphorodithioate. O,O-Dimethyl phosphorodithioic 
acid (27) was reacted with an equimolar amount o f sodium carbonate in methanol at 0 °C. 
Following filtration and concentration o f the solvent, crystallization was induced with ethyl 
ether (45 g, 92% yield). ‘H NMR 6  3.43 (d, J =  14.4 Hz, 6  H). I3C NMR 6  52.8 (d, J  = 9 
Hz). 31P NMR 6  117.6.
_ „  N2/benzene
P 4 S 1 0  + M eO H  ^
reflux, 48 h
Na2C 0 3, 0 °C
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s  s
II il
CH30 - P- s -Na-  DMS. MeOH CH30 ^ P- SCh 3 
CH30  reflux, 3 h CH30
28 24
0 ,0,S-Trimethyl phosphorodithioate (24). As described previously (Umetsu 
1977). dimethyl sulfate (25 g. 194 mmol) was added dropwise to a stirring solution of 
sodium-0,0-dimethyl phosphorodithioate (28: 35 g, 194 mmol) in 100 mL o f methanol 
previously chilled to 0 °C. The mixture was then heated to reflux for 3 h and cooled to 
room temperature. The solution was then filtered and concentrated to an oil. Purification 
via Kugelrohr distillation (40 °C at 0.6 mm Hg) gave a colorless oil (30.07 g, 90% yield). 
'H  NMR 5 3.89 (d , J=  14.1 Hz, 6  H), 2.23 ( d , J  = 14.2 Hz. 3 H). :3C NMR 6  52.8 (d, J =  9 
Hz). 5.4 (d, .7=9  Hz). 3IP N M R S  100.4
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s S C 0 2Etii C 0 2Et nCH30 'f'.s-Na* +
CF3S 0 3' ^ ^ C02EtCH3O
28 2 6 5 6 R
(/?)-Malathion (6/?). This synthesis has been described previously (Berkman, 
1993) and is presented here with slight modification. Triflate 265 (3.47 g; 10.6 mmol) was 
dissolved in 20 mL THF and chilled to 0 °C under Ar(a). In a separate flask,sodium 0 ,0 -  
dimethyl-phosphorodithioate 28 (2.86 g, 15.9 mmol) was dissolved in 10 mL THF, chilled 
to 0 °C and added dropwise to the triflate solution over 15 minutes. The reaction mixture 
was allowed to warm slowly to room temperature, stirred for 2  h, and partitioned between 
50 mL ethyl ether and 50 mL water. The ether layer was separated and the aqueous layer 
re-extracted with ether (3 x 50 mL). The organic layers were combined, dried over sodium 
sulfate, and concentrated to an oil. Purification via chromatography using silica
(hexane:EtOAc. 9:1 -  1:1) gave a colorless oil (2.64 g, 80% yield). [a]^  = +19.1° (c =
1.25, CHCI3 ). 'H  NMR 6  1.22 (t, 7 = 7 .2  Hz, 3 H), 1.25 (t, 7 =  7.2 Hz, 3 H), 2.84 (dd, 7  =
5.4, 17.1 Hz, 1 H), 3.00 (dd, 7 = 9 .0 , 17.1 Hz, I H), 3.77 (d d ,7 = 3 .0 , 15.3 Hz, 6  H), 4.03- 
4.22 (m, 5 H). ,3C NM R 6  13.9, 14.0, 37.7, 37.8, 45.0 (d, 7 =  5 Hz), 54.2 (d, 7 =  6  Hz), 
61.1,62.0, 169.9, 170.0. 31P NMR: 6  96.2.
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|  C 02Et n ? ° 2Et
CH30 - /P- s -Na- J C / C 0 2Et  ™ F *- CH30 - P- s - ^ C 0 2Et
c h 3o  CF3S 0 3' ^ v^  2 o °c  c h 3o
28 26R  6 S
(5)-MaIathion (65"). Prepared as described for 6R  starting with triflate 26 (3.47 g;
10.6 mmol). Purification via chromatography using silica (hexane:EtOAc, 9:1 -  1:1) gave
a colorless oil (2.79 g, 84% yield), [a]2̂ = -80.0° (c = 1.25. CHCl3). The NMR spectra o f 
65 were identical to that o f  6R.
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S C 0 2Et O C 0 2Et
CH30 'P - s A ^ C 0 2Et CH30 -> ^ s A ^ C 0 2E.
CH3 O CH 3 O
6 R  13 R
(/?)-Maloxon (13/?). This synthesis has been described previously (Berkman. 
1993) and is presented here with slight modification. (/?)-Malathion (6R) (0.20 g. 0.606 
mmol) was dissolved in 3 mL of CH2 CI2  and added to a stirring suspension of 80% 
monoperoxyphthalic acid, magnesium salt (0.187 g, 0.606 mmol), in 2  mL of CFLCL at 
room temperature. The mixture was heated to reflux for 24 h, cooled to room temperature, 
and partitioned between 20 mL of ethyl ether and 20 mL o f saturated sodium bicarbonate 
solution. The aqueous layer was extracted with 20 mL o f  ether, and the organic layers 
were combined, extracted with brine, dried over sodium sulfate, and concentrated to an oil. 
Purification via flash chromatography using silica gel (ethyl ethenpetroleum ether, 2:1)
gave a colorless oil (0.098 g, 52% yield). Rf -  0.13 (ethyl ethenpetroleum ether, 2:1). [a]
= + 51.5 0  (c = 0.59, CHCI3 ). 1H NMR 6  1.23 (t, J  = 7.0 Hz, 3 H), 1.27 (t, J  = 7.0 Hz, 3 H), 
2.90 (dd, 7 = 5 .1 , 17.1 Hz, I H), 3.06 (dd, J =  8.7, 17.1 Hz, 1 H), 3.81 (dd, 7 = 5 .1 , 12.9 Hz, 
6  H), 4.08-4.24 (m, 5 H). 13C NMR 6  13.9, 14.0, 38.2, 42.4 (d, J =  5 Hz), 54.1, 54.2, 61.1, 
62.1,169.8,170.1. 31P NMR 6  28.3.
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S C 0 2Et O COoEt
P X r n p t  MMPP ^ " ? r n  _C H 30 ^ s / ^ C 0 2E t c  T  C H 30 ^ p - - s - ^ / C 0 2Et
c h 3o  c h 3o
6S  13 S
(5^-Malo\on (13S). Prepared as described for 13/? starting with (5)-malathion 6S  
(0.20 g, 0.606 mmol). Purification via flash chromatography using silica gel (ethyl 
ethenpetroleum ether. 2 :1) gave a colorless oil (0.114 g, 60 % yield). R/= 0.13 (ethyl
ethenpetroleum ether. 2 :1). [a]^  = -49.2° (c = 0.63. CHCb). The NMR spectra o f 135" 
were identical to that o f  13/?.
I *-* ->33
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Strychnine-0,0,S-trimethylphosphorodithioate salt (25a and 25b). This 
procedure has been reported previously (Hilgetag 1969) but is repeated here with slight 
modifications. Strychnine (25.2 g, 75 mmol) was added to a stirring solution o f 0 ,0 ,S- 
trimethyl phosphorodithioate 24 (13.0 g, 75 mmol) in 180 mL o f methanol. The reaction 
mixture was brought to reflux for 24 h. Upon cooling, the first crop o f crystals (/?/+) 
precipitated and were filtered, washed with methanol, and recrystallized twice from
methanol. Data for 25a: mp = 202-203 °C. [a ]* = + 16.2° (c = 0.64, MeOH). ‘H NMR 8
1.38 ( d t , /=  3.1, 10.7 Hz, 1 H), 1.56 ( d ,J =  14.8 Hz, 1 H), 1.97 (d ,.7=2.8 Hz, 1 H), 2.02 
(d, .7=14.1 Hz, 3 H), 2.14 (dt, .7= 7.6, 13.7 Hz, 1 H), 2.44-2.59 (m, 2 H), 2.97 (dd, .7=8.2,
17.8 Hz, 1 H), 3.27 (s, 3 H), 3.30 (s, 1 H), 3.44 (d, J =  14.6 Hz, 3 H), 3.56-3.76 (m, 3 H), 
3.95-4.25 (m, 5 H), 4.35 (dt, J =  3.2, 8.3 Hz, 1 H), 6.28 (s, I H), 7.12 (t, J =  7.6 Hz, 1 H), 
7.25 (t, .7= 7.7 Hz, 1 H), 7.37 (d, 7 =  7.6 Hz, 1 H), 7.78 (d, 7 =  8.1, 1 H). l3 C N M R 5 13.5 
(d ,y = 3  Hz), 24.2, 28.9, 38.8, 40.7, 46.0, 48.83, 52.8, 53.1 (d, J = 3  Hz), 54.4, 58.4, 61.6,
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64.2 (d ,J =  10 Hz), 74.7, 76.4, 115.8, 122.9, 125.4, 129.1, 129.9, 132.7, 135.6, 140.7,
171.3. J,P NMR 8  78.87. The mother liquor was stored at 0 °C and gave a second crop 
that was recrystallized in 95% ethanol. The mother liquor was concentrated in vacuo to a 
solid and recrystallized in 95% ethanol to give a third crop o f crystals. The second and 
third crop were combined and recrystallized once more in 95% ethanol (5/-). Data for 25b:
mp = 253 °C. [a]* = -13.5° (c = 0.63. MeOH). 'H NMR 8  1.36 (d, J  = 10.7 Hz. 1 H),
1.55 (d ,./=  15.7 Hz, I H), 1.91 (d, / =  12.2 Hz, I H).2.01 (d, J =  14.1 Hz, 3 H), 2.12 (d t,7  
= 7.8, 13.7 Hz, 1 H), 2.44-2.57 (m. 2 H), 2.96 (d d ,/=  8.2. 18.1 Hz. 1 H), 3.27 (s. 4 H),
3.44 (d, J=  14.5 Hz, 3 H), 3.53-3.76 (m, 3 H), 3.93-4.25 (m, 5 H). 4.34 (dt, J  = 3.1, 8.3 Hz, 
I H), 6.28 (s, I H), 7.12 ( t .J  = 7.6 Hz, I H), 7.24 ( t,7 =  7.6 Hz. I H), 7.36 (d .7 =  7.6 Hz, 1 
H). 7.76 (d, J=  8.1 Hz, 1 H). 13C N M R S  13.4 (d,J= 3 Hz), 24.2, 28.9. 38.8, 40.7. 46.1,
52.8.53.1 ( d , /= 3  Hz), 54.4, 58.4,61.6,63.9 (d, J= 10 Hz), 74.7, 76.4, 115.8, 123.0, 
125.5, 129.1, 130.0, 132.7, 135.6, 140.7, 171.3. 3IP NMR 8  78.79.
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General procedure for the synthesis of isomalathion stereoisomers (HRpRc, 
RpSc, SpRc, and SpSc) from strychnine-0,S-dimethvl phosphorodithioate salts (25a 
and 25b). To a chilled (0 °C) solution of triflate ( 1.23 g. 3.8 mmol) in 25 mL o f CFLCN. 
the (+ o r-) strychnine-O.S-dimethyl phosphorodithioate salt (1.75 g, 3.45 mmol) is added 
all at once. The solution is brought to room temperature and vigorously mixed for 2 h.
The solution is then diluted two-fold with ethyl ether to precipitate the strychninium triflate 
salt. The mixture is filtered and the filtrate was concentrated in vacuo to an oil.
Purification by gravity chromatography using silica (hexane:EtOAc, 9 :1 - 1:1) gave a 
colorless oil.
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° B  £°2E< CH3CN 5? i ° 2B
CHCH3o"'S +  CF3S 0 3 ' ^ ' C° 2Et 0 -2 5 » C .2 h “
25b 26S 12RPRC
RpRc -Isomalathion (12/?P/?c)* To a chilled (0 °C) solution o f triflate 265" (1.23 g,
3.8 mmol) in 25 mL o f  CH 3 CN, the (—) strychnine-O.S-dimethyl phosphorodithioate salt 
25b (1.75 g, 3.45 mmol) is added all at once. The solution is brought to room temperature 
and vigorously mixed for 2 h. The solution is then diluted two-fold with ethyl ether to 
precipitate the strychninium triflate salt. The mixture is filtered and the filtrate 
concentrated in vacuo to an oil. Purification by gravity chromatography using silica
(hexane:EtOAc, 9 :1 - 1:1) gave a colorless oil (0.86 g, 75 % yield). [a]~J = + 42.0° (c = 
0.57. CHCI3). 1H NMR 6  1.23 (t, .7=7.1 Hz, 3 H), 1.27 (t, J  = 7.1 Hz. 3 H), 2.36 (d. J  =  
16.9 Hz, 3 H), 2.97 (dd, .7 = 5 .2 . 17.2 Hz, I H), 3.08 (dd, .7 = 8 .9 . 17.1 H z, 1 H), 3.84 (d, J  
= 13.6 Hz, 3 H), 4.08-4.25 (m, 5 H). 1 3 C N M R 8  13.4, 14.1, 38.1, 38.2, 43.2 (d ,J =  10 
Hz), 53.9 (d ,y =  3 Hz), 61.1,62.2, 169.9, 170.0. 3IP NM R 6  58.30. C ^ c A T S ?  (m +l) 
requires 331.0439; found 331.0438.
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?©  c o 2e  CH3CN o go2a
C C3̂ 3 + C ^ S c A ^ '  « « S "C .2 h - CH3S ^ s ^ C 0 2E,
25b 26 R  12/?PS C
Rf S c  -Isomalathion (l^/Jp^c)' To a chilled (0 °C) solution o f triflate 26R  (1.34 g, 
4.16 mmol) in 25 mL o f CH 3 CN, the (—) strychnine-O,S-dimethyl phosphorodithioate salt 
25b (1.91 g, 3.77 mmol) is added all at once. The solution is brought to room temperature 
and vigorously mixed for 2 h. The solution is then diluted two-fold with ethyl ether to 
precipitate the strychninium triflate salt. The mixture is filtered and the filtrate 
concentrated in vacuo to an oil. Purification by gravity chromatography using silica
(hexane:EtOAc, 9:1- 1:1) gave a colorless oil (0.94 g, 76 % yield), [a]^ = - 57.5° (c =
0.63, CHCI3 ). 'H NMR 6  1.23 ( t ,7 = 7 .1  Hz, 3 H). 1 .2 7 ( t ,7 = 7 .l  Hz, 3 H), 2.37 (d ,7 =
16.8 Hz. 3 H), 2.94 (d d ,7 = 5 .2 , 17.1 Hz, 1 H).3.08 (d d .7 = 8 .8 . 17.1 Hz, 1 H). 3.85 (d, 7 =
13.7 Hz, 3 H), 4.09-4.26 (m, 5 H). 13C N M R S 13.1, 13.2. 14.1, 38.0, 43.4 (d ,7 =  5 Hz),
54.1 (d .7 =  11 Hz), 61.1. 62.2, 169.9, 171.0. 3,P NMR 6  56.91. C m ^cA P S ? (m+1) 
requires 331.0439; found 3 3 1.0440.
138
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Q 0 2Et CH3CN 9 ° 2 Et
+ CF3S 0 3' ^ - - C02El 0 - 2 5 - 0 . 2 “  C H s O ^ s - ^ - C O a E t
25a 26S 12 SPRC
SpRc -Isomalathion (nSp/fc)- To a chilled (0 °C) solution o f triflate 26S  (1.19 g, 
3.69 mmol) in 25 mL o f CFLCN, the (-) strychnine-0,S-dimethyl phosphorodithioate salt 
25a (1.57 g, 3.10 mmol) is added all at once. The solution is brought to room temperature 
and vigorously mixed for 2 h. The solution is then diluted two-fold with ethyl ether to 
precipitate the strychninium triflate salt. The mixture is filtered and the filtrate 
concentrated in vacuo to an oil. Purification by gravity chromatography using silica
(hexanerEtOAc, 9 :1- 1:1) gave a colorless oil (0.78 g, 76 % yield), [a]'^ = + 58.9° (c =
0.67, CHCI3 ). The NMR spectra o f I2£p/?c were identical to that o f  12/?p5c- CioFLoOsPS 
(m+1) requires 331.0439; found 331.0437.
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C F 3 S 0 3 ^ ^ C02Et
CQ2Et
0-25 °C, 2 h
CH3CN
CH30 " ^ s ^ ^ ' C°2 Et
CH3S
O C 02Etii
c h 3s
25a 12SPSC
SpSc -Isomalathion (125p5c)- To a chilled (0 °C) solution o f  triflate 26R  ( I . i 1 g,
3.44 mmol) in 25 mL of CH3CN. the (—) strychnine-O.S-dimethyl phosphorodithioate salt 
25a (1.58 g, 3.13 mmol) is added all at once. The solution is brought to room temperature 
and vigorously mixed for 2 h. The solution is then diluted two-fold with ethyl ether to 
precipitate the strychninium triflate salt. The mixture is filtered and the filtrate 
concentrated in vacuo to an oil. Purification by gravity chromatography using silica
(hexane:EtOAc, 9 :1 - 1:1) gave a colorless oil (0.61 g, 59 % yield). [a]'J = - 44.2° (c =
0.62, CHCI3 ). The NMR spectra o f  12£p£c were identical to that o f  12/fp/fc- C 1 0 H 2 0 O 6 PS 
(m+1) requires 331.0439: found 331.0441.
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Na2C0 3 , acetone 
reflux, 4 h
p-nitrophenol
33 7
0,0-DimethyI-p-nitrophenoxy phosphorothionate (Parathion Methyl) (7).
This synthesis (Fletcher et ah, 1950) is reported here with some modification, p- 
Nitrophenol (13.86 g, 100 mmol) and sodium carbonate (1 1.62 g, 110 mmol) were added to 
a vigorously stirring solution o f 0 ,0-d im ethyl phosphorochloridothioate (16.00 g, 100 
mmol) in 100 mL o f freshly distilled acetone. The resulting suspension was brought to 
reflux for approximately 3 h until consumption of the starting material was observed by 
TLC. The mixture was then cooled to room temperaOture, filtered through a bed of 
Celite*. and the excess solvent removed by rotary evaporation. The resulting oil was then 
suspended in 100 mL o f ethyl ether, washed twice with saturated sodium carbonate and 
brine, and dried over sodium sulfate. After filtration, the solution was concentrated to an 
oil and the crude product was purified by flash chromatography (ethyl ethenpetroleum
ether, 3:1) to yield a colorless oil (20 g, 76%). Rj = 0.46 (ethyl ethenpetroleum ether. 3:1). 
'H  NMR 6 3.84 (d, 7  = 14.1 Hz, 6 H), 7.29 (d, 7= 8 .3  Hz, 2 H). 8.20 (d ,7 = 8 .3  Hz, 2 H). 
I3C NMR 6 54.5 (d, 7  = 5 Hz), 121.5, 125.9, 145.5 (d, 7 =  6 Hz), 154.1. 3IP NMR 6 66.09.
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N
Acetone./ 
Na2C 0 3 
Reflux, 9 h
H,
no2
S -P "O C H 3
n o 2
Strychnine-isoparathion methyl salt (32a and 32b). This procedure has been 
reported previously (Hilgetag 1969) but is repeated here with slight modifications. (-)- 
Strychnine (2.54 g, 7.07 mmol) was added to a stirring solution of parathion methyl (2.02 
g, 7.7 mmol) in 100 mL o f methanol and the resulting mixture heated to reflux for 9 h. 
Upon cooling, the first crop of crystals (32a, as prisms) precipitated and were filtered, 
washed with methanol, and recrystallized twice from methanol. The mother liquor was 
concentrated to a solid which was then recrystallized twice from acetonitrile (32b, needles).
Data fo r32a: mp = 219 °C. [af* = -22.9° (c = 0.45, MeCN). ‘H N M R :6 1.43-1.51 (m, I
H), 1.57-1.64 (m, 1 H), 2.17-2.33 (m, 2 H), 2.60-2.76 (m, 2 H), 2.96 (dd, J =  8.2, 17.2 Hz,
1 H), 3.34 (s, 1 H), 3.42 (s, 3 H), 3.51 ( d ,J =  13.2 Hz, 3 H), 3.57-3.76 (m, 4 H), 4.36-4.42 
(m, 2 H), 6.36 (s, 1 H), 7.17 (t, J  = 7.6 Hz, 1 H), 7.33 (t, J =  7.6 Hz, 1 H), 7.40 (d, J =  9.3 
Hz, 2 H), 7.72 (d, J =  7.6 Hz, I H), 7.94 (d, J =  8.1 Hz, 1 H), 8.17 (d, J  = 9.3 Hz, 2 H). 13C
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NMR: 8 23.8, 28.7.45.9, 52.2, 52.3, 52.5, 54.2, 58.0, 61.3, 63.1, 63.3. 73.9, 75.7, 115.2,
120.4, 120.5. 123.5, 123.9, 124.9, 129.3. 129.3. 133.0, 135.2, 141.5. 141.6, 159.3. 168.8.
3IP NMR: 8 55.87. D atafor32b: mp = 214-216 °C. [a]:̂  = +23.0° (c = 0.1, MeCN). 'H 
NMR: 8 1.45-1.49 (m, 1 H), 1.50-1.64 (m, 1 H), 2.08 (s, 2 H), 2.19-2.26 (m. 2 H), 2.60- 
2.71 (m. 2 H), 2.96 (dd. J =  8.2, 17.0 Hz. 1 H), 3.36 (s. 3 H). 3.49 (d, J =  13.2 Hz. 3 H). 
3.59-3.70 (m, 2 H). 3.94 (d, J =  13.5 Hz, 1 H). 4.10-4.25 (m. 4  H), 4.34-4.38 (m. 2 H),
6.31-6.39 (m, 1 H). 7.17 (t, J =  7.5 Hz, 1 H), 7.32 (d .y = 7 .9  Hz, 1 H). 7.38 (d ,J =  9.4 Hz, 
2 H), 7.70 (d, J -  7.32 Hz, 1 H), 7.94 (d, J =  8.1 Hz, 1 H), 8.16 (d, J = 9 .3  Hz. 2 H). t3C 
NMR: 8 23.9, 28.7, 46.0, 52.3, 52.4, 52.6, 54.3, 58.1, 61.4. 63.2, 63.4, 73.9, 75.8. 115.3.
120.4, 120.5, 123.5. 124.0, 125.0, 129.4, 129.4, 133.1. 135.3, 141.6, 159.4. 159.5. 168.9. 
3lP NMR: 8 55.86.
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General procedure for the synthesis of the stereoisomers o f 2-[methoxy-(4- 
nitro-phenoxy)-phosphorylsulfanyl]-succinic acid diethyl ester (3L/?p/?o S PRc, 
and SpSc) from strychnine-isoparathion methyl salt (32a and 32b). To a chilled (0 °C) 
solution o f triflate (1.94 g, 6.02 mmol) in THF, (25 mL) the (+ or -) strychnine-isoparathion 
methyl salt (3.00 g, 5.02 mmol) is added all at once. The solution is vigorously mixed for 
24 h at room temperature and then diluted two-fold with ethyl ether to precipitate the 
strychninium triflate salt. The mixture is filtered and the filtrate was concentrated in vacuo 
to an oil, The products were purified by flash chromatography using silica (ethyl 
ethenpetroleum ether, 3:1) to give colorless oils.
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o 2n o2n
c h 3o
31 RpRg
C 02Et THF O C 0 2Et 
-•P^s A ^ C 0 2Et,•—^ \ / c 0 2Et 0-24 °C, 24 l-T
CH3 O
32b 26S
/?p/?c-2-[Metho\y-(4-nitro-pheno\\')-phosphoryIsulfanyll-succinic acid diethyl 
ester (31/fP/?c). To a chilled (0 °C) solution o f  triflate 265 (1.94 g, 6.02 mmol) in 25 mL 
o f THF, the (+) strychnine-isoparathion methyl salt 32b (3.0 g, 5.02 mmol) is added all at 
once. The solution is brought to room temperature and vigorously mixed for 24 h. The 
solution is then diluted two-fold with ethyl ether to precipitate the strychninium triflate salt. 
The mixture is filtered and the filtrate concentrated in vacuo to an oil. Purification by flash 
chromatography using silica (ethyl ethenpetroleum ether, 3:1) gave a colorless oil ( 1.10 g,
48 % yield). [ a £  = + 13.0° (c = 1.10, MeCN). *H NMR 6  1.19 (t, 7 = 7 .2  Hz, 3 H), 1.20 
(t, 7 =  7.2 Hz, 3 H), 2.89 (dd, 7 = 5 .2 , 17.0 Hz, I H), 3.04 (dd, 7 =  8.4 , 17.0 H z, 1 H).3.91 
(d, 7 =  12.8 Hz, 3 H), 4.10 (q, 7 =  7.2 Hz, 2 H), 4.11 (q, 7 =  7.2 Hz, 2 H), 4.17 (dd, 7 =  5.2,
8.4 Hz, 1 H), 7.38-7.42 (m, 2 H), 8.19-8.23 (m, 2 H). ,3C NMR 6  13.9, 14.0, 38.0, 43.1,
55.0 (d ,7 =  6  Hz), 61.3,62.4, 121.2, 121.3, 125.6, 154.5 (d .7 = 7 H z ), 162.2, 169.3, 169.7. 
j lP NMR 6  23.8. C 1 5 H2 1 NO9 PS (m+1) requires 422.0674; found 422.0677.
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o 2n
C 0 2Et
A ^ / C 0 2Et
o 2n
k W  +
° '  i  S CF3 SO 3
c h 3o
THF
' k 0 "4P- s ^ / C°2Et
CH3 O 
31 RpSc
O C 0 2Et
0-24 °C, 24 h
32b 26 R
/?PiSc-2-[lVIethoxy-(4-nitro-phenoxy)-phosphorylsuIfanylj-succinic acid diethyl 
ester (31/fpSc). To a chilled (0 °C) solution o f triflate 26 ?̂ (1.94 g, 6.02 mmol) in 25 mL 
o f  THF, the (+) strychnine-isoparathion methyl salt 32b (3.0 g, 5.02 mmol) is added all at 
once. The solution is brought to room temperature and vigorously mixed for 24 h. The 
solution is then diluted two-fold with ethyl ether to precipitate the strychninium triflate salt. 
The mixture is filtered and the filtrate concentrated in vacuo to an oil. Purification by flash 
chromatography using silica (ethyl ethenpetroleum ether, 3:1) gave a colorless oil (1.00 g,
47 % yield). [cc£ = - 16.3° (c = 0.91, MeCN). ‘H NMR 6  1.20 (t, J=  7.2 Hz, 3 H), 1.22
(t, J =  7.2 Hz, 3 H), 2.89 (dd, J = 3.9, 17.2 Hz, I H), 3.00 (dd, / =  7.5, 17.2 Hz , I H), 3.96 
(d, J =  13.6 Hz, 3 H), 4.10 (q, J =  7.2 Hz, 2 H), 4.11 (q, J=  7.2 Hz, 2 H), 4.17 (dd, J=  3.9,
7.5 Hz, I H), 7.38-7.42 (m, 2 H), 8.21-8.25 (m, 2 H). I3C NMR 6  13.8, 13.9, 37.8, 43.1,
55.1 (d, J  = 9 Hz), 61.2, 62.4, 121.2, 125.6, 154.5 (d, J  = 6 Hz), 162.2, 169.3, 169.7. 3,P 
NMR 6  23.8. C,5 H2 iN0 9PS (m+l) requires 422.0674; found 422.0670.
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o 2n
+ CF3S 03-^ Sv̂ C° 2Et 0-24 °c, 24 hT
C 0 2Et THF
o 2n
O C 02Et 
CH30";P'-S' ^ 0 ' C° 2 Et
32a 26S 31 SpRQ
5 P/fc-2-[Methoxy-(4-nitro-phenoxy)-phosphorylsulfanyl]-succinic acid diethyl 
ester (31Sp/?c). To a chilled (0 °C) solution o f triflate 26S  (0.65 g, 2.00 mmol) in 25 mL 
o f THF. the (-) strychnine-isoparathion methyl salt 32a (1.0 g, 1.68 mmol) is added all at 
once. The solution is brought to room temperature and vigorously mixed for 24 h. The 
solution is then diluted two-fold with ethyl ether to precipitate the strychninium triflate salt. 
The mixture is filtered and the filtrate concentrated in vacuo to an oil. Purification by flash 
chromatography using silica (ethyl ethenpetroleum ether, 3:1) gave a colorless oil (0.20 g,
57 % yield), [a]^ = + 16.0° (c = 0.86, MeCN). The NMR spectra o f 31£P/?c were 
identical to that o f  31/fpSc- CisH^NOgPS (m+l) requires 422.0674; found 422.0680.
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o 2n
O C 0 2Etii -
CH30 " / - S' ^ / C 02Et
32a 26 R 31 SpS^
5'p5’c-2-[Methoxy-(4-nitro-phenoxy)-phosphoryIsulfanyl)-succinic acid diethyl 
ester (3LS'pS,c). To a chilled (0 °C) solution o f triflate 2 6 R  (0.65 g, 2.0 mmol) in 25 mL o f 
THF, the (-) strychnine-isoparathion methyl salt 32a (1.0 g, 1.68 mmol) is added all at 
once. The solution is brought to room temperature and vigorously mixed for 24 h. The 
solution is then diluted two-fold with ethyl ether to precipitate the strychninium triflate salt. 
The mixture is filtered and the filtrate concentrated in vacuo to an oil. Purification by flash 
chromatography using silica (ethyl ethenpetroleum ether, 3:1) gave a colorless oil (0 .17 g,
49 % yield). [cc]:̂  = - 12.9° (c = 1.0, MeCN). The NM R spectra of Sl-SpSc were identical 
to that o f  31/?p/?C- C 1 5 H 2 1 NO 9 PS (m-H) requires 422.0674; found 422.0673.
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7.3-Kinetic Analysis
The potency o f each stereoisomer as inhibitors o f electric eel acetylcholinesterase 
(EEAChE) and recombinant mouse brain acetylcholinesterase (rMAChE) was determined. 
As previously mentioned, there are both a time dependent and a concentration dependent 
method for measuring the bimolecular inhibition constant k\. Since the concentration 
dependent method affords k\ , Ko and kp, this more rigorous method was primarily used. 
However, the time-dependent method o f analysis was also performed in an attempt to 
verify the accuracy of the kinetic perimeters obtained from the concentration dependent 
method. The concentration dependent method is based upon equation 2, while the time 
dependent method is based upon equation 3. Both equations contain the term v, which 
represents the relative velocity and is equal to AJA, where A0 is the activity o f AChE at 
time equals 0 and A, is the activity o f  AChE after t minutes o f inhibition.
In order to measure the activity of the enzyme, a colorimetric assay originally 
developed by Ellman et al. (Ellman 1961) was utilized. In this method, acetylthiocholine 
(ATCh-I) is used as the substrate for AChE instead o f ACh. The determination o f AChE 
activity is dependent upon the enzyme-catalyzed hydrolysis o f ATCh-I and the subsequent 
thiocholine-mediated reaction with 5,5'-dithiobis-[2-nitrobenzoic acid] (DTMB or Ellman’s 
reagent), a chromogen, to yield a yellow chromophore (the anion of 5-thio-2-nitrobenzoic 
acid, see Figure ) whose absorbance is measured spectrophotometrically at 412 nm. The 
rate at which this yellow color is generated is directly proportional to the enzyme’s rate of 
hydrolysis.
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7.3.1-Materials
Chemicals. Other chemicals in the enzyme assays were commercially obtained as 
follows: acetylthiocholine iodide, Aldrich Chemical Company (Milwaukee, WI); 
diisopropylphorofluoridate (DFP), 5.5'-dithio-[2-nitrobenzoic acid] (DTNB), EEAChE 
Type V-S, and 1, 19-trimethylene-67s(4-formylpyridinium bromide) (TMB-4). pyridine-2- 
aldoxime methioaide (2-PAM), Sigma Chemical Company (St. Louis, MO). Soluble 
recombinant mouse AChE expressed in HEK-293 cells and purified by affinity 
chromatography as described previously (Marchot 1996) was a generous gift from Dr. 
Palmer Taylor (University o f California, San Diego, La Jolla, CA). All other chemicals 
were reagent grade or the highest grade commercially available. Aqueous solutions were 
prepared in distilled deionized water.
7.3.2-Enzvme and Tissue Preparation 
Recombinant Mouse AChE. rMAChE is truncate at its carboxy-terminal end by 
the insertion of an early stop codon at position 549. This modification allows the enzyme 
to be expressed into the extra (-)cellular medium as the deleted residues undergo post- 
transitional modifications, including glycosylation, that dictate their association with the 
cell membrane. While these modifications have been demonstrated to have a negligible 
effect on the enzymes activity and specificity relative to the native enzyme, it has been 
shown that this lack of glycosylation decreases the thermal stability o f the expressed AChE 
(Velan 1993). Our experiments with rMAChE verify these observations o f thermal 
instability. It was established that the enzyme was also particularly sensitive to the effects
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o f solvents used to dilute inhibitors demonstrating as much as 10% reduction in activity for 
solutions containing 0.5% (vol/vol) o f isopropyl alcohol, ethanol, or ACN (see Figure 7 .1).
Figure 7.1. Effect o f Solvent on the Activity o f AChE
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tQrtWChEvs ACN40 40
30-
20
10
0.03 0.06 0 .13 0.25 0.5 
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Consequently, prior to use the enzyme was stored at -20 °C. All studies that 
required an incubation period greater than I h (see Reactivation section) were conducted at 
4 °C. The highest final concentration o f solvent resent in all experiments was less than 0.3 
%, and the control reaction in each study contained the same amount o f  solvent as was 
present in the inhibited samples.
Stock solutions o f rMAChE were prepared by diluting 100 pL o f  the purified 
enzyme to a finale volume o f 20 mL with 0 .1 M phosphate buffer at pH 7.6 and were kept 
at 4 °C. Working solutions were prepared as needed by diluting the necessary volume of 
stock solution in pH 7.6 phosphate buffer (0.1 M) to achieve desired activity. Activity of 
the working solution must be attenuated such that the optical density o f  the reaction
151
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
558822^4
mixture does not exceed the detection limit o f the spectroscopic device used to monitor the 
reaction during the time scale o f the study.
Electric Eel AChE. Stock solutions o f EEAChE were prepared by dissolving 5.0 
mg o f  lyophilized enzyme (sigma) in 20 mL of 0 .1 M phosphate buffer at pH 7.6 and were 
kept at 4 °C. Working solutions o f EEAChE were prepared as needed by the method 
outlined for rMAChE above. Gel electrophoresis and Western Blotting experiments 
demonstrated the presence of contaminants in the commercially available preparations o f 
EEAChE (George 2000). Despite these observations, the enzyme has proven to be very 
robust to both solvent effects and temperature extremes and has consistently provided 
reproducible results. These factors combined with the availability of this source have made 
it the enzyme of choice for conducting all preliminary studies. All tissue homogenate 
AChE preparations used were prepared as reported previously (Berkman 1993a: Berkman 
1993b; Jianmongkol 1996; Jianmongkol 1999).
All studies were conducted in 0 .1 M phosphate buffer at pH 7.6 at 24 °C unless 
noted otherwise. These pH and temperature conditions were chosen for all assays and 
determinations o f kinetic constants to facilitate comparisons with previously published 
work with the isomalathion stereoisomers, namely inhibition of AChE from rat and hen 
brain (Berkman 1993a; Berkman 1993b; Jianmongkol 1996; Jianmongkol 1999). It is 
recognized that the average body temperature o f the animals from which the enzyme is 
obtained is considerably different and the pH optima for substrate hydrolysis, inhibition, 
and postinhibitory reactions for a given source o f AChE may vary (Aldridge 1975).
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7.3.3- Methods
Method 1: Time Dependent Determination of k\. Six cuvettes containing 20 pL 
ATCh-I solution (75 mM ATCh-I; phosphate buffer pH 7.6) and 2.50 mL of DTNB 
solution (0.33 mM DTNB. 0.59 mM NaHCCh; phosphate buffer pH 7.6) are placed in a 
Beckman DU-7500 diode-array spectrophotometer and maintained at 24 °C. Two 480 pL 
aliquots o f working enzyme solution are placed in test tubes and maintained at 24 °C. To 
the first test tube, 20 pL o f the solvent used to dilute the inhibitor is added and this mixture 
serves as the control (A 0). At t — 0, 20 pL o f  the inhibitor solution is added to the other 
enzyme aliquot, and vortexed gently. At select time points (t), the residual activity o f  the 
two solutions (A,) is determined by adding 20 pL aliquots o f the solutions to the cuvettes 
and the rate o f ATCh-I hydrolysis is monitored at 412 ran (15 sec intervals) for 4 min 
following the addition o f the enzyme. The bimolecular rate constant o f inhibition, k;, is 
determined as the average of 10 runs by plotting \n(AJAt) versus the incubation time. The 
resulting slopes are determined by linear regression based on the equation [n{AJA,) — [i]k\t 
(Aldridge 1950). A0 represents the activity o f the uninhibited enzyme (t -  0) and A, is the 
depressed enzyme activity at time = t following addition of the inhibitor. The final 
concentrations o f the reactants during enzyme assay were: 0.33 mM DTNB, 0.59 mM 
ATCh-I, and 0.58 mM N aHC03.
Method 2: Concentration Dependent Determination of k„ KD, and Ap. Five test 
tubes containing 480 pL of working AChE solution are each treated with 20 pL o f five 
progressive inhibitor concentrations ranging from [/] to 10[/]. A sixth test tube is treated
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with 20 pL o f the solvent used to dilute the inhibitor serves as control. The inhibition was 
permitted to progress for a specific period o f time, t (3 to 30 min dependent upon the 
concentration and inhibitory potency o f the inhibitor used, the temperature at which the 
experiment is conducted, and the activity o f the enzyme solution used), and the remaining 
enzyme activity (A,) was determined as described above (Method I ) over a period of 4 min 
( 15-s intervals). The bimolecular reaction constant (A;), dissociation constant (ATD), and 
phosphorylation constant (Ap) were determined using the following equation as defined 
previously (Main, 1964):
!/[/] = (At./ Alnv)A'i - I/KD (2)
where:
t = the time o f  inhibition,
Inv = ln(Ao/Ar),
A'i =  k^'Ko.
Method 3: Concentration Dependent Determination of k-„ A'd- and k p. AChE 
activity was determined spectrophotometrically in 0.10 M sodium phosphate buffer pH 7.6 
at 24 °C using the colorimetric method o f Ellman et al. (1961), which was modified for use 
in 96-well plates and a temperature-controlled VERSAmax 340 microplate reader 
(Molecular Devices Corporation, Sunnydale, CA).
Stock solutions o f inhibitors were prepared by dissolving the compounds in an
appropriate amount o f solvent. Working solutions o f the inhibitors were prepared by first
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diluting an aliquot o f  the stock inhibitor solution 10-fold with 0.1 M phosphate buffer at pH
7.6 followed by 6 serial dilutions with more phosphate buffer for a total o f  7 individual 
inhibitor solutions with concentrations ranging from [/] to 64[/]. An eighth solution 
containing 10% (vol/vol) o f  the solvent used to dissolve the inhibitor is prepared with 0.1 
M phosphate buffer at pH 7.6 to serve as a control.
At t = 0, 2 pL aliquots o f each solution are then combined with 98 pL o f enzyme 
stock solution in an array similar to that represented in Figure 7.2 using a 96 (-) well plate 
as the reaction vessel (note that the larger volume should always be added last to insure 
thorough mixing o f the components). The well plate is subjected to intermittent agitation 
in order to maintain the homogeneity of the resulting mixtures while they are incubated for 
a discrete period o f time (3 to 30 min dependent upon the concentration and inhibitory 
potency of the inhibitor used, the temperature at which the experiment is conducted, and 
the activity o f the enzyme solution used). The inhibition progress can be monitored by 
combining 2 pL aliquots from the mixtures with 2 pL o f  a 75 mM ATCh-I solution in 0.1 
M phosphate buffer at pH 7.6 and 196 pL of a standard DTNB solution (0.33 mM DTNB 
and 0.59 mM NaHCOs in 0.1 M phosphate buffer at pH 7.6) positioned in a 96 (-) well 
plate to match the configuration of the first well plate. This 100-fold dilution o f  the 
enzyme-inhibitor mixture effectively stops the inhibition reaction and provides the reagents 
necessary for spectrophotometric monitoring o f the residual enzyme activity at 412 nm as 
per the method o f Ellman et cil.{ 1961) The 12th row of the well plate contains 2 pL o f the 
ATCh-I solution and 198 pL o f  the DTNB solution and serves as a blank during the 
spectaphotometric monitoring.
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Residual enzyme activity is calculated by the SOFTmax PRO (slope o f  absorbance 
at 412 nm vs. time during the first 4 min) by linear regression following subtraction of 
control sample. The values obtained for each column are combined with their 
corresponding inhibitor concentrations using Eqn. 2 and represented graphically. The 
kinetic parameters kt. Kq, and kp are determined as described in Method 2. If the inhibition 
reactions are monitored at least 4 times during the course of the study it is also possible to 
use Eqn. 3, as presented in Method 1, to determine k\ in a time-dependent fashion.
Figure 7.2. Weil Plate Configuration for Method 3.
\
1 2 3 4 5 6 7 8 9 1 0 11 1 2
A Con Con Con Con Con Con Con Con Con Con Con Blank
B Ml M M M M M M M M M M Blank
C 2M 2M 2[i\ 2M 2M 2M 2M 2M 2M 2M 2M Blank
D 4[/l 4[/l 4M 4M 4M 4M 4M 4M 4M 4M 4M Blank
E 8 i/1 8[,1 SM 8M SM 8M 8M 8M 8M m 8M Blank
F 16[/1 16[,1 16[/1 16M 16M 16M 16M 16M 16M 16M 16M Blank
G 32M 32 M 32 M 32 M 32M 32M 32M 32M 32M 32M 32M Blank
H 64[,1 64M 64 H 64[/] 64 M 64 M 64M 64 M 64 M 64M 64 M Blank
Con = Control
[f] = Inhibitor Concentration
The result o f  this configuration is 11 equivalent and independent experiments, each 
consisting of 7 different inhibitor concentrations, which are run in parallel. That the 
individual experiments are run simultaneously nearly eliminates the potential for variability
156
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
in the conditions between them. This combined with the volume o f  data obtained during 
the experiments greatly enhances the statistical validity o f the kinetic parameters obtained 
by this method.
Method 4: Determination o f k}, The Rate Constant of Spontaneous 
Reactivation. Aliquots (200 p.L) o f  working enzyme solutions that contain inhibitor 
concentrations that have caused 90% enzyme inhibition (I go) after a specific period of 
incubation are isolated. The inhibition reaction is stopped by diluting the samples 100-fold 
with 0.1 M phosphate buffer at pH 7.6. Effectiveness o f 100-fold dilution to retard further 
inhibition was checked in two ways: (A) results obtained with 100- and 200-fold dilution 
were comparable, and (B) inhibitory capacity o f  100-fold diluted sample was similar to that 
o f  inhibitor-free buffer. Immediately following dilution (r = 0 ), and at discrete time points 
thereafter (t), I mL aliquots are added to cuvettes containing 1.5 mL o f DTNB solution 
(0.33 mM DTNB and 0.59 mM NaHCCb in 0.1 M phosphate buffer at pH 7.6 and 24 °C) 
and the residual enzyme activity (A0 and A,, respectively) is determined 
spectraphotometrically (using Beckman DU-7500) as detailed in Method I. In parallel, a 
second set o f aliquots from working enzyme solution that has been exposed to the same 
concentration o f solvent as used to dilute the inhibitor in the first sample are diluted with 
0.1 M phosphate buffer at pH 7.6 100-fold and their residual enzyme activity and serves as 
a control for the reaction (A). The rate constant for spontaneous reactivation, ^3 Spon, is 
calculated from the linear portion o f  the graph using the following equation (Clothier 1981; 
Berkman 1993b):
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In(lOO/%inhibition) = fat (7)
where % inhibition = (A - At)/(A - A 0) x 100.
Enzyme activity was assayed periodically to determine the total % reactivation of 
enzyme activity after 60 min. Total % reactivation is calculated using the following 
equation:
% reactivation = 1 0 0  — (% inhibition at 60 min) (8 )
Method 5: Determination of fa (2-PAM or TMB-4), The Rate Constant of 
Oxime-Mediated Reactivation. This procedure is identical to that described for the 
determination of spontaneous reactivation Method 4 except that the buffer solution used to 
dilute the samples also contains an oxime (2-PAM or TMB-4, final concentration, 50 mM). 
The rate constant for oxime-mediated reactivation fa (2-PAM or TMB-4) and the amount 
o f  total % reactivation is calculated using the procedures detailed in Method 4.
Method 6: Simultaneous Determination of fa Spontaneous, fa (2-PAM), and fa
(TMB-4). Inhibited and control AChE samples obtained during the inhibition studies
outlined in Method 3 can be used to determine the postinhibitory kinetic parameters faspoa,
faa-p a m ) ,  and A.'3 (tmb-4 ) simultaneously by the following method. Aliquots (30 pL) from
samples that contained inhibitor concentrations that caused 90% enzyme inhibition ( / 9 0 )
after a specific period o f  incubation are isolated. The inhibition reaction is stopped by
diluting the samples to a final volume of 3 mL (100-fold) with DTNB solution (0.33 mM
DTNB and 0.59 mM NaHCOs in 0.1 M phosphate buffer at pH 7.6 and 24°C) or with
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DTNB solution that also contains the oxime 2-PAM or TMB-4 (final concentration, 0.1 
mM) and the initial residual enzyme activity (A 0) is measured immediately (time, t = 0) by 
removing 198 p.L aliquots o f the resulting mixtures and combining them with 2 fj.L o f a 75 
mM ATCh-I solution followed by spectrophotometric monitoring similar to that outlined in 
Method 3. The residual enzyme activity (A ,) is determined at designated intervals (t) for up 
to t = 60 min. In parallel, the AChE activity in the absence o f inhibitor is determined in 
the same manner to serve as the control. The rate constant o f  spontaneous and oxime- 
mediated reactivation for the inhibited AChE ( £ 3  (spon). £ 3  (2-PAM), and £ 3  (TMB-4)) and 
the total %reactivation are determined according to the equations set forth in Method 4.
Figure 7.3. Well Plate Configuration for A3 Determination (Method 6 ).
1 2 3 4 5 6 7 8 9
A C o n C o n C o n B l a n k B l a n k B l a n k M M M
( s p o n ) (2-PAM) ( T M B - 4 ) ( s p o n ) (2-PAM TMB-4) ( s p o n ) (2-PAM) TMB-4)
B C o n C o n C o n B l a n k B l a n k B l a n k w M W
( s p o n ) (2-PAM) m rB -4) ( s p o n ) (2-PAM) TMB-4) ( s p o n ) (2-p.\.\r) TMB-4)
C C o n C o n C o n B l a n k B l a n k B l a n k ['1 M M
( s p o n ) (2-PAM; ( T M B - 4 ) ( s p o n ) (2-PAM) m re -4 ) ( s p o n ) (2-PAM) m.rB-4)
D C o n C o n C o n B l a n k B l a n k B l a n k H f 'l
1
W
( s p o n ) (2-p.\.\r) TMB-4) ( s p o n ) (2-PAMi ( T M B - 4 ) ( s p o n ) (2-PAM) T.\rB-4)
E C o n C o n C o n B l a n k B l a n k B l a n k M ['1
1
M
( s p o n ) (2-PA.\n { T N f B - 4 ) ( s p o n ) (2-PAM) (TMB-4) ( s p o n ) (2-PAM) (TMB-4)
r~
F C o n C o n C o n B l a n k B l a n k B l a n k M M M
( s p o n ) (2-p.\.\r) T M B - 4 ) ( s p o n ) (2-PAM) TMB-4) ( s p o n ) (2-PAM) TMB-4)
r
G C o n C o n C o n B l a n k B l a n k B l a n k f'l f 'l M
( s p o n ) (2-P.MM T - \ f B - 4 ) ( s p o n ) (2-PAM) ( T M B - t ) ( s p o n ) (2-PA.\r) T M B - 4 )
H C o n C o n C o n B l a n k B l a n k B l a n k M ['1 M
( s p o n ) (2-PAM) c n r e - 4 ) ( s p o n ) (2-PAM) ( T N t B - 4 ) ( s p o n ) (2-PAM) ( T M B - 4 )
Con = Control
Spon = Spontaneous Reactivation samples
2-PAM and TMB-4 = Samples that contain the Respective Oximes 
[/] = Samples that contain inhibitor
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If the samples are configured in a 96 well plate in a fashion similar to that 
represented in Figure 7.3 it is possible to monitor the progression o f spontaneous 
reactivation and two types o f  oxime-mediated reactivation simultaneously for eight 
individual experiments. Further, this configuration is optimized to allow the SOFTmax 
PRO software to subtract both the inhibitory effect o f  the oximes themselves and the rate of 
spontaneous ATCh-I hydrolysis that is caused by the presence o f the oximes affording a 
more accurate determination of the respective kinetic parameters. As with Method 3, the 
fact that the experiments are run simultaneously greatly diminishes the variance between 
individual runs thus enhancing the statistical validity o f  the results obtained.
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